A teaspoon of cayenne pepper in hot water, taken orally, will stop a heart attack immediately. The same dose in extra-warm water stops hemorrhage anywhere in the body (lungs, stomach, uterus, nose) by the count of ten, because the pepper equalises pressure across the vascular system rather than allowing it to remain centralised at the rupture, and clotting accelerates as a result. Dr. John R. Christopher documents both protocols in School of Natural Healing (1976), the 680-page reference volume compressed from thirty-five years of clinical practice, teaching, and study, and describes having been called to heart attack patients in the middle of the night many times. Cayenne, straight from the tin rather than in capsules, was his first-reach herb for acute crisis, and one of ten therapeutic classes of medicinal plants the book teaches the practitioner to work with.

Christopher was left in a Salt Lake City orphans’ home at fourteen months of age and adopted by a Mormon family in the community. His own health was catastrophic for three decades. Rheumatoid arthritis put him on crutches in youth. Heart trouble and high blood pressure followed. At thirty-five, no insurance company would cover him for any amount. Twenty years later, after applying diet and herbs to himself, two doctors examining him for a hundred-thousand-dollar policy found perfect systolic and diastolic readings, and one of them said he had the venous structure of a seventeen-year-old boy. He ran the School of Natural Healing in Provo, Utah, taught a correspondence course of twenty lessons that became the spine of the book, and wrote as an heir to Samuel Thomson, whose lobelia work Christopher defended in detail against two centuries of pharmacopeial libel.

The tradition Christopher wrote from had been legislated out of American medical practice a century and a half before the book appeared. Thomson’s success as a rustic herbal doctor in the late 1700s and early 1800s had exposed what Christopher calls “the deceit and fraud in orthodox inorganic theories and practices,” provoked professional jealousy, and drawn first malpractice charges and then organised legislation making the regulars’ craft the only legal medical practice. Lobelia, Thomson’s most versatile herb, was classified as a poison in the British, Canadian, and United States pharmacopoeias, and remained so when Christopher wrote in 1976. Christopher himself once swallowed four tablespoons of honey-sweetened lobelia tincture in error, retched and vomited profusely, and felt nothing but improvement. The book was written for a readership the profession had spent a hundred years pretending did not exist: readers who wanted to gather their own herbs, prepare their own formulas, and treat themselves and their families outside a system that had criminalised the practice.

Christopher’s framework aligns closely with the terrain tradition without borrowing its French and German theoretical vocabulary. The body is self-healing. Symptoms are intelligent work. Disease is accumulated waste, impaired elimination, and denatured food, and the practitioner’s task is to assist the body’s own eliminative channels rather than to override them. The full summary works through the ten therapeutic classes of medicinal herbs Christopher built his practice on, the specific named formulas the reader assembles in the kitchen (Composition Powder from bayberry, pinus, ginger, cayenne, and cloves; the Antispasmodic Tincture that Christopher reached for in epilepsy, convulsions, and fainting), the three-day Cleansing Program and permanent Regenerative Diet, and the wheatgrass chlorophyll method Christopher takes from Dr. Ann Wigmore. Take a glass bottle of raw milk and a glass bottle of pasteurised milk. Set them both in the sun for a day or two. The raw milk clabbers, sours, and remains a living food. The pasteurised milk will not clabber. It rots. The stench is horrible, and the rotted milk goes from green to black.

Read more

Author’s Note

This essay pushes the origin story of American medical monopoly back sixty-three years, from the Flexner Report of 1910 to the AMA’s founding Code of 1847. The standard critical account, including my own earlier work, treats Flexner as the moment the enclosure was drawn. The 1847 document had already drawn it. Flexner arrived to enforce what the profession’s founding charter had authorized more than six decades earlier, in language a Manchester physician had provided in 1803 for a different purpose entirely.

Whether the drafters believed their own vocabulary is not the essay’s concern. Enclosure acts hold their new boundaries regardless of the sincerity of the drafters. Bell, Hays, and Emerson may have written every word in earnest. The fence they drew still stands either way.

The essay compounds with Extraction: The Middle Class as Colony on the extraction system’s economic architecture, The Guards Who Love You on the professional class that carries the system’s authority into the clinical encounter, and The Gratitude of the Captured on the psychological posture the system maintains in its patients. Readers new to the body of work will find at the end a portable diagnostic they can carry into their next medical encounter.

The present essay was written in response to and building on Michael Bryant's The Cult of Modern Medical Expertise, published in August 2026 at the Health Freedom Defense Fund. Bryant traces the corporate engineering of the modern American physician from the Flexner Report forward and notes in passing that the 1847 AMA Code forbade consultation with practitioners of "exclusive dogmas." The present essay returns to that Code and examines what it authorized.

The founding ethical code of American medicine, adopted in Philadelphia in May 1847, contains the following provision in Chapter II, Article IV, §1:

But no one can be considered as a regular practitioner, or a fit associate in consultation, whose practice is based on an exclusive dogma, to the rejection of the accumulated experience of the profession, and of the aids actually furnished by anatomy, physiology, pathology, and organic chemistry.

The sentence is known in medical history as the consultation clause. Most critical accounts of American medical monopoly locate its enforcement in the twentieth century, in the American Medical Association’s mid-century use of the clause to expel physicians who consulted with homeopaths and osteopaths, and in the Flexner Report of 1910, which shut down the schools that had trained the excluded practitioners. That story is accurate as far as it goes. It also arrives sixty-three years late to the mechanism it describes.

The mechanism was in the founding document. The AMA, formed at the same 1847 Philadelphia convention, wrote its exclusion clause into its first ethical code, using language Thomas Percival had provided in 1803, and put the document into circulation before the year was out. Every twentieth-century enforcement action and every rhetorical device the modern medical establishment uses against dissenting physicians and patients has this document as its ancestor.

The Field Before the Fence

American medicine in 1847 was not the profession the Code claimed to represent. Homeopathy, imported from Germany in the 1820s, had grown by mid-century into a substantial presence in American medical practice, concentrated in the cities the AMA drafters lived in. The American Institute of Homeopathy, formed in New York in 1844, predated the AMA by three years. Eclectic medicine, Thomsonian botanic medicine, hydropathy, and midwifery competed on relatively level ground with allopathy across most states, licensing monopolies for the “regular” profession having been repealed through the 1830s and 1840s under Jacksonian pressure.¹ The field was open. The AMA was founded to close it.

The Code articles are written in the impersonal moral vocabulary of ethics: duty, honor, sacred trust, beneficence. The register in which the drafters spoke about their competitors appears in John Bell’s Introduction to the Code, a four-thousand-word essay preceding the Code proper. Bell chaired the committee and wrote the Introduction in his own voice. The practitioners the Code would exclude were described in the following language:

The choice is not indifferent, in an ethical point of view, besides its important bearing on the fate of the sick themselves, between the directness and sincerity of purpose, the honest zeal, the learning and impartial observations, accumulated from age to age for thousands of years, of the regularly initiated members of the medical profession, and the crooked devices and low arts, for evidently selfish ends, the unsupported promises and reckless trials of interloping empirics, whose very announcements of the means by which they profess to perform their wonders are, for the most part, misleading and false, and, so far, fraudulent.²

Read the passage twice, then read the Code articles that follow with Bell’s Introduction in your ear. Every impersonal provision beginning “A physician should…” translates into the register of ethics what Bell has already said in the register of commerce. What the Code articles authorize is not a professional standard. It is a defense against a specific commercial threat, phrased in the vocabulary a Manchester physician had provided in 1803 for a different purpose.

The Code’s own explanatory Note, written by Isaac Hays on presenting the report to the convention, states that the drafters preserved Percival’s language wherever it “convey the precepts it is wished to inculcate.”³ Percival’s Medical Ethics, published in 1803, was written to resolve a dispute at the Manchester Infirmary. It was an institutional quarrel within a single hospital, among colleagues who worked side by side and needed rules of engagement.⁴ The 1847 committee lifted his hospital-dispute language and applied it, verbatim in places, to an entire national medical field that had never been enclosed. Percival’s rules governed how colleagues should behave with one another in a shared institution. The 1847 version used the same words to exclude a national profession from the field the Code claimed to define. A fence built for a hospital ward became the fence around American medicine.

The Code drew that fence in four specific ways.

I. The Consultation Clause

The Code’s consultation clause defines the “regular practitioner” by what he does not do. He does not adhere to “an exclusive dogma” or reject “the accumulated experience of the profession.” He does not decline the aids of anatomy, physiology, pathology, and organic chemistry. Read positively, the definition is empty. Read as it was written, it is a boundary. Everyone inside the fence may consult with everyone inside. Everyone outside is a non-practitioner in the eyes of the profession, ineligible for consultation as a colleague.

Outside the fence in 1847 were homeopaths, eclectics, botanic practitioners, and hydropathists. Each had claimed at some point that a specific therapeutic principle organized their practice: for homeopathy the law of similars, for the botanic schools the doctrine of vegetable remedies, for the hydropathists water cure, for the eclectics the selective use of proven remedies drawn from multiple traditions. Each had, in the drafters’ vocabulary, “an exclusive dogma.” Osteopathy, founded by Andrew Taylor Still in Missouri in 1874, joined the list once it emerged and became by the twentieth century the second major test of the clause. The mechanism did not care which principle the practitioner held; it cared only that she held one. The word “exclusive” does the work. The reading offered by the profession, that the clause targets only quacks, is not what the clause supports. Any physician working within a defined therapeutic framework was captured. The framework did not have to be wrong. It had to be defined.

Bell stated what the clause was for. Speaking of the ethical superiority of the “regularly initiated members of the medical profession” over “interloping empirics,” he wrote: “Adverse alike to ethical propriety and to medical logic, are the various popular delusions which, like so many epidemics, have, in successive ages, excited the imagination with extravagant expectations of the cure of all diseases and the prolongation of life beyond its customary limits, by means of a single substance.”⁵ The passage is aimed. Homeopathy, at mid-century, was the most conspicuous of the “popular delusions,” and homeopathy is what the language of “a single substance,” meaning the highly diluted remedy, was drafted to name without naming.

Two facts about mid-century American homeopathy explain why the drafters bothered. The first is market share. By the late 1840s homeopathy held roughly ten to fifteen percent of American medical practice, concentrated in the eastern cities where the AMA committee members practiced. The second is patient survival. During the cholera crisis of 1849 and the successive waves of the 1850s, homeopathic hospitals in Cincinnati, New York, and elsewhere published mortality rates dramatically lower than the allopathic hospitals in the same cities. Commonly cited figures ran from three to seven percent for the homeopathic institutions against forty to sixty percent for the allopathic ones.⁶ The precise numbers come from the homeopathic literature and are contested by mainstream historians. The differential itself, and public awareness of it, is not. Whether homeopathic remedies were the reason is beside the point. Abstention from calomel, bleeding, and blistering was probably sufficient explanation. The numbers were public, and the patients had seen them. American medicine in 1847 was in a market crisis. The “regular” profession was losing patients, and the schools training the competitors were growing. The Code was written into that rout.

The transposition matters here more than anywhere. Percival’s rules addressed physicians who worked in the same hospital and disagreed about cases they saw together, meaning collegial deliberation. The 1847 committee applied the same language at a national scale, marking a national class of practitioners as ineligible for the profession’s recognition through the same words Percival had used to govern colleague relations. The vocabulary of insider-regulation had become the vocabulary of national exclusion.

Enforcement was rapid. Within a decade, state and local medical societies began expelling homeopathic members. The Massachusetts Medical Society expelled several Boston homeopaths in the 1870s, and the AMA suspended recognition of state societies that admitted homeopaths.⁷ A physician who consulted with a homeopath had, by the terms of the Code, consulted with someone whose practice was “based on an exclusive dogma.” His license did not need to be revoked by a state board. His profession revoked him.

Flexner’s role in 1910 was to complete what the Code had begun. The Report evaluated 155 medical schools against the Johns Hopkins model of laboratory-based, germ-theory-aligned scientific medicine. It recommended closure of the schools teaching what the Code had already defined as “exclusive dogma”: homeopathy, eclectic medicine, physiomedical practice, and the botanic systems. Rockefeller and Carnegie money flowed to the compliant institutions; the rest closed. The number of American medical schools dropped from 162 to 66 within two decades.⁸ Flexner made sure everyone on the wrong side of the line was out of the profession by 1930.

The clause continues to operate. A state medical board today can revoke a physician’s license for practicing outside “the accepted standard of care,” a phrase that carries the exact function of the 1847 language. During the 2020–2022 period, physicians who prescribed ivermectin or hydroxychloroquine for symptomatic patients labeled with COVID were subject to license suspension in multiple states, and the Federation of State Medical Boards issued a July 2021 statement warning that physicians spreading what the Federation called vaccine misinformation could lose their licenses.⁹ Physicians who criticized mRNA products in public writings faced professional consequences ranging from complaints and board warnings to loss of hospital privileges.¹⁰ The specific therapies were beside the point. A physician who has adopted “an exclusive dogma,” meaning the wrong one, has ceased to be a “regular practitioner.” He may be dismissed by his own profession without recourse to evidence, because the mechanism does not adjudicate evidence. It adjudicates membership.

Whatever the physician did or did not do at the bedside, the ethical instrument invoked against him in 2021 was drafted in 1847.

II. The Obedience Clause

Chapter I, Article II, §6 of the Code addresses the patient’s duties. The provision reads in full:

The obedience of a patient to the prescriptions of his physician should be prompt and implicit. He should never permit his own crude opinions as to their fitness, to influence his attention to them.

The sentence has been quoted so often as an example of nineteenth-century paternalism that the specific weight of the wording has been lost. Each word is chosen. “Prompt” removes the interval in which the patient might consider, “implicit” forecloses the framework in which she might inquire, “crude opinions” degrades her judgment about her own body to a category unworthy of consultation, and “never” removes the exception. The provision does not ask for cooperation or enjoin trust. It authorizes neither dialogue nor reservation. The Code is telling the patient not merely to obey, but to distrust the faculty by which she might not.

Bell’s Introduction supplies the vocabulary the Code article contracts. Speaking of the physician’s authority in the sickroom, Bell wrote that “the more necessary is it that the physician —he who performs the chief part, and in whose judgment and discretion under Providence, life is secured and death turned aside— should be allowed the free use of his faculties, undisturbed by a querulous manner, and desponding, angry, or passionate interjections, under the plea of fear, or grief, or disappointment of cherished hopes, by the sick and their friends.”¹¹ The physician’s authority is placed under Providence. The patient’s emotions are named as “interjections” the physician should not have to hear. The register is sacerdotal. The sickroom is a chapel, the physician its officiant, and the patient’s own experience of her body an unruly congregation the officiant is authorized to silence.

What the patient was being asked to obey, “promptly and implicitly,” in 1847, was heroic medicine. Calomel, the mercurous chloride salt commonly prescribed by the mid-century American allopath, was administered for fevers, dysentery, cholera, syphilis, teething in infants, and a range of other conditions. It was given until the patient salivated, a sign of mercury poisoning that the profession interpreted as therapeutic action. Bleeding by lancet or leech followed as routine treatment for inflammations and fevers, with several pints commonly removed in a single session. Blistering (raising blisters on the skin to draw disease outward) and purging with antimony compounds and croton oil completed the repertoire.¹² Oliver Wendell Holmes, an allopathic physician, told the Massachusetts Medical Society in 1860 that if the whole materia medica, as then used, could be sunk to the bottom of the sea, it would be all the better for mankind and all the worse for the fishes.¹³

The patient who exercised her “crude opinions” about the fitness of these prescriptions had, by mid-century, ample reason to. The homeopathic hospitals demonstrating survival rates several times better than the allopathic ones were not doing so because their remedies worked. They were doing so because their remedies did not poison the patient. The reader who refused calomel had a substantially higher chance of surviving cholera than the reader who accepted it, and by 1849 many American readers knew this. The obedience clause was written to close that door.

Percival’s obedience provisions were drafted for a charity hospital in which patients had no medical alternative. Applying the same language to the American medical field in 1847, when patients did have alternatives and increasingly good reasons to prefer them, was a different operation carried out with the same words.

Flexner does not need to be traced through the obedience clause at length. Eliminating the schools that trained physicians who did not practice heroic medicine removed the therapeutic alternatives to which the patient’s “crude opinions” might have directed her. Once the alternatives were gone, the obedience clause hardened into a description. There was nothing else to obey.

The modern operation of the clause is unmistakable. When a mother declines a vaccine or delays a schedule and is told her decision reflects “vaccine hesitancy,” a term the World Health Organization elevated to a “top ten global health threats” designation in 2019,¹⁴ she is being told that her judgment about her own child’s body is a diagnostic category. The language does not adjudicate the merits of her decision. It adjudicates the fact of her having made one. Her reasons may be well-informed; the products she declines may have documented safety signals; her physician may not have read the inserts she has read. Her decision is the pathology. Her “crude opinion” is the symptom.

When a patient asks a pharmacist about a package insert, the standard response is that the insert is a legal document not intended for patient interpretation, and the patient should discuss any concerns with the prescribing physician. The prescribing physician, in most modern practice settings, does not have time for the discussion. The Code’s provision has become the ambient posture of the entire clinical encounter.

The 2020–2022 period compressed the mechanism into a form that even sympathetic observers found difficult to miss. Patients who reported adverse events after mRNA injections were classified, when they were classified at all, as coincidences, anxiety symptoms, or products of misinformation exposure. The category “medical misinformation,” deployed as grounds for license actions in multiple states, is the obedience clause writ large. The judgment authorized in the sickroom belongs to the “regular practitioner” adhering to “the accumulated experience of the profession.” All other judgment is, in the Code’s original word, crude.

III. The Vocabulary of Dismissal

The Code and its Introduction together contain roughly forty distinct pejorative references to competing practitioners. The vocabulary was drafted as a working tool.

The core lexicon: “empirics,” “quacks,” “impostors,” “pretenders,” “interlopers,” “charlatans,” “empirical imposture,” “empirical confusion,” “nostrums,” “secret compounds,” “delusions,” “popular delusions,” “extravagant expectations,” “misleading and false,” “crooked devices,” “low arts,” “reckless trials,” “unsupported promises,” “credulous.” Each term names a category. Together they constitute a semantic field within which any practitioner outside the profession may be dismissed without any specific claim about her practice needing to be evaluated.

The mechanism is what a philosopher of language would call a category-membership operation. The reader who has been given the vocabulary does not have to think about whether a homeopath’s remedy worked. The homeopath is an empiric, his remedy a nostrum, the patient credulous, her observation a delusion. The vocabulary does the analytical work that evidence would otherwise have to do, and does it so completely that the evidence never has to be looked at. Bell’s Introduction is explicit about this operation:

The credulous, on these occasions, place themselves in the dilemma of bearing testimony either to a miracle or to an imposture: to a miracle, if one particular agent, and it often of known inertness or slight power, can cure all diseases, or even any one disease in all its stages; to an imposture, if the alleged cures are not made, as experience shows that they are not.¹⁵

The passage does not ask whether the cures were made. It defines the epistemic situation such that any answer is captured in advance. If the patient recovered, the recovery was either miraculous, which is impossible, or fraudulent, which was Bell’s meaning by “imposture.” The physician outside the Code’s fence could not, by the terms of the vocabulary the Code had provided, have simply helped his patient. Help was not a permitted description.

This vocabulary is where the enclosure hides, because it functions inside the reader’s own reasoning. Once the vocabulary was in place, no evidence from outside the fence could register as evidence.

The vocabulary described competitors without describing what they did. The label carried the same content regardless of what a particular homeopath prescribed or how his patients fared. The description was portable, applicable to any homeopath by any allopath, without any claim about the specific practice.

Bell went further in the Introduction than the Code articles allowed. Of patents he wrote of “crooked devices and low arts, for evidently selfish ends.” Alternative medicine movements were “delusions” that “excited the imagination with extravagant expectations.” Clergy who endorsed alternative practitioners “ought to keep aloof from vagaries of any description.” Newspapers that advertised alternative practices were “too ready for the sake of lucre to aid and abet the enormities of quackery.”¹⁶

The reader living in 2026 recognizes this vocabulary immediately, because it has been aimed at her or at physicians she trusts in exactly this form. “Interloping empirics” becomes “grifters.” “Popular delusions” becomes “misinformation” or “conspiracy theories.” “Impostor” remains “quack.” “Credulous” becomes “vaccine-hesitant” or “anti-science.” Change a few words and the Bell Introduction could appear in JAMA or The Lancet next week.

The vocabulary’s specific 2020–2022 form can be sketched. A physician who reported adverse events after mRNA products was a spreader of misinformation. Prescribing off-label therapies with published mechanisms of action made a physician a grifter or a quack, and by extension a threat to public health. A patient who declined the products was hesitant, or in the more aggressive phrasing that became widespread by 2021, an anti-vaxxer. In each case the vocabulary determined the assessment in advance of any evidence. The homeopath in 1849 who reported three percent mortality in his cholera ward was, in Bell’s vocabulary, a fraud whose reports were “misleading and false.” The physician in 2021 who reported cardiac events after a specific injection was, in the ambient vocabulary, a spreader of misinformation whose observations were “unsupported.”

The vocabulary is portable in time because it does not describe the practitioners it names. It describes only their location: outside the fence. Any practitioner outside the fence can be captured by it, in any decade, with adjustments only to the specific pejoratives currently in fashion. The device was drafted in 1847. The device is still working.

IV. The Prohibition on Patents

Chapter II, Article I, §4 of the Code addresses the physician’s relationship to patented medicines and secret compounds. The provision reads:

Equally derogatory to professional character is it, for physician to hold a patent for any surgical instrument, or medicine; or to dispense a secret nostrum, whether it be the composition or exclusive property of himself, or of others. For, if such nostrum be of real efficacy, any concealment regarding it is inconsistent with beneficence and professional liberality; and, if mystery alone give it value and importance, such craft implies either disgraceful ignorance, or fraudulent avarice. It is also reprehensible for physicians to give certificates attesting the efficacy of patent or secret medicines, or in any way to promote the use of them.

Read the words the drafters chose. The Code names the offense as “disgraceful ignorance” and “fraudulent avarice.” It did not merely discourage patents and secrecy. It named them as marks of moral disqualification from the profession. Holding a patent on a medicine was fraudulent avarice; dispensing a secret compound was disgraceful ignorance. Certifying the efficacy of a patented medicine in a testimonial was reprehensible on its own terms.

The provision has a logic. The Code was drafted at a moment when the patent-medicine industry, meaning manufacturers and vendors of trademarked, secret-formula proprietary remedies sold directly to the public through newspaper advertising, was one of the largest sectors of the American commercial pharmaceutical trade. Patent medicines were the “nostrums” the Code refers to throughout: brand-name preparations of undisclosed composition, marketed at the credulous. They competed with the physician. A patient who bought Dr. So-and-So’s Vegetable Compound at the drugstore did not need a physician’s prescription. The physician was being routed around.

The Code’s response was to place patents and secrecy under an ethical prohibition. A physician who participated in that trade was, in the profession’s language, no longer a physician. Bell reinforced this in the Introduction:

But by no class are quack medicines and nostrums so largely sold and distributed as by apothecaries, whose position towards physicians, although it may not amount to actual affinity, is such that it ought, at least, to prevent them from entering into an actual, if not formally recognized, alliance with empirics of every grade and degree of pretention.¹⁷

The passage is aimed at the pharmacy trade of the 1840s and its relationship with the patent-medicine manufacturers. The physician’s ethical duty was to distance himself from the trade, and from any physician who participated in it. A physician associated with patents was polluted by the association.

Percival’s 1803 formulation was written for a European medical culture that had not yet developed a modern pharmaceutical industry. The 1847 committee applied his language to a rapidly industrializing American pharmaceutical sector with manufacturing operations, trademark protection, and newspaper advertising infrastructure. A prohibition drafted for a world of individual vendors was applied to the industrial order the profession would eventually join.

That is where the Code’s history reverses itself. The prohibition held, in formal terms, for roughly seventy years. Physicians who patented medicines were sanctioned or shunned. The AMA maintained the prohibition through revisions of the Code in 1903 and 1912. What broke it was not a decision by the profession to reverse its ethical position but the emergence of the modern pharmaceutical industry as the profession’s largest institutional patron, over a period roughly coincident with Flexner and the two decades after him.

The Flexner Report’s laboratory-based, germ-theory-aligned reform of American medical education created the conditions in which the pharmaceutical industry became indispensable. Where the older therapeutic frameworks had relied on remedies the physician gathered, prepared, or diluted himself, the reformed framework called for laboratory-synthesized compounds, and laboratory synthesis meant industrial manufacture with patent protection. The schools that survived Flexner’s cull trained physicians to prescribe those compounds. The profession that emerged was one whose therapeutic activity was, more and more completely, the administration of patented pharmaceutical products.

By the middle of the twentieth century the reversal was complete. The pharmaceutical industry funded medical research, journals, schools, and continuing education. Individual physicians did not need to hold patents; the industry did the patent-holding on their behalf. The 1847 prohibition on “certificates attesting the efficacy of patent or secret medicines” survived nominally in professional conduct codes. From the 1950s forward, the structure of pharmaceutical marketing to physicians consisted of certificates of exactly this kind: opinion leaders publishing favorable trial data at industry expense, department chairs lecturing on manufacturer compounds at manufacturer-funded conferences, guideline-committee members whose recommendations tracked the manufacturer’s product line, continuing-education instructors whose course materials the manufacturer had underwritten. Each was, in the Code’s own 1847 language, doing something reprehensible.¹⁸

The compounds were patented, their compositions substantially secret. The clinical trial data on which the patents were justified were, and are, held in significant portion by the manufacturers and released selectively. Peter Gøtzsche’s Deadly Medicines and Organised Crime documents the industry’s post-1970 record: fraud settlements in the tens of billions of dollars, published trials whose full datasets contradicted their published conclusions, ghostwritten manuscripts placed under academic bylines, and internal marketing documents showing coordinated manipulation of prescribing guidelines.¹⁹ The physician who prescribed the products was not, in the ambient discourse of the twentieth century, engaged in “fraudulent avarice.” He was practicing evidence-based medicine.

The founding ethical prohibition became the founding business model. The Code that had described physician patent-holding as “disgraceful” was, within a century of its adoption, the ethical charter of a profession whose primary economic activity was the administration of patented compounds. The prohibition was not repealed. It was inverted. What the Code named as the mark of disqualification from the profession became the arrangement without which the profession could not have continued to exist.

Coda

The Code drew its fence in 1847 and the fence is still standing. Every subsequent development the reader has been trained to think of as characteristic of modern medical practice is a downstream operation of one of the Code’s founding provisions. The state medical board that revokes a dissenting physician’s license and the pharmacist who declines to discuss the insert are extensions of the founding document, not innovations upon it. So is the professional vocabulary that classifies parental judgment as a diagnosis of hesitancy. The Code is 179 years old and still executing its instructions.

The portable diagnostic the essay hands the reader is this. When she next hears a physician called “irregular,” or a patient described as “noncompliant,” or a treatment dismissed as “unproven,” or a critic labeled a “spreader of misinformation,” she is not hearing modern medical language. She is hearing 1847 language spoken by 2026 institutions. The specific pejoratives have been updated. The mechanism the pejoratives operate has not. The category of “the regular practitioner,” defined by adherence to “the accumulated experience of the profession,” remains the fence. Everyone outside it is what the fence-holders have always called them.

The reader is not looking at the fence from outside. She was born within it, as were her parents. Her physician was trained under its authority, and her insurance recognizes only care it defines as legitimate. The essay has walked her to the fence and named what it is.

How Would I Explain This to a Six-Year-Old?

Imagine there is a big playground with lots of children, and some of them like to play doctor. Different children play doctor in different ways. Some use bandages, some sing songs, some give warm tea, and some just sit with the child who feels sad. All of them are trying to help.

One day a group of children get together and write a rule on a piece of paper. The rule says: Only children who play doctor OUR way are Real Doctors. All the other children are just pretending. You can’t be friends with them. You can’t play together. If they say they helped somebody, they are lying.

They give the paper to all the grown-ups, and the grown-ups agree.

The children who wrote the rule are not always better at helping. Sometimes the children they called pretenders help more people. But the rule does not say anything about who helps more. The rule only says who counts as a Real Doctor.

The rule has another part. It says: When a Real Doctor gives you medicine, you must take it and not ask questions. Your own feelings about the medicine do not count. If you think the medicine is making you sick, that is only your feelings talking.

And the rule has a last part. It says: No Real Doctor is allowed to sell secret medicines, because that would be greedy and dishonest.

That last part got broken a long time ago. Nobody wrote a new rule. The paper still says the old thing, but Real Doctors now sell secret medicines all day. Everyone acts as if the rule was never there.

You were born inside this rule. Your mommy and daddy were born inside it. Your doctor learned inside it. When you visit a doctor today, you are visiting somebody who is still following the rule that was written down when your great-great-great-great-grandparents were babies.

The rule is one hundred and seventy-nine years old. It is still telling everyone who counts as a Real Doctor, and what a Real Doctor is allowed to sell, and how a patient is supposed to sit quietly and take her medicine without asking questions.

The paper is still doing what it was written to do.

References

1. On the state licensing repeals of the 1830s and 1840s, and the pluralist medical field of the pre-AMA period, see William G. Rothstein, American Physicians in the Nineteenth Century: From Sects to Science (Baltimore: Johns Hopkins University Press, 1972), chapters 4–7; and Martin Kaufman, Homeopathy in America: The Rise and Fall of a Medical Heresy (Baltimore: Johns Hopkins University Press, 1971).

2. American Medical Association, Code of Medical Ethics (Philadelphia, 1847), Introduction (Document D), pp. 86–87.

3. American Medical Association, Code of Medical Ethics (1847), Note by Isaac Hays accompanying the report of the Committee, p. 92.

4. Thomas Percival, Medical Ethics; or, a Code of Institutes and Precepts, Adapted to the Professional Conduct of Physicians and Surgeons (Manchester: J. Johnson and R. Bickerstaff, 1803). On the Manchester Infirmary dispute that prompted Percival’s original code, see Chauncey D. Leake, ed., Percival’s Medical Ethics (Baltimore: Williams & Wilkins, 1927), Introduction.

5. American Medical Association, Code of Medical Ethics (1847), Introduction (Document D), p. 87.

6. The homeopathic versus allopathic cholera mortality comparison rests on two principal compilations. Thomas L. Bradford’s The Logic of Figures or Comparative Results of Homoeopathic and Other Treatments (Philadelphia: Boericke & Tafel, 1900) collects contemporary hospital returns from the 1849 and 1854 cholera years, drawing on published reports of the New York Homeopathic Hospital, the Cincinnati Homeopathic Hospital, and comparable institutions in Europe. Harris L. Coulter’s Divided Legacy: The Conflict Between Homoeopathy and the American Medical Association, Volume III (Berkeley: North Atlantic Books, 1973/1982), reviews these figures in chapters 4 and 5 alongside the medical-political context. Both authors write from within the homeopathic tradition, and both should be read with that provenance in view. For the mainstream historical treatment of American cholera and allopathic response, see Charles E. Rosenberg, The Cholera Years: The United States in 1832, 1849, and 1866 (Chicago: University of Chicago Press, 1962), which does not compile the survival comparison but establishes the epidemiological context in which the reported differential mattered. The specific ranges cited in the essay reflect the range across reporting institutions rather than any single facility.

7. On the expulsion of homeopathic physicians from state and local medical societies in the third quarter of the nineteenth century, see Kaufman, Homeopathy in America, chapters 5–6; and Coulter, Divided Legacy, Volume III, chapters 6–7.

8. Abraham Flexner, Medical Education in the United States and Canada: A Report to the Carnegie Foundation for the Advancement of Teaching (New York: Carnegie Foundation, Bulletin No. 4, 1910). For the reduction in medical schools and the funding structure of Flexner reform, see Thomas P. Duffy, “The Flexner Report — 100 Years Later,” Yale Journal of Biology and Medicine 84, no. 3 (2011): 269–276.

9. Federation of State Medical Boards, “FSMB: Physicians Spreading COVID-19 Vaccine Misinformation May Put Medical License at Risk,” statement dated July 29, 2021, fsmb.org.

10. For documentation of state medical board actions against physicians during the 2020–2022 period, see reporting in Medscape, STAT News, and state-level board records. The Federation of State Medical Boards has maintained ongoing summaries of state actions.

11. American Medical Association, Code of Medical Ethics (1847), Introduction (Document D), pp. 84–85.

12. On mid-nineteenth-century American heroic medicine and its therapeutic practices, see John Harley Warner, The Therapeutic Perspective: Medical Practice, Knowledge, and Identity in America, 1820–1885 (Cambridge, MA: Harvard University Press, 1986); and Rothstein, American Physicians, chapters 2–3.

13. Oliver Wendell Holmes, “Currents and Counter-Currents in Medical Science,” annual address before the Massachusetts Medical Society, May 30, 1860. The full quotation reads: “I firmly believe that if the whole materia medica, as now used, could be sunk to the bottom of the sea, it would be all the better for mankind, and all the worse for the fishes.”

14. World Health Organization, “Ten Threats to Global Health in 2019,” who.int.

15. American Medical Association, Code of Medical Ethics (1847), Introduction (Document D), p. 87.

16. American Medical Association, Code of Medical Ethics (1847), Introduction (Document D), pp. 86–88.

17. American Medical Association, Code of Medical Ethics (1847), Introduction (Document D), p. 87.

18. On pharmaceutical industry marketing to physicians, including opinion-leader payments, ghostwriting, and industry funding of guidelines, see Marcia Angell, The Truth About the Drug Companies: How They Deceive Us and What to Do About It (New York: Random House, 2004); and Ben Goldacre, Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients (London: Fourth Estate, 2012).

19. Peter C. Gøtzsche, Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare (London: Radcliffe Publishing, 2013), specifically the chapters on GlaxoSmithKline, Pfizer, Merck, and industry-wide fraud settlement patterns.

Author’s note: The word “adolescence” appears in this essay in two registers. In quotation, attribution, and reference to G. Stanley Hall’s 1904 book and its intellectual descendants, it names the category as its inventors used it. In my own analytical voice, I treat it as what it is: a manufactured framework devised at a specific moment by specific people for specific institutional purposes, not a biological reality that pre-existed being named. Hall’s own words carry most of what follows. His book is publicly available. What he wrote is what he wrote.

The Children Knew

In 1909, a Chicago factory inspector named Helen Todd surveyed 500 working children across twenty factories. She asked them a single question: would they rather return to school, or keep working in the factory. Four hundred and twelve of the five hundred children chose the factory.¹

The children knew something the reformers were not saying. Whatever the factory was doing to them, the school was doing worse.

A book had been published five years earlier that supplied the framework for what the school was doing, though not one the reformers acknowledged and not one the children could name. Its author was Granville Stanley Hall. Its subject was a stage of life he called adolescence.

“Adolescence is a new birth,” Hall wrote in 1904, “for the higher and more completely human traits are now born.”²

Two sentences later, he explained what kind of birth he meant.

“The child comes from and harks back to a remoter past; the adolescent is neo-atavistic, and in him the later acquisitions of the race slowly become prepotent. Development is less gradual and more saltatory, suggestive of some ancient period of storm and stress when old moorings were broken and a higher level attained.”³

The elevated language obscures what Hall was actually asserting. In his framing, the adolescent is a creature retracing an ancient racial past, a walking recapitulation of ancestral primitivism, temporarily inhabiting what Hall calls a “storm and stress” older than civilization. What emerges in adolescence, Hall writes, is “relatively limp and inept, like an insect that has just accomplished its last molt, and is therefore far more in the need of protection, physical care, moral and intellectual guidance.”⁴

The framework is not descriptive. It is prescriptive. If the adolescent recapitulates savagery, then the adolescent requires management: institutional supervision by professionals trained in the science of the stage, held in facilities designed for the purpose.

That science did not exist before Hall wrote it. The two-volume, roughly 1,300-page work he published in 1904 was titled Adolescence: Its Psychology and Its Relations to Physiology, Anthropology, Sociology, Sex, Crime, Religion and Education. It was the first attempt in English to construct adolescence as a distinct developmental category requiring its own field of study. The category the book named barely existed in the form we now use it before Hall named it.

Hall did not discover a stage of life. He invented one.

The Book

Adolescence is not the book its modern reputation suggests. Reading it directly demolishes the assumption that Hall was documenting a biological phenomenon that pre-existed his description of it.

The chapter titles establish what kind of work this is. Chapter IV covers hygiene. Chapter V: “Juvenile Faults, Immoralities, and Crimes.” Chapter VI: “Secret Vice.” A chapter on menstruation and the education of girls. Extended treatment of adolescent insanity, adolescent suicide, and adolescent religious conversion, all handled as psychological phenomena requiring institutional management. This is a catalogue of what Hall considered the pathologies inherent to a dangerous stage of life.

The crime chapter opens with the assertion that “in all civilized lands, criminal statistics show two sad and significant facts: First, that there is a marked increase of crime at the age of twelve to fourteen, not in crimes of one, but of all kinds, and that this increase continues for a number of years... The second fact is that the proportion of juvenile delinquents seems to be everywhere increasing and crime is more and more precocious.”⁵ From this observation Hall builds the theoretical case that adolescence is inherently criminal, inherently unstable, and inherently in need of external control.

The disease material runs on the same logic. “Never has youth been exposed to such dangers of both perversion and arrest as in our own land and day,” Hall writes.⁶ His list of dangers includes urban life, early emancipation, “the mad rush for sudden wealth and the reckless fashions set by its gilded youth,” and anything that lets young people take their turn before adults have finished processing them. He describes what he calls “the submerged fraction of the population not adequate to achieve success in its ever fiercer competitions, who drop limp and exhausted in body and soul to a condition acknowledged by many anthropologists to be essentially inferior to that of most of the lowest savages.”⁷

Every section of the book returns to the same operating claim: adolescence is a dangerous and unstable stage requiring management. And the institution for that management already existed, waiting to expand into the teenage years.

The Man

Hall did not develop this framework in isolation. He built it from within the American academic establishment he had largely built himself.

Leila Zenderland’s biography of Henry Herbert Goddard, Hall’s most consequential graduate student, records the sequence of Hall’s credentials. Hall earned his PhD under William James at Harvard, then went to Germany, where he became “the first American to work in Wilhelm Wundt’s psychological laboratory in Leipzig.” He opened one of America’s first psychological laboratories at Johns Hopkins University. He started the American Journal of Psychology in 1887. He founded the American Psychological Association in 1892. He had been president of Clark University since 1889.⁸ Every institutional lever of American academic psychology in its founding period ran through Hall.

Wundt’s Leipzig laboratory was the source from which experimental psychology spread outward globally. In John Taylor Gatto’s account, sons of powerful families arrived from Japan, Russia, the United States, and elsewhere, took the German credential, and returned home to run universities, government bureaus, and educational systems.⁹ Gatto describes Wundt as “the premier behavioral psychologist on Earth” of that period.¹⁰ The Prussian pedagogical project Hall carried back to America was not a neutral science. Its purpose, in Gatto’s reading, was the production of manageable populations. Hall’s Adolescence was one piece of that project’s American implementation.

Zenderland captures the underlying framework Hall taught his graduate students. Human development, in the “new psychology” Hall promoted, was a fluid evolutionary process best understood by studying its “simpler, less evolved manifestations first.” One of Hall’s followers put the research premise plainly: the “phenomena necessary for such a study can be found in the animal world; others in the history of mankind; still others in the primitive races, or in imbeciles or in other undeveloped groups, all can be found in children.”¹¹

Children, animals, “primitive races,” and the “imbecile” grouped together as objects of comparative developmental study. That is the intellectual world Hall built and taught in.

The framework Hall’s book gave that world provided the intellectual justification for extending compulsory schooling into the teenage years. Before Hall, there was no scientific reason to keep sixteen-year-olds in classrooms. After Hall, there was a diagnosed developmental stage requiring exactly that intervention.

The category and the institution grew together.

Recapitulation

The theoretical spine of Hall’s book is recapitulation theory: the claim, drawn from nineteenth-century Darwinian biology, that individual human development retraces the ancestral history of the species. Hall’s framework treats the infant as a primitive organism, the child as a savage, and the adolescent as a creature reliving an ancient “storm and stress” of racial development.

“The boy of ten or eleven,” Hall writes, “is tolerably well adjusted to the environment of savage life in a warm country where he could readily live independently of his parents, discharging all the functions necessary to his personal life, but lacking only the reproductive function. In his instincts, amusements, and associations, his adjustment to such an environment is quite stable... We shall later also see in how many of his ways he resembles the savage and how each furnishes the key for understanding both the good and bad points in the other’s character.”¹²

Hall means this literally. In his framework, the child recapitulates what he calls a “pigmoid” ancestral stage that Darwinian theory posited for the human phyletic past, a stage when “our prehuman forebears were pigmoid adults, leading short lives and dying at or before the pubic growth increment now occurs.”¹³ The adolescent, on Hall’s account, is undergoing an unstable transition from that primitive state to civilized adulthood. “This last great wave of growth throws the child up on to the shores of manhood or womanhood relatively helpless as from a second birth, rejuvenated, as if every cell in his body had striven to revive for the last time its failing reproductive potency.”¹⁴

The framework does a specific piece of work. If adolescents literally recapitulate ancestral savagery, then any independence granted to them registers as a return to savagery, and any early competence becomes pathology requiring correction. The Franklins and Farraguts and Carnegies of earlier American life, teenagers who ran newspapers and commanded ships and built businesses, become, under recapitulation theory, cases of arrested or accelerated development requiring institutional intervention. The stage requires management because the stage is a savage passage.

The theory works by producing what it claims to describe. Once the adolescent-as-savage frame is installed, everything a young person does gets read through it.

What Hall Was Actually Doing

To read Hall on adolescence without reading Hall on what he thought should be done with defective humans is to miss what the project was.

In the crime chapter of Adolescence, Hall approvingly summarizes the proposals of W. Duncan McKim, whose 1900 book Heredity and Human Progress offered what Hall and his contemporaries called a solution to the crisis of criminality and degeneration. Hall writes:

“His plan is ‘the gentle removal from this life’ of defectives and degenerates, committers of heinous crimes or chronic recidivists for less grave crimes, and all others whose bodily and mental characters and ancestry show them to be hopelessly incorrigible. Idiots, and especially moral imbeciles, most epileptics that are hopelessly degenerate, and perhaps the worst habitual drunkards, should be selected for extinction, though not without a physical and mental examination. The essential question should be, to what degree the candidate is dangerous to society. Great discretion should always be used. Perhaps nocturnal house-breakers, who are more ruthlessly regardless of human rights than almost any others, should be included. Such have forfeited self-ownership and should come under the absolute control of the state, which should administer gentle and painless death.”¹⁵

Hall adds: “Ultimately, his cure would so purify society that the cure itself would be no longer necessary. The world is hardly ready yet for this method.”¹⁶

Hall’s objection to state-administered killing is timing. The world is not yet ready. That is the reservation he registered, in the book that invented adolescence.

The passage does not sit outside the wider intellectual current of its moment. Francis Galton, Darwin’s cousin, was building the international eugenics movement in this period, with Galton Clubs spreading across America.¹⁷ Gatto notes that most of the elite private boarding schools and women’s colleges in the United States were founded in the thirty years after Darwin’s Descent of Man published its ranking of racial hierarchies.¹⁸ Better Families competitions ran at American county fairs after the First World War, arranging daughters like prize livestock for judging.¹⁹ By the 1920s and 1930s, American academic institutions had built the sterilization infrastructure that would sterilize tens of thousands of citizens deemed “biological defectives,” and American academics would receive medals from the Nazi government for their contributions to racial hygiene.²⁰

Hall’s approving citation of McKim is not a stray remark. It is consistent with the framework he was building. If adolescence is a savage passage requiring institutional management, then defective humans who cannot complete the passage require something further. Both propositions issue from the same intellectual apparatus.

The Student

The intellectual apparatus produced people. Hall’s most consequential graduate student was Henry Herbert Goddard, who earned his psychology PhD under Hall at Clark University in 1899.²¹ Goddard would spend the next two decades taking Hall’s developmental framework out of the university and installing it inside American public institutions.

In 1910 Goddard coined the word “moron” as a technical classification for adults with what he called a mental age between eight and twelve years.²² The definition tells you what it depended on. To identify adults as “arrested” at a childhood stage, someone had first to establish what the normal childhood stage looked like. Hall’s Adolescence had provided exactly that developmental scaffolding, along with the wider theoretical framework treating “arrest” as a diagnosable condition. Goddard’s classification system for adult “feeblemindedness” ran on Hall’s staging of childhood.

In 1912 Goddard published The Kallikak Family: A Study in the Heredity of Feeble-Mindedness, which Zenderland describes as “the most popular American eugenics tract” and as “more popular than anything else generated by the American eugenics movement.” The book was reprinted eleven more times in the three decades that followed.²³ The Kallikak study purported to trace hundreds of “feebleminded” descendants from a single Revolutionary-era illegitimate union, offering apparent scientific proof that mental defect was hereditary and that its bearers were producing generations of paupers, criminals, and prostitutes.

Goddard did not stop with publication. In 1913 he began testing arriving immigrants at Ellis Island. In 1914 he became the first psychologist to present intelligence-test evidence in a court of law. In 1918 he helped bring intelligence testing into the United States Army.²⁴ The apparatus he had built moved from a small institution in Vineland, New Jersey to the immigration station, the courthouse, and the military draft board within eight years.

The apparatus produced legal outcomes. In 1927 the Supreme Court decided Buck v. Bell, the case that legalized involuntary sterilization in the United States. The trial record shows that Goddard’s 1911 article “Heredity of Feeble-Mindedness” and a version of the Kallikak case were entered into evidence.²⁵ Justice Oliver Wendell Holmes, writing for the majority, upheld Virginia’s right to sterilize an eighteen-year-old inmate named Carrie Buck: “It is better for all the world, if instead of waiting to execute degenerate offspring for crime, or to let them starve for their imbecility, society can prevent those who are manifestly unfit from continuing their kind... Three generations of imbeciles are enough.”²⁶ Under laws whose scientific justification traced through Goddard’s work, tens of thousands of American citizens were surgically sterilized without their consent in the decades that followed.²⁷

Goddard also applied Hall’s specific adolescence framework directly in court. In 1914 he testified in the murder trial of Jean Gianini, a sixteen-year-old boy from upstate New York accused of killing an adult woman. On the stand, Goddard invoked “the theory of ‘adolescence,’ made popular by his former mentor, G. Stanley Hall,” to explain Gianini’s behavior. The defendant, Goddard testified, was of an age when “the new physiological function of sex is established, great psychic changes have occurred,” and the impulse might express itself in “rough horseplay with girls, such as pushing, pulling... up to physical injury, torture, and even murder.”²⁸

Gianini’s own courtroom affect, Goddard added, told the story. When defense counsel brought in expert witnesses to help the boy, Gianini had been more interested in his dinner. “As between soup and safety,” one expert testified, “Jean prefers soup.”²⁹

Hall’s storm-and-stress framework, deployed as forensic explanation for a killing. The book that invented adolescence had produced a graduate student who could stand in court and explain a murder as a specimen of the developmental stage his teacher had named.

Goddard was not the only student who carried Hall’s framework into American life. But Goddard’s trajectory, mentored by Hall at Clark, coining “moron,” producing the Kallikak study, testing at Ellis Island, providing evidence used in Buck v. Bell, applying Hall’s adolescence theory in a murder trial, is the direct mentorship chain from the book that invented adolescence to the American sterilization laws that followed.

An account of what adolescence “is” that leaves this chain out functions as laundering. It strips the category from the intellectual project that produced it.

The Function

What did the category do once it was installed?

It provided the scientific justification for extending compulsory schooling into the teenage years. Before Hall, there was no diagnostic category requiring the institutional confinement of teenagers. Ariel Durant was happily married at fifteen and co-wrote a multi-volume history of the world.³⁰ David Farragut took command of a captured British ship as a preteen. Ben Franklin apprenticed to a printer at the same age and put himself through a program of self-education “that would choke a Yale senior today,” in Gatto’s phrase. Andrew Carnegie left elementary school at seven and became a partner in business with the president of the Pennsylvania Railroad at twenty.³¹ George Washington, Thomas Jefferson, Abraham Lincoln, Melville, Twain, Edison, Rockefeller: none of them went through the twelve-year sequential schooling that later became compulsory.³²

These were not exceptional biological cases. They were ordinary humans operating in a society that had not yet accepted adolescence as a developmental stage requiring institutional management. Gatto’s reading is direct: “In this dazzling coup, the teenagers who had helped build the new nation were now officially deprived of fully engaged lives such as Edison or Carnegie had once enjoyed.”³³

The economic function was clear at the time and remains clear on the record. The industrial economy of the post-Civil War period could not tolerate the entrepreneurial productivity of the pre-war period. Independent livelihoods produced overproduction. Overproduction destroyed capital accumulation. Capital accumulation required a proletariat: consumers rather than producers, employees rather than owners. The productive teenage years were exactly the years that had to be removed from the productive economy and installed in classrooms.³⁴

Adolescence was the intellectual instrument that made the confinement look developmentally appropriate. Without the category, keeping healthy sixteen-year-olds in classrooms all day looked like what it was: the removal of productive humans from productive life. With the category, it looked like scientifically informed pedagogy addressing the natural pathologies of a dangerous developmental stage.

The word did the work.

The Apparatus

The economic function did not run on hidden intent. The men who built the American school system stated what they were doing openly, in print and in the Congressional record.

Ellwood Cubberley, dean of Stanford University’s School of Education and one of the most influential figures in American educational administration, wrote in his 1922 textbook Public School Administration: “Our schools are... factories in which the raw products (children) are to be shaped and fashioned... And that is the business of the school to build its pupils according to the specifications laid down.”³⁵ Not a critic’s metaphor. The declared operating model, taught by the man in charge of training American school administrators, in the textbook he wrote for them.

Woodrow Wilson, then president of Princeton University, told the New York City School Teachers Association in 1909: “We want one class of persons to have a liberal education, and we want another class of persons, a very much larger class, of necessity, in every society, to forgo the privileges of a liberal education and fit themselves to perform specific difficult manual tasks.”³⁶ Four years before he became President of the United States, Wilson stated the two-tier design at the podium.

The intent had been documented in government records decades earlier. The US Bureau of Education’s April 1872 Circular of Information discussed what it called “the problem of educational schooling,” worrying that knowledgeable workers would “perceive and calculate their grievances,” making them “redoubtable foes” in labor struggles.³⁷ The Senate Committee on Education and Labor filed a report in 1885 noting on page 1382: “We believe that education is one of the principal causes of discontent of late years manifesting itself among the laboring classes.”³⁸

Andrew Carnegie put the industrialist’s view in print. Educational schooling, Carnegie wrote in The Empire of Business, gave working people “bad attitudes,” taught what was useless, and imbued the future workforce with “false ideas” that gave it “a distaste for practical life.”³⁹ The problem, from the industrialist’s perspective, was that education worked. Educated workers organized. Educated workers competed. Educated workers had opinions about the terms of their own labor.

The apparatus for producing something else was assembled through private philanthropy operating on leverage. Two Congressional investigations, one chaired by Frank Walsh in 1915 and one chaired by Carroll Reece in the 1950s, reached the same conclusion: the Rockefeller, Carnegie, and Ford foundations used leverage, not expenditure, to control the American school system, including curriculum, testing systems, and public perception.⁴⁰ The mechanism required no direct operation of schools. It required control of the pension system, the teacher-training colleges, the textbook publishing houses, and the accreditation bodies. Everything downstream followed.

The Carnegie Foundation established teacher pensions and a credit system in the early twentieth century. Schools that adopted what became the Carnegie unit for tracking coursework qualified for the pension money. Every school in the country adopted it. Local parents demanded compliance, because refusing free money looked absurd. An entire nation’s high school curriculum was standardized in one motion, without any federal mandate.⁴¹

Mayor John Hylan of New York City stated the arrangement openly in a 1922 public address. The schools of his city, Hylan said, had been seized by “tentacles” of “an invisible government, just as an octopus would seize prey.” The octopus he named was the Rockefeller Foundation.⁴²

In April 1933, the president of the Rockefeller Foundation, Max Mason, announced publicly that the Foundation was funding a comprehensive national program aimed at “the control of human behavior.” Schools were central to the design.⁴³

The invention of adolescence sits inside this apparatus. Hall’s 1904 book supplied the developmental theory that made teenage confinement look pedagogical rather than economic. The foundations supplied the funding that installed the theory across the American school system. The universities supplied the psychologists and administrators who applied it. The credit system and pension money supplied the standardization that made local resistance impractical.

Gatto’s summary of the transformation captures what happened when these pieces assembled: “With this radical transformation from local democracy to de facto oligarchy, people with minds of their own became an impediment to efficient management. Think of it this way: lives assigned to routine work are best kept childish.”⁴⁴

That is what adolescence does. It legitimizes keeping people childish into their twenties, so that the productive years of the American teenager become the property of the institutions that own the productive years of the American adult. The word is the label attached to the transfer.

The Retrofit

Contemporary defenses of adolescence typically invoke brain development research. The prefrontal cortex, this argument goes, continues to mature into the mid-twenties, therefore adolescence is a real biological stage requiring extended supervision.

The claim mistakes what the data shows. Neural maturation is gradual and continuous across the lifespan, and highly variable across individuals. What the research demonstrates is that the brain changes over time. It does not demonstrate that human beings require a decade or more of classroom confinement while those changes occur. Franklin, Farragut, and Carnegie had brains that were still maturing into their twenties, and they took on adult work during exactly those years. Their neural anatomy did not prevent them from carrying adult responsibilities.

The category of adolescence was installed in American education by 1910. Functional neuroimaging did not exist until the 1990s. The biological justification arrived eighty years after the institutional framework. The retrofit ran in one direction: the neurology was recruited to defend the category, not to establish it.

The mechanism was already running. The brain research came later, and was fitted to what was already in place.

The Extension

A manufactured category, once installed, can grow.

Hall’s original framework applied roughly to the years fourteen through twenty-four. Modern practice has extended it in both directions. Kindergarten pushes formal institutional processing down into what was once early childhood. Graduate school, professional school, and postdoctoral training extend it upward into the late twenties and beyond. Developmental psychology in recent decades has proposed “emerging adulthood” as a new stage covering roughly ages eighteen through twenty-nine, on the argument that the transitions Hall assigned to adolescence have shifted upward. The category, once accepted, admits its own extension without natural limit.

Gatto’s observation from The Ultimate History Lesson: “school’s intention is to artificially extend childhood and there really is no practical terminus for that if they can extend it through graduate school and postgraduate.”⁴⁵

The mechanism is not accidental. Every extension serves the same institutional function the original invention served. It removes productive humans from productive life, and it produces adults who arrive at their thirties having rarely operated outside institutional supervision, having never carried the responsibilities that Franklin, Farragut, and Carnegie carried as teenagers.

Contemporary teenagers and young adults show high rates of depression, anxiety, and suicide. This is often presented as evidence of a natural adolescent developmental crisis. Hall would have agreed. The framework he built predicts exactly this: adolescence is inherently unstable, inherently prone to shipwreck, and inherently in need of ever more intensive institutional intervention.

The simpler reading requires no framework. Caged animals show signs of psychological distress. Adolescents caged for a decade or more in classrooms show the signs. Reading those signs as the pathology of a developmental stage rather than as the response to institutional confinement is Hall’s original move, still operating.

Hall named a claim on your life. He called it a stage. The word has been doing that work ever since.

The Man Speaks

Hall wrote roughly 1,300 pages on adolescence. What he actually thought is available to anyone who opens the book.

On the young people he was theorizing about: “the submerged fraction of the population not adequate to achieve success in its ever fiercer competitions, who drop limp and exhausted in body and soul to a condition acknowledged by many anthropologists to be essentially inferior to that of most of the lowest savages.”⁴⁶

On the state’s role in managing humans deemed defective: “the absolute control of the state, which should administer gentle and painless death.”⁴⁷

On the eugenic project he approvingly summarized: “Ultimately, his cure would so purify society that the cure itself would be no longer necessary. The world is hardly ready yet for this method.”⁴⁸

On the developmental stage he named: the adolescent is “neo-atavistic,” recapitulating ancestral savagery, “relatively limp and inept, like an insect that has just accomplished its last molt,” requiring “protection, physical care, moral and intellectual guidance.”⁴⁹

This is the man who named adolescence. This is the intellectual framework from which the category emerged. This is what he thought he was doing when he wrote the book that installed the concept in American education, American psychology, and American common sense.

The book is publicly available. A two-volume work published in 1904 by D. Appleton and Company of New York, written by a man who earned his PhD under William James at Harvard, worked in Wilhelm Wundt’s laboratory in Leipzig, opened the Johns Hopkins psychology lab, founded the American Psychological Association, presided over Clark University, mentored the graduate student who coined “moron” and whose Kallikak study helped move American sterilization law through the Supreme Court, and approvingly cited the proposal that the state administer death to defective humans in the same chapter where he built the theoretical case for adolescent management through institutional confinement.

The word carries what its inventor put into it. What its inventor put into it is documented, printed, and reprinted, sitting on library shelves in every serious university.

Four hundred and twelve out of five hundred children, working in factories in 1909, said the factory was better than the school. They were not wrong.

How to Explain It to a Six-Year-Old

A long time ago, some very rich men wanted to build big factories all across America. Big factories need two things to make money. They need lots of workers who will do the same job every day and not get bored or angry. And they need lots of people who will buy things, even when they do not really need them.

But young people back then were not like that. Twelve-year-olds ran their own printing shops. One twelve-year-old boy took command of a warship in the middle of a battle. Teenagers built businesses and made their own money. They were too busy being useful to sit in a room for many years.

The rich men needed to change how young people grew up. They needed a way to keep young people in rooms for a long, long time, until the young people were used to being told what to do.

So a man wrote a very long book. In the book he said all teenagers were sick with something called “adolescence.” He said they needed to sit in rooms with teachers all day, for many years. He said if they tried to do grown-up things too early, that was part of the sickness.

The rich men loved this book. They used their money to make sure every school in America taught the idea. Very soon, every child in America was sitting in a room for many years, learning to be quiet and do what they were told.

The plan worked. That is why you go to school for so long. That is why so many grown-ups feel like they never quite grew up. Your body does not need this. Your body knows how to grow. The plan needs it.

The word “adolescence” is what they call the years they take from you. When someone uses the word about you, they are borrowing the plan. It is a story that keeps you in a room, so that other people can keep the years that should have been yours.

References

1. Helen Todd, “Why Children Work,” McClure’s Magazine, April 1913, as quoted in John Taylor Gatto, Weapons of Mass Instruction (Gabriola Island, BC: New Society Publishers, 2008), Ch. 1.

2. G. Stanley Hall, Adolescence: Its Psychology and Its Relations to Physiology, Anthropology, Sociology, Sex, Crime, Religion and Education, Vol. I (New York: D. Appleton and Company, 1904), Preface.

3. Ibid.

4. Hall, Adolescence, Vol. I, Ch. II, “Growth in Height and Weight.”

5. Ibid., Ch. V, “Juvenile Faults, Immoralities, and Crimes.”

6. Ibid., Preface (Vol. I).

7. Ibid., Vol. I, Ch. IV.

8. Leila Zenderland, Measuring Minds: Henry Herbert Goddard and the Origins of American Intelligence Testing (Cambridge: Cambridge University Press, 1998), Ch. 1, “Spirit and Science: Faith, Healing, and Mission,” pp. 28-29.

9. Gatto, The Ultimate History Lesson: A Weekend with John Taylor Gatto, Hour 2 (Tragedy and Hope, 2012), transcript.

10. Ibid.

11. Zenderland, Measuring Minds, Ch. 1, p. 29.

12. Hall, Adolescence, Vol. I, Ch. II, “Growth in Height and Weight.”

13. Ibid.

14. Ibid.

15. Hall, Adolescence, Vol. I, Ch. V, “Juvenile Faults, Immoralities, and Crimes,” summarizing W. Duncan McKim, Heredity and Human Progress (New York, 1900).

16. Ibid.

17. Gatto, The Ultimate History Lesson, Hour 2, transcript.

18. Ibid.

19. Ibid.

20. Gatto, Weapons of Mass Instruction, Ch. 2.

21. Zenderland, Measuring Minds, Introduction, p. 2, and Ch. 1.

22. Ibid., Ch. 3, “’Psychological Work among the Feeble-Minded,’” p. 92.

23. Ibid., Ch. 5, “Causes and Consequences: The Kallikak Family as Eugenic Parable,” p. 144, and Ch. 9.

24. Ibid., Introduction, p. 2.

25. Ibid., Ch. 9, “Leaving Vineland,” p. 324, discussing Buck v. Bell, 274 U.S. 200 (1927).

26. Buck v. Bell, 274 U.S. 200 (1927), as quoted in Zenderland, Measuring Minds, Ch. 9, p. 324.

27. Gatto, Weapons of Mass Instruction, Ch. 2, on the American sterilization campaigns of the early twentieth century.

28. Zenderland, Measuring Minds, Ch. 8, quoting Henry Herbert Goddard’s testimony in the 1914 trial of Jean Gianini.

29. Ibid.

30. John Taylor Gatto, Dumbing Us Down: The Hidden Curriculum of Compulsory Schooling (Gabriola Island, BC: New Society Publishers, 2005).

31. Gatto, Weapons of Mass Instruction, Ch. 3.

32. Gatto, Dumbing Us Down.

33. Gatto, Weapons of Mass Instruction, Ch. 3.

34. Ibid.

35. Ellwood P. Cubberley, Public School Administration (Boston: Houghton Mifflin, 1922), as quoted in Gatto, Weapons of Mass Instruction and Dumbing Us Down.

36. Woodrow Wilson, address to the New York City School Teachers Association, 1909, as quoted in Gatto, Dumbing Us Down.

37. US Bureau of Education, Circular of Information, April 1872, as quoted in Gatto, Weapons of Mass Instruction.

38. US Senate Committee on Education and Labor, Report, 1885, p. 1382, as quoted in Gatto, Weapons of Mass Instruction.

39. Andrew Carnegie, The Empire of Business, as quoted in Gatto, Weapons of Mass Instruction.

40. Gatto, The Ultimate History Lesson, Hour 2, transcript, on the Walsh (1915) and Reece (1950s) Congressional investigations.

41. Ibid.

42. Mayor John Hylan, public address, New York City, 1922, as quoted in Gatto, Weapons of Mass Instruction.

43. Max Mason, Rockefeller Foundation announcement, April 11, 1933, as quoted in Gatto, Weapons of Mass Instruction.

44. Gatto, Weapons of Mass Instruction.

45. Gatto, The Ultimate History Lesson, Hour 1, transcript.

46. Hall, Adolescence, Vol. I, Ch. IV.

47. Ibid., Ch. V, “Juvenile Faults, Immoralities, and Crimes.”

48. Ibid.

49. Ibid., Preface and Ch. II.

The same people repeatedly line up on opposite sides of unrelated political questions, from military spending to drug laws to monetary policy to education, and the pattern happens too often to be coincidence and is too uncontrolled to be a plot. Thomas Sowell’s A Conflict of Visions, published in 1987 and revised in 2006, argues that this alignment comes from something deeper than any of the surface issues. It comes from two competing visions of what human beings are and what human beings are capable of. One vision treats human nature as fixed, narrow, and imperfect, and builds institutions to channel imperfect people toward tolerable outcomes. The other treats human nature as currently limited but capable of vast improvement, and builds institutions to close the gap between what people are and what they could become. Every major political disagreement of the past two centuries, Sowell argues, reduces to a disagreement between these two starting points. The words themselves. Justice, equality, freedom, power. Mean opposite things depending on which vision the speaker holds.

Sowell wrote the book from the Hoover Institution at Stanford University and identified it as his favorite among his own works, part of an informal trilogy with The Vision of the Anointed and The Quest for Cosmic Justice. The other two books in the trilogy try to adjudicate between the visions; A Conflict of Visions does not. Its stated purpose is to reveal the inherent logic behind each set of views and the ramifications of their assumptions, without determining which is more valid. Sowell brings to the task the analytical discipline that runs through his broader body of work in economics and social theory, and the resulting book has been in continuous print for nearly four decades because it does something few political books attempt. It makes the reader’s own vision visible. Not by attacking it, but by tracing where it comes from and what it commits its holder to across otherwise unrelated questions.

The book’s central observation runs against a habit deeply ingrained in modern political discourse: the habit of treating opponents as either stupid or wicked. If a policy is obviously right, then those who oppose it must be either failing to see what is obvious or opposing it for corrupt reasons. This habit is not evenly distributed between the two visions, and Sowell documents the asymmetry. The unconstrained vision, which assumes human capacity for direct social improvement, has consistently treated its opponents as venal, class-biased, or morally deficient. Malthus, writing on his adversaries, would say “I cannot doubt the talents of such men as Godwin and Condorcet. I am unwilling to doubt their candor.” Godwin, writing on Malthus, called him “malignant,” questioned “the humanity of the man,” and hinted that his academic appointment was payment for defending the privileged. The pattern has persisted for two centuries and helps explain why political argument feels increasingly poisonous. People are not merely disagreeing; one side is systematically inclined to treat the other as morally compromised for holding its position at all.

The full summary unpacks the specific machinery by which two starting assumptions about human nature produce opposite conclusions on economics, law, war, justice, and equality. It traces how Adam Smith’s defense of capitalism rested on unintended benefit, a moral category William Godwin’s system literally did not contain. It follows Oliver Wendell Holmes as he deliberately chose the lower standard of justice for human courts, over the fierce objections of an unconstrained tradition that treats such a trade-off as unconscionable. It shows why Hayek called social justice a “mirage” while Rawls made it the first virtue of institutions, and why the two men were not disagreeing about ethics but about what human institutions can achieve. It works through the hybrid cases, Marxism, utilitarianism, fascism, libertarianism, that resist the dichotomy and reveal what happens when the two visions are combined or when one is appropriated for the purposes of the other. Sowell’s line, laid down early and returned to at the end, sets the terms of the whole book. We will do almost anything for our visions, except think about them.

Read more

The remedies below have something in common that mainstream medicine cannot see. They do not attack invaders. They do not suppress symptoms. They work with the body, not against it. Every one of them operates through a mechanism the terrain paradigm recognises, and every one of them has been sitting in plain sight for decades or centuries, largely ignored by the institutions that should know better.

The reason they stay obscure is not that they don’t work. Charcoal has been used to draw poisons out of the body since the ancient Egyptians. Iodine was medicine’s universal remedy in the nineteenth century. Castor oil has a documented clinical record older than most pharmaceuticals. The reason they stay obscure is the streetlight effect: research money follows patents, patents cannot be granted on substances that grow in the ground or precipitate from seawater, and so the studies that would confirm what practitioners have observed for generations never get funded. The absence of studies becomes, in the hands of fact-checkers and physicians, evidence that these substances do not work. In reality it is evidence of what was not investigated.

The ten books below share a second feature. Each is written by a physician, a practitioner, or a serious researcher who noticed something the mainstream had walked past, took the time to document it, and put the case in print. Between them they cover ten substances and practices that a reader can begin using this week, without a prescription, without a specialist, and without waiting for institutional permission.

They sort naturally into three groups based on what they actually do in the body:

• What draws out — substances and practices that bind toxins, mobilise stored poisons, and route them out through the body’s elimination channels.

• What restores — substances that replenish minerals, electrons, and elements the modern terrain is stripped of.

• What supports — practices and whole-food remedies that give the body’s own cleansing and repair systems the conditions they need to function.

The full summary and the audio deep dive for each of these ten sit behind the paywall, alongside the wider archive of book summaries the paid subscription unlocks. What follows is the introduction to each: the substance, the mechanism, and why the book belongs in a terrain reader’s library.

Subscribe now

Give a gift subscription

What Draws Out

What Restores

What Supports

What To Do With This List

Ten substances and practices is more than any reader will investigate at once. The most useful way to approach the list is to pick one from each group and start there.

Pick one drawing agent — the substance or practice you would keep in your medicine cabinet for when the body needs to clear something out. Charcoal and bentonite are the most versatile starting points. Castor oil packs are the most powerful for chronic congestion. Oil pulling is the simplest daily practice.

Pick one restorative — the element or compound your terrain is most likely to be depleted of. For most readers this is iodine or sulphur. For readers dealing with chronic toxic load or damaged tissue, it is vitamin C at meaningful doses.

Pick one supportive practice or food — the daily habit that maintains the terrain rather than intervening in a crisis. Kneipp’s hydrotherapy costs nothing and can begin tomorrow morning. Chaga becomes a daily infusion.

Then read the summaries.

Each of the ten runs to thousands of words. Each has an audio deep dive on the same page. Between them they distil the clinical experience of ten physicians and practitioners — thousands of pages of dense material — into a form a reader can actually use. What would take a serious student months to read through in the original texts, a paid subscriber can move through in an afternoon.

And the ten are the beginning of it. A single paid subscription unlocks the wider archive of over 250 book summaries covering germ theory and terrain, vaccines, cancer, birth control, fasting, hidden history, central banking, consciousness, and the paradigm that ties them together. It unlocks the audio deep dive on every essay and every interview — a listening library that grows alongside the reading one. It unlocks new books as they publish. One subscription. A whole library.

For a reader who wants to understand what mainstream medicine has been busy forgetting, there is no faster way in.

Subscribe now

Give a gift subscription

The Pink Book is the CDC’s core reference document for the diseases on the childhood immunization schedule. Every chapter contains an epidemiology section. Those sections, read as their authors wrote them, do not say what the vaccine narrative depends on them saying. This essay pulls the numbers directly from the Pink Book and places them alongside the historical mortality record for diseases where no vaccine was ever developed. Two independent source streams. One pattern. Establishment vocabulary such as “cases,” “incidence,” and “vaccine-induced immunity” appears inside quotation, official body names, or direct reference to the CDC’s own text. Where the essay speaks in its own voice, the terrain paradigm operates: mortality collapsed because living conditions changed, and the injections arrived to take credit for a decline the terrain had already produced.

The Sentence

The CDC’s Epidemiology and Prevention of Vaccine-Preventable Diseases is the reference document for the childhood immunization schedule. It is known as the Pink Book. On page 102 of Chapter 7, under the heading “Secular Trends in the United States,” the following sentences appear:

“During the 1920s, 100,000 to 200,000 cases of diphtheria (140 to 150 cases per 100,000 population) and 13,000 to 15,000 deaths were reported each year. After diphtheria toxoid-containing vaccines became available in the 1940s, the number of cases gradually declined to about 19,000 in 1945 (15 cases per 100,000 population). A more rapid decrease began with implementation of a universal childhood vaccination program which included diphtheria toxoid-containing vaccines beginning in the late 1940s.”¹

Read the middle sentence twice. Cases dropped from between 100,000 and 200,000 down to 19,000 before the universal childhood vaccination program began. The Pink Book places the beginning of that program in the late 1940s. The decline it describes had already cut cases by between 80 and 90 percent, depending on which end of the 1920s range is used as the baseline, before the program the document exists to promote was implemented.

The document does not phrase it this way. The document says vaccines “became available” in the 1940s and cases “gradually declined.” The word “available” is doing quiet work. A product being available on a shelf is not the same as a product being administered at population scale. The Pink Book knows the difference and marks it, in its own sentence, by placing “a more rapid decrease” after the universal program is described as beginning. The decline before the program is not attributed to the program because the document itself will not sustain that attribution.

This is the essay. What follows extends the reading across the schedule.

The Diphtheria Curve in Longer Focus

The Pink Book’s numbers cover the 1920s forward. Suzanne Humphries and Roman Bystrianyk, working from US Public Health Service mortality tables, extend the picture backward and forward. In the United States, deaths from diphtheria declined by 98 percent between 1900 and the mid-1940s, before the DTP vaccine came into use.² The graph they publish for New York City shows the diphtheria mortality rate for children up to ten years of age already collapsing between 1894 and 1900, falling from 785 per 100,000 to under 300, and reaching below 100 by 1920, the year mass toxoid vaccination of school children began.³

There is a further wrinkle in the historical record that complicates the standard story. Diphtheria antitoxin, the horse-serum product introduced in 1895 and celebrated as a great medical advance, preceded a large spike in diphtheria mortality in Leicester, England. The rise in deaths ran roughly ten to fifteen times higher than in the previous fifty-seven years and continued for another five years.⁴ In the United States, the downward trend in diphtheria mortality was interrupted after the toxoid vaccine was introduced in 1920. Mortality spiked briefly, then resumed its decline.⁵ In the version of the story taught to medical students, the toxoid ended diphtheria. In the actual sequence of events, the toxoid arrived at the tail end of a long descent, was followed by a spike in deaths, and was then credited with the recovery from the setback it had caused.

The Pink Book does not include this. It reports the CDC’s own preferred window, which begins in the 1920s and shows only the descent. Even within that window, the descent from 100,000 to 200,000 cases down to 19,000 is admitted to have taken place before universal vaccination. Extending the window backward strengthens the point. The direction of the curve was set before the products arrived.

The Experiment the CDC Never Had to Run

The obvious rebuttal is that the diphtheria toxoid, once it became widely used, drove the final descent. Even if the pre-vaccine decline was real, the vaccine did the last mile.

The natural experiment that would decide the question is a disease with the same historical trajectory as diphtheria but no vaccine at any point. Two such diseases exist. The CDC never had to run the experiment. History ran it.

Scarlet fever was, in the 1800s, a larger killer of children than smallpox, whooping cough, measles, or diphtheria.⁶ It was blamed for one in every twenty-three deaths in London during the fifteen years from 1847 to 1861.⁷ In Providence, Rhode Island, the scarlet fever death rate for children aged two to four fell from 691 per 100,000 in 1865 to 28.3 per 100,000 in 1924, a decline of about 96 percent.⁸ England and Wales mortality data show the same descent from the mid-1800s into the mid-1900s, near total elimination by the time antibiotics came into use in the 1940s.⁹ No scarlet fever vaccine was ever developed for population use. A toxin-based vaccine existed briefly in the 1920s and was abandoned because of severe adverse reactions.¹⁰

The bacterium is still present. It colonizes 15 to 20 percent of school children today.¹¹ Nothing eradicated it. What used to kill children now barely produces symptoms, by a mechanism that had nothing to do with a vaccine, because no vaccine was ever developed.

Typhoid tells the same story with different numbers. In the late 1800s and early 1900s, typhoid killed 40,000 to 50,000 Americans a year.¹² The Pink Book has no chapter on typhoid, because typhoid is not on the childhood immunization schedule. A typhoid vaccine exists for travelers to endemic regions. It is not a childhood vaccine and never has been. From 1900 to 1943, US deaths from typhoid and paratyphoid fever combined declined by 98 percent, from 31.3 per 100,000 to 0.5 per 100,000.¹³ The historical record attributes this to chlorination of drinking water, sewage systems, milk pasteurization, and the end of the era in which cows drank from filthy water and the milkman diluted the product with more of it.¹⁴

The 98 percent decline in typhoid mortality between 1900 and 1943 is the same magnitude and the same time frame as the 98 percent decline in diphtheria mortality across the same period. One had a vaccine coming into use at the end of that window. One had no vaccine at all. The curves are identical. The variable that mattered was not the presence or absence of a vaccine. It was elsewhere.

Note what this closes. The critic cannot say that vaccination accelerated a decline that would otherwise have stalled, because scarlet fever and typhoid show the decline running to near completion without any vaccination program at all. The critic cannot say that the pre-vaccine decline plateaus and only the vaccine finishes the job, because the plateau does not appear in the no-vaccine cases. What the data show is uninterrupted descent, arriving at near zero in the same window across which diphtheria descends by the same magnitude and along the same slope. The pattern is not vaccine-dependent. Something else drove it, and the rest of this essay asks what.

Measles Followed the Same Curve

Chapter 13 of the Pink Book, page 196, describes measles in the pre-vaccine era:

“Before 1963, approximately 500,000 cases and 500 measles deaths were reported annually, with epidemic cycles every 2 to 3 years. However, the actual number of cases was estimated at 3 to 4 million annually. More than 50% of persons had measles by age 6 years, and more than 90% by age 15 years.”¹⁵

Do the arithmetic. Five hundred deaths on 500,000 reported cases is a case fatality rate of 0.1 percent. One in a thousand. This is the CDC’s own figure for the year the vaccine was licensed. By 1963, a child who developed measles was, on the CDC’s own numbers, 99.9 percent likely to survive it.

Compare that to the historical record. In Glasgow in 1908, 14.2 percent of children under five developed measles and 5.8 percent of them died, a case fatality rate of 5.8 percent.¹⁶ In a Paris orphanage between 1867 and 1872, 612 of 1256 children who developed measles died, a case fatality rate of 49 percent.¹⁷ By 1960, in England and Wales, case fatality from measles had fallen to 0.030 percent, one two-hundredth of the 1908 Glasgow rate.¹⁸ The Pink Book’s 0.1 percent figure for the United States in the same era sits in the same order of magnitude.

The measles vaccine was licensed in 1963. The 99 percent-plus reduction in measles case fatality had already occurred. Humphries and Bystrianyk, using US mortality data from 1900 onward, document that population mortality from measles declined by more than 98 percent before the vaccine was introduced.¹⁹ The vaccine did not save the children who had already stopped dying.

The Pink Book credits the vaccine with a further decline in reported cases after 1963. Reported cases and mortality are different measurements. The number of cases counted by health authorities can fall for many reasons, including changes in diagnostic criteria, changes in reporting requirements, and changes in what a health worker considers worth reporting. Mortality is harder to move. When 999 out of every 1000 children who become ill from a condition survive it, that condition is no longer a mortality threat. The vaccine arrived in that world. It did not create that world.

Pertussis: The Vaccine the CDC Admits Does Not Work

Chapter 16 of the Pink Book, pages 244-245, opens the pertussis epidemiology section:

“Before the availability of vaccine, pertussis was a common cause of morbidity and mortality among children. During the 6-year period from 1940 through 1945, more than 1 million cases of pertussis were reported, an average of 175,000 cases per year (approximately 150 cases per 100,000 population). Following introduction of whole-cell pertussis vaccine in the 1940s, pertussis incidence gradually declined.”²⁰

The Pink Book gives case numbers but withholds pre-vaccine mortality data in this section. Humphries and Bystrianyk provide it: whooping cough mortality in the United States had declined by more than 90 percent before the DTP vaccine came into use in the mid-1940s.²¹ The pattern established for diphtheria and measles repeats.

The pertussis chapter then does something the other chapters do not do. It documents the failure of the vaccine after decades of use. Continuing on page 245:

“Reported pertussis incidence has been gradually increasing in the United States since the late 1980s and early 1990s, and large epidemic peaks in disease have been observed since the mid-2000s. A total of 48,277 pertussis cases were reported in 2012, the largest number reported since the mid-1950s.”²²

Read those numbers. In 2012, pertussis case counts reached their highest level since 1955. The same chapter reports that among children born in 2016-2017, vaccination coverage stood at 93.3 percent for at least three doses of DTaP by age 24 months.²³ Peak case counts under 93 percent vaccination coverage now match the peaks from the era before mass vaccination began.

The Pink Book explains this on the same page:

“waning of vaccine-induced immunity is thought to play a key role in countries, including the United States, that have transitioned to acellular vaccines in the 1990s.”²⁴

And on the next page:

“an increasing burden of reported cases in the United States is now occurring among fully vaccinated children and adolescents.”²⁵

The CDC is not describing an edge case. It is describing how the pertussis vaccine operates in the general population, over the ordinary course of a childhood, under conditions of high coverage. The vaccine wears off. Vaccinated children get pertussis. The peak case count under 93 percent coverage now matches the peak from the era before the vaccine existed. All three facts are on page 244 and 245 of the Pink Book, in the CDC’s own text.

The document that exists to promote the vaccine says the vaccine does not do what it is credited with doing.

Polio: A Statistical Artifact and a Vaccine

Polio is the case the reader may think defeats the pattern. It does not, but it requires a longer accounting than this essay can provide. What follows is enough to close the immediate objection. A fuller treatment, and Forrest Maready’s The Moth in the Iron Lung is that treatment, belongs in its own essay.

Chapter 18 of the Pink Book, page 278, states:

“From the more than 21,000 paralytic cases reported in 1952, only 2,525 cases were reported in 1960 and 61 cases in 1965.”²⁶

This looks, on its face, like vaccine success. The inactivated polio vaccine was introduced in 1955. Cases fell dramatically thereafter. The chapter presents this as the story.

Two facts complicate the reading. The first appears earlier on the same page:

“In the immediate prevaccine era, during the first half of the 20th century, improved sanitation resulted in less frequent exposure and increased the age of primary infection, resulting in large epidemics with high numbers of deaths.”²⁷

The Pink Book is here using a terrain argument. The rise in polio cases in the early twentieth century, on the CDC’s own account, was driven by environmental change, specifically the effects of improved sanitation on the age at which children encountered the organism. The document invokes terrain to explain the rise. It then abandons terrain to explain the fall.

The second fact concerns diagnostic definition. In 1954, the year before the Salk vaccine was introduced, the diagnostic criteria for paralytic poliomyelitis were changed. Before 1954, a case counted as paralytic polio if symptoms of paralysis were present at two examinations 24 hours apart. From 1954 forward, residual paralysis had to be documented 10 to 20 days after onset and again 50 to 70 days after onset.²⁸ Cases were also reassigned to newly distinguished diagnostic categories, including what the establishment classifies as Coxsackie virus infection and aseptic meningitis.

The consequence of this change was stated in 1960 by a biostatistician working within the mainstream of American public health. Bernard Greenberg was chairman of the biostatistics department at the University of North Carolina School of Public Health. He was not a critic of vaccination. He was not writing outside the establishment literature. He was addressing a conference on the polio data, five years after the Salk vaccine’s introduction. He said the following:

“This change in definition meant that in 1955 we started reporting a new disease, namely, paralytic poliomyelitis with a longer lasting paralysis. Furthermore, diagnostic procedures have continued to be refined. Coxsackie virus infections and asceptic meningitis have been distinguished from paralytic poliomyelitis. Prior to 1954 large numbers of these cases undoubtedly were mislabeled as paralytic poliomyelitis. Thus, simply by changes in diagnostic criteria, the number of paralytic cases was predetermined to decrease in 1955-1957, whether or not any vaccine was used.”²⁹

The claim on the page is that the number of paralytic polio cases was going to fall in 1955 through 1957 regardless of whether any vaccine was used. The claim was made in 1960 by a chairman of biostatistics at a major public health school. It was published in the conference proceedings. It was never retracted.

It appears nowhere in the Pink Book.

Cases counted under one definition were bound to fall when the definition was tightened. The Pink Book’s own numbers, 21,000 in 1952 down to 2,525 in 1960, are the record of a definitional change and a vaccine introduction happening in the same window. The document presents them as a single cause. The historical record, as documented in Maready and traceable to the 1960 conference proceedings, shows two causes running in parallel and one being credited with the work of both.

The longer account of polio, which includes the correlation between reported polio case peaks and pesticide use (lead arsenate through the 1930s, DDT after 1945), the Cutter incident, and SV40 contamination, is a separate essay.

What Actually Changed, and How the Credit Was Assigned

The Pink Book’s polio chapter says it. Improved sanitation changed the terrain. So did water chlorination, sewage systems, milk pasteurization, refrigeration, less overcrowded housing, better nutrition, the end of tenement life on the scale of the late 1800s. Humphries and Bystrianyk trace the mortality declines for diphtheria, scarlet fever, whooping cough, measles, typhoid, and tuberculosis and place them all within the same window and against the same underlying causes.³⁰ Thomas McKeown, working from British mortality data, arrived at the same conclusion decades earlier from within mainstream epidemiology.³¹ On the question of what drove the mortality decline, the evidence points in one direction from every angle it has been examined from.

The vaccines were licensed at the end of that decline. Diphtheria toxoid was available in the 1920s, universal program in the late 1940s. Whole-cell pertussis in the 1940s. Measles in 1963. Each product arrived at a point when the disease it was designed to prevent had already been reduced to a fraction of its historical mortality.

The reassignment of credit followed the ordinary path of institutional teaching. Public health authorities credited the vaccines, medical schools taught the credited version, textbooks reproduced it, pediatricians received it in their training and passed it on. Within a generation, the credited version was institutional common knowledge.

The presentation of the data adjusted accordingly. The Pink Book’s diphtheria chapter begins its narrative in the 1920s. If the chapter began in 1900, the 98 percent pre-vaccine mortality decline would be visible on the page. It does not begin in 1900.

The schedule then became a bureaucratic fact. Vaccines already licensed and on the schedule are difficult to remove. Once the schedule exists, questioning any element becomes questioning the schedule itself, which becomes questioning public health, which becomes disqualifying.

The reassignment of credit did not require a conspiracy. It was the natural output of a system in which each participant had every reason to accept the story as given and no reason to check the source documents. The source documents remain, mostly untouched, in the Pink Book, in the vital statistics of every industrialized country, in the mortality tables Humphries reproduced from US Public Health Service records, in the diagnostic redefinitions Maready documented, in the historical scholarship of McKeown. Nobody has to read any of them for the credited version to continue operating.

The decline curves belong to conditions that changed. The credit was assigned to products that arrived after the change.

How to Explain It to a Six-Year-Old

There is a fire in a house. The neighbors run over with buckets of water and put most of it out. What is left is smoke and a few embers.

Then the fire truck arrives. The firemen point their hoses at the smoke, spray water on the embers, and the smoke goes away.

The fire chief writes a report. In the report, the fire truck saves the house. The neighbors are not mentioned. The buckets are not mentioned. When the mayor gives out medals, the medals go to the firemen.

The next week, another fire. The neighbors are told to put down their buckets and wait for the fire truck. That is what saved the house last time, they are told.

The house burns.

Appendix A: Mortality and Case Data by Disease

Diphtheria

• Source: Pink Book Ch. 7, p. 102

• Peak reported burden: 1920s: 100,000-200,000 cases and 13,000-15,000 deaths annually

• Pre-vaccine decline: Cases down to 19,000 by 1945 (80-90% decline); mortality down 98% between 1900 and mid-1940s (Humphries)

• Vaccine introduced: Toxoid available in 1940s; universal childhood program late 1940s

• Notes: The Pink Book itself locates the major decline before universal vaccination

Scarlet Fever

• Source: Historical vital statistics; Humphries Ch. 11

• Peak reported burden: Mid-1800s (1 in 23 London deaths, 1847-1861)

• Pre-vaccine decline: ~96% decline in Providence, RI, 1865-1924; near total in England and Wales by mid-1900s

• Vaccine introduced: Never developed for population use

• Notes: Bacterium still colonizes 15-20% of school children

Typhoid

• Source: US Public Health Service; Humphries Ch. 11

• Peak reported burden: 1900: 31.3 deaths per 100,000; 40,000-50,000 US deaths per year in late 1800s to early 1900s

• Pre-vaccine decline: 98% decline in mortality between 1900 and 1943

• Vaccine introduced: Not on childhood schedule; traveler’s vaccine only

• Notes: Attributed to chlorination, sewage systems, milk pasteurization

Measles

• Source: Pink Book Ch. 13, p. 196

• Peak reported burden: Pre-1963: ~500,000 reported cases and 500 deaths annually (CFR ~0.1%)

• Pre-vaccine decline: Population mortality down 98%+ from 1900 to 1963 (Humphries); CFR down from 5.8% (Glasgow 1908) to 0.030% (E&W 1960)

• Vaccine introduced: 1963

• Notes: The mortality collapse preceded the vaccine by decades

Pertussis

• Source: Pink Book Ch. 16, pp. 244-245

• Peak reported burden: 1940-45: ~175,000 cases per year

• Pre-vaccine decline: Mortality down 90%+ before mid-1940s (Humphries)

• Vaccine introduced: Whole-cell in 1940s; acellular in 1990s

• Notes: 2012 case count (48,277) highest since mid-1950s despite ~93% coverage

Polio

• Source: Pink Book Ch. 18, p. 278

• Peak reported burden: 1952: 21,000+ paralytic cases

• Pre-vaccine decline: Cases to 2,525 by 1960; 61 by 1965

• Vaccine introduced: IPV 1955; OPV 1961

• Notes: Diagnostic criteria changed in 1954 (Greenberg); Pink Book invokes terrain to explain the rise

Appendix B: Direct Quotes from the Pink Book

Diphtheria (Chapter 7, p. 102):

“During the 1920s, 100,000 to 200,000 cases of diphtheria (140 to 150 cases per 100,000 population) and 13,000 to 15,000 deaths were reported each year. After diphtheria toxoid-containing vaccines became available in the 1940s, the number of cases gradually declined to about 19,000 in 1945 (15 cases per 100,000 population). A more rapid decrease began with implementation of a universal childhood vaccination program which included diphtheria toxoid-containing vaccines beginning in the late 1940s.”

Measles (Chapter 13, p. 196):

“Before 1963, approximately 500,000 cases and 500 measles deaths were reported annually, with epidemic cycles every 2 to 3 years. However, the actual number of cases was estimated at 3 to 4 million annually. More than 50% of persons had measles by age 6 years, and more than 90% by age 15 years.”

Pertussis (Chapter 16, pp. 244-245):

“Before the availability of vaccine, pertussis was a common cause of morbidity and mortality among children. During the 6-year period from 1940 through 1945, more than 1 million cases of pertussis were reported, an average of 175,000 cases per year (approximately 150 cases per 100,000 population).”

“A total of 48,277 pertussis cases were reported in 2012, the largest number reported since the mid-1950s.”

“waning of vaccine-induced immunity is thought to play a key role in countries, including the United States, that have transitioned to acellular vaccines in the 1990s.”

“an increasing burden of reported cases in the United States is now occurring among fully vaccinated children and adolescents.”

Polio (Chapter 18, p. 278):

“In the immediate prevaccine era, during the first half of the 20th century, improved sanitation resulted in less frequent exposure and increased the age of primary infection, resulting in large epidemics with high numbers of deaths.”

“From the more than 21,000 paralytic cases reported in 1952, only 2,525 cases were reported in 1960 and 61 cases in 1965.”

References

1. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. Hall E., Wodi A.P., Hamborsky J., et al., eds. 14th ed. Washington, D.C.: Public Health Foundation, 2021. Chapter 7 (Diphtheria), p. 102.

2. Humphries S. and Bystrianyk R. Dissolving Illusions: Disease, Vaccines, and the Forgotten History. 2013. See Chapter 11 and Graph 11.9 (United States diphtheria mortality rate from 1900 to 1967).

3. Ibid. Discussion of New York City data, citing period from 1894 to 1920.

4. Ibid. Discussion of Leicester, England, diphtheria mortality following the 1895 introduction of diphtheria antitoxin. See Graph 11.7.

5. Ibid. Discussion of United States diphtheria mortality following the 1920 introduction of the toxoid vaccine.

6. Ibid. Chapter 11, on the mortality burden of scarlet fever in the 1800s.

7. Ibid. Citing English and Welsh mortality data for the fifteen years 1847-1861.

8. Ibid. Citing Providence, Rhode Island, scarlet fever mortality data for children aged two to four, 1865-1924.

9. Ibid. See Graph 11.1 (England and Wales scarlet fever mortality rate from 1838 to 1978).

10. Ibid. Discussion of the abandoned scarlet fever toxin vaccine.

11. Ibid. Chapter 11, noting that Streptococcus pyogenes continues to colonize 15-20 percent of school children.

12. Ibid. Chapter on typhoid, citing estimates for late 1800s and early 1900s US mortality.

13. Ibid. Citing US Public Health Service mortality data, 1900 to 1943.

14. Ibid. Discussion of chlorination, sewage systems, milk pasteurization, and their role in the decline of typhoid and related waterborne conditions.

15. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 14th ed. Chapter 13 (Measles), p. 196.

16. Humphries S. and Bystrianyk R. Dissolving Illusions. Chapter 14, citing Glasgow measles data for 1908.

17. Ibid. Citing Hospice des Enfants Assistés data for 1867-1872.

18. Ibid. Citing England and Wales measles mortality data for 1960.

19. Ibid. See Graph 11.6 (United States measles mortality rate from 1900 to 1987) and accompanying text.

20. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 14th ed. Chapter 16 (Pertussis), p. 244.

21. Humphries S. and Bystrianyk R. Dissolving Illusions. See Graph 11.5 (United States whooping cough mortality) and accompanying text.

22. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 14th ed. Chapter 16, p. 244.

23. Ibid. Chapter 16, p. 245.

24. Ibid. Chapter 16, p. 244.

25. Ibid. Chapter 16, p. 245.

26. Ibid. Chapter 18 (Poliomyelitis), p. 278.

27. Ibid. Chapter 18, p. 278.

28. Maready F. The Moth in the Iron Lung: A Biography of Polio. Feels Like Fire, 2018. Discussion of the 1954 diagnostic criteria change for paralytic poliomyelitis.

29. Greenberg B., quoted in Maready F., The Moth in the Iron Lung. Statement from a 1960 conference on the polio data. The full source citation for the conference proceedings is in Maready’s endnote 112.

30. Humphries S. and Bystrianyk R. Dissolving Illusions. Chapter 11 in particular, covering the parallel mortality declines for the major conditions medicine classifies as infectious diseases of childhood.

31. McKeown T. The Role of Medicine: Dream, Mirage, or Nemesis? Nuffield Provincial Hospitals Trust, 1976. On the historical role of improved living standards in the mortality decline for the conditions classified as infectious in Britain.

Empathy scores correlate positively with support for communism, with governmental intervention scales that include items such as “the government needs to be a part of leveling the playing field for people from different racial groups,” and with support for censorship in the service of protecting feelings. Women score higher on empathy than men across every measured population and across the lifespan, and correspondingly prefer socialism over capitalism at higher rates, support woke ideas at higher rates, and are more likely to endorse open borders regardless of consequences. This is the empirical infrastructure beneath Suicidal Empathy: Dying to Be Kind (2025), and it explains a great deal that the standard cultural commentary cannot. The book documents a specific measurable trait, distributed unequally across the population, now controlling the institutions that decide what a civilization is and whom it protects.

Gad Saad is a professor at Concordia University in Montreal, where he has taught for over thirty-one years at the intersection of evolutionary psychology and consumer behavior. His prior book, The Parasitic Mind: How Infectious Ideas Are Killing Common Sense, examined how ideological rapture disables human cognition; Suicidal Empathy extends the same analytical framework to the emotional system. Saad was born in Lebanon into a Jewish family that fled the civil war in 1975 after his parents were kidnapped by Fatah — a biographical fact that shapes his approach to questions of cultural theory of mind and Islamic immigration policy. He testified before the Canadian Senate on Bill C-16 in 2017 and has been a persistent public critic of woke ideology, incurring costs at his own university including death threats and security protocols. His podcast The Saad Truth provides much of the raw material the book synthesizes.

The book arrived in 2025, following an eighteen-month stretch in which the West’s calibration of empathy had become impossible to ignore. Empathy as public virtue had reached its most operationally destructive form in the preceding decade: COVID-era policies that treated any discussion of taboo trade-offs as psychopathy; academic institutions restricting Canada Research Chairs by identity category; European courts delivering probation-level sentences for gang rapes of children on the reasoning that harsh punishment would damage the perpetrators’ integration prospects; the systematic replacement of merit with demographic representation across universities, medicine, and aviation. Suicidal Empathy was written into this environment, drawing on evolutionary psychology, behavioral economics, and documented case-by-case failures to name a mechanism the establishment could not name because the establishment was the mechanism.

Where the book underdelivers is in the causal weighting of what Helen Andrews and Janice Fiamengo have named directly: female demographic dominance of the institutions that manufacture Western belief. Saad has the trait — he documents that women score higher on empathy, that women are more likely to endorse the ideological package that flows from empathy misfiring, that the feminization of academia has been astonishing to watch. What he does not fully reckon with is the vector. Law schools became majority female in 2016. The New York Times newsroom in 2018. Medical schools in 2019. The Great Awokening arrived simultaneously with these tippings, at the 30% threshold researchers identify as the point where minority preferences begin reshaping organizational culture. Saad’s framework describes the destination without fully accounting for the timing. His seven inoculation prescriptions are gender-neutral, addressing the trait while leaving untouched the structural fact that the institutions setting the terms of public life are now demographically configured to reward exactly the misfiring he warns against. A complete account would say that feminization created the institutional conditions under which suicidal empathy became the operating logic of Western public life. Saad names one and gestures at the other, treating female-higher empathy as one variable among many rather than as the demographic vector through which the trait now dominates.

The full summary unpacks what Saad calls empathy agnosia — the inability to identify appropriate targets for compassion — through the specific research and documented cases that ground his argument. It walks through the 890 medals lost by female athletes across more than 400 competitions to biological men and the 44% of trans women inmates in Canadian correctional facilities incarcerated for sexual crimes; the Huddersfield grooming case naming twenty perpetrators and the pattern replicated across Britain, Germany, Sweden, Austria, the Netherlands, and Finland; the 1,288 public health officials who signed the open letter declaring anti-racism protests exempt from COVID restrictions while grandmothers died alone; the seven inoculation prescriptions Saad offers as the reintroduction of the evolved capacity to discriminate. Maria Ladenburger, a nineteen-year-old German medical student who volunteered at migrant shelters, was raped and murdered by an Afghan asylum seeker in December 2016. Her family requested donations to refugee charities in lieu of flowers.

Read more

This essay is written for the parent who has been told her child needs surgery. It reads the situation through a paradigm the surgical consultation does not offer. The tonsils are drainage tissue. They swell when they are working. The load they are being asked to carry has changed in specific ways during the past four decades.

The essay speaks in two registers. When it engages establishment material, including vaccine package inserts, CDC reference documents, and peer-reviewed studies on tonsillectomy outcomes, it uses the establishment’s own vocabulary in quotation and attribution. Terms like “immune response,” “antibody titer,” “infectious disease,” and “pathogen” appear inside the register of the sources being examined. When the essay speaks in its own voice, the language shifts to describe what the tissue is observably doing. The prosecution register uses their words to expose their contradictions. The analytical register uses accurate language for what is happening.

Nothing here constitutes medical advice. Decisions about surgery for a child are decisions between a family and the practitioners the family trusts. The purpose is to make the primary-source evidence and the terrain understanding available to families weighing that decision.

1. Where the Aluminum Goes

Christopher Exley, professor of bioinorganic chemistry at Keele University, has spent his career tracking what happens to aluminum after it enters the human body. His 2016 paper in Morphologie stated the finding without softening it. Significant amounts of aluminum adjuvant can be collected from injection sites and transported throughout the body, delivered in potentially acute amounts to target sites which would normally receive only very low but persistent exposure.¹

The mechanism of transport is white blood cells. Macrophages arrive at the injection site, engulf the aluminum particles, and carry them through the lymphatic circulation. Where lymphoid tissue concentrates, the cells carrying aluminum concentrate. Where the cells carrying aluminum concentrate, the aluminum accumulates.

Forrest Maready, in his footnote to the Crohn’s disease chapter of Crooked, described the specific consequence for the tissue at the throat. “Your body contains a few areas of specialized lymph tissue that provide an early warning for your immune system. Some of this tissue surrounds your tonsils and adenoids and because they tend to hold a lot of white blood cells, they will also accumulate aluminum.”²

Waldeyer’s ring is the anatomical name for that tissue. The palatine tonsils, visible at the back of the throat, sit inside the ring. So do the adenoids at the roof of the nasopharynx, the lingual tonsils at the base of the tongue, and the tubal tonsils near the openings of the Eustachian tubes. The ring constitutes the largest concentration of lymphoid tissue in the head and neck. It is positioned by design at the point where inhaled air, ingested food, and drainage from the head and cranial cavity converge.

Peyer’s patches are the equivalent structure at the end of the small intestine, patches of lymphoid tissue positioned to concentrate and drain gut contents. Maready’s central mechanism for Crohn’s disease traces the identical pathway. White blood cells traffic aluminum to the Peyer’s patches. Aluminum accumulates in the lymphoid tissue. Chronic inflammation develops in the tissue that received the load. Under the microscope, Crohn’s disease looks like aluminum accumulation in gut lymphoid tissue.² Chronic tonsillitis, examined outside the germ-theory framework that presupposes an invader, looks like aluminum accumulation in throat lymphoid tissue.

The peak age of pediatric tonsillitis in clinical practice runs from roughly four to eight years. The peak age of cumulative aluminum body burden from the injection schedule runs across the same window. The overlap is not coincidence.

2. The Tissue That Was Named an Enemy

Ulric Williams, the New Zealand physician who abandoned his surgical practice in the 1930s to develop a naturopathic understanding of disease, described the tonsils in a single line. “Tonsils and adenoids are accessory eliminating channels.”³ The framing was clinical rather than metaphorical. The tissue does drainage work. When the drainage load exceeds ordinary capacity, the tissue swells. Williams continued: “The cause of unhealthy tonsils is unhealthy living, faulty feeding and general habits. Do not seal them up; correct the unhealthy living and, in course of time, the diseased condition will recover.”³

The modern medical framing calls the same tissue immune sentinels. The vocabulary presupposes a body under siege from external invaders and a lymphatic system organized to defend against attack. Neither presupposition survives contact with what the tissue actually does. The work is drainage. Material entering through the airway gets filtered at this point. Lymph from the head, sinuses, mouth, and upper neck arrives here for processing, and what the body is working to eliminate concentrates in this tissue so that elimination can proceed.

Williams’ framing does not require the germ theory framework to describe what the tonsils do. It describes an organ performing recognizable physiological work. The outcome data on tonsillectomy, examined later in this essay, is what one would predict if a drainage organ were removed and the drainage load continued.

3. What the Schedule Delivers

The American childhood vaccine schedule in 1983 included 24 doses of four vaccines through the entire childhood period.⁴ The schedule in 2024 included approximately 88 doses of 17 vaccines before age 18, with most of them concentrated in the first six years of life.⁴ The expansion accelerated in specific years. The Haemophilus influenzae type b vaccine was introduced in 1985 and universally recommended in 1990. Universal infant Hepatitis B vaccination began in 1991. Varicella was added in 1995. The rotavirus vaccine was introduced in 1998, withdrawn after intussusception reports in 1999, and reintroduced in a modified form in 2006. Multiple DTaP formulations replaced DTP through the 1990s.

Almost every one of these products contains aluminum as an adjuvant. The CDC lists nearly thirty vaccines that include aluminum salts.⁵ The diphtheria, tetanus, pertussis, Hib, hepatitis A, hepatitis B, meningococcal, pneumococcal, and HPV vaccines all contain aluminum. Gardasil-9, the current HPV vaccine, contains more than double the aluminum of its predecessor.⁵

Russell Blaylock has documented the difference between oral and injected aluminum absorption. Ingested aluminum is absorbed at roughly 0.1% by the gastrointestinal tract, and what is absorbed is rapidly excreted. Injected intramuscular aluminum is absorbed at 100%.⁶ The comparison the FDA and WHO routinely offer, that vaccine aluminum is comparable to dietary aluminum, is not a comparison of like with like. It is a comparison of a rare and briefly present molecule with an intramuscular deposit that traffics through the lymphatic system for months to years.

The Informed Consent Action Network filed a Freedom of Information Act request in 2019 asking the NIH for human or animal studies establishing the safety of injecting infants and children with aluminum. The NIH responded that no records responsive to the request could be located. The searched departments included the Office of Intramural Research, the National Institute of Allergies and Infectious Diseases, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.⁷ No safety study exists.

What exists instead is the outcome data. Heather Fraser, in her documentation of the peanut allergy epidemic, tracked the rate of ear infections in American children during the years the schedule expanded most rapidly. Between 1988 and 1994, the number of children with recurrent ear infections (three or more) rose by 720,000.⁸ Anthony Mawson’s 2017 pilot study of 666 homeschooled American children, comparing 261 unvaccinated with 405 partially or fully vaccinated, found significantly higher rates of otitis media, sinusitis, allergic rhinitis, and neurodevelopmental disorders in the vaccinated cohort.⁹

Thomas Cowan, drawing on decades of pediatric practice, has stated the same finding from the clinical side. He rarely saw chronic illness in unvaccinated children.¹⁰

4. The Establishment Describes What It Denies

The Merck package insert for M-M-R II, revised November 2024, lists among adverse reactions: regional lymphadenopathy, parotitis, sore throat, cough, rhinitis, pneumonia, pneumonitis, otitis media, and bronchial spasm.¹¹ The manufacturer, in the document required by federal regulation to disclose known adverse effects, states that the vaccine produces swelling of regional lymph nodes, inflammation of the salivary glands, inflammation of the throat, inflammation of the middle ear, and inflammation of the lung. Every listed condition is inflammation of tissue in Waldeyer’s ring or the respiratory tract it drains.

The CDC Pink Book, the agency’s own reference document on vaccine-preventable diseases, contains further admissions. Chapter 20 of the 14th edition states plainly that rubella “replicates in the nasopharynx and regional lymph nodes.” Chapter 15 states that mumps “replicates in the nasopharynx and regional lymph nodes.” The Pink Book acknowledges that transient lymphadenopathy sometimes occurs following MMR vaccination and is attributed to the rubella component, and that parotitis follows MMR in less than 1% of recipients.¹²

The RotaTeq vaccine trial results, reported in the current Merck package insert, list otitis media, nasopharyngitis, and bronchospasm among the most common adverse events. In the clinical trial reported in the insert, otitis media occurred in 14.5% of vaccine recipients versus 13.0% of comparator recipients. Nasopharyngitis occurred in 6.9% versus 5.8%. Bronchospasm occurred in 1.1% versus 0.7%.¹³ The comparator was not an inert placebo. Any absolute increase in respiratory adverse events is therefore understated by the trial design.

The pattern is consistent across the aluminum-adjuvanted schedule. The tissues at the throat inflame. The children who receive the products present with the conditions the establishment has documented in its own trials. The medical response frames the inflammation as evidence of an infectious process requiring antimicrobial treatment or surgical excision. The framing preserves the schedule. The tissue does the accounting.

5. The Bacteria That Arrive Later

Chronic tonsillitis is typically cultured for bacteria. Staphylococcus aureus, Streptococcus pyogenes, Haemophilus, and various anaerobes are recovered. The medical framing describes these organisms as the cause of the inflammation. The terrain reading treats them as the response to it.

Antoine Béchamp, whose microzyma work preceded Pasteur’s germ theory and was displaced by it, described bacteria as arising from the tissue in response to the tissue’s condition. Lida Mattman’s mid-twentieth-century research documented that bacteria exposed to environmental stress shed their cell walls, transform into L-forms, and pass into intracellular and biofilm states from which conventional antibiotic therapy cannot dislodge them. The transformation is reversible when conditions change.¹⁴

Andreas Zautner and colleagues, publishing in PLoS ONE in 2010, examined tonsil specimens from 130 patients with recurrent tonsillitis. Using antibiotic protection assays, flow cytometry, fluorescent in situ hybridization, and immunohistochemistry, they found that Staphylococcus aureus was the predominant species, recovered in 57.7% of cases, and that nearly all recurrent-tonsillitis-associated strains were located inside tonsillar cells rather than on their surface.¹⁵ The bacteria the surgical consultation blames for the inflammation live inside the tissue that is being removed. Antibiotics targeting extracellular bacteria cannot reach them. The bacteria persist. The inflammation recurs. The recommendation moves toward surgery.

The clinical sequence follows the biology. A child develops a sore throat. A rapid strep test returns positive. Amoxicillin is prescribed. The acute inflammation resolves. Weeks or months later, the same child returns with the same symptoms. A second course is prescribed. The pattern repeats through a third, fourth, and fifth episode. The medical framing calls this recurrent strep throat and eventually recommends surgical removal. Each course of penicillin-family antibiotics selects for bacteria that have shifted into cell-wall-deficient or intracellular forms. The forms do not respond to further courses of the same class. The tissue burden continues. Recurrence is built into the treatment.

Shelton described the cycle at the general level a century ago, without the microbial specifics. “A child frequently develops colds. It develops sore throat, tonsillitis, bronchitis, pneumonia, all of which are cured, and soon followed by another cold, another tonsillitis, another bronchitis, and this process continues until chronic disease of the lungs evolves.”¹⁶ Each acute presentation is the body attempting to clear accumulated burden. Each pharmaceutical intervention adds toxic material to the burden while preventing the clearing. The acute condition becomes chronic. The chronic condition is labeled recurrent. The recommendation moves toward surgery.

6. The Study the Consultation Omits

In June 2018, JAMA Otolaryngology–Head and Neck Surgery published the largest and longest-running study ever conducted on the long-term outcomes of pediatric tonsillectomy and adenoidectomy. Sean G. Byars, Stephen C. Stearns, and Jacobus J. Boomsma analyzed the health records of 1,189,061 children born in Denmark between 1979 and 1999, following them to age 30.¹⁷

Cases and controls were matched for pre-surgery health status, addressing the standard objection that tonsillectomized children were sicker to begin with. The Danish national health data provided the completeness required to trace outcomes across three decades.

The findings on the conditions the surgery is meant to prevent are clear. Only 33% of the treated conditions showed reduction after surgery. Forty-three percent showed no change. Twenty-four percent, including otitis media, actually increased. The rate of chronic ear infection following adenoidectomy rose two-to-five-fold.¹⁷

The findings on long-term disease risk are more damaging. Upper respiratory tract disease showed a relative risk of 2.72 following tonsillectomy, with a 95% confidence interval of 1.54 to 4.80. The absolute risk increase was 18.61 percentage points. The number needed to harm was five. Adenoidectomy produced a relative risk of 2.11 for chronic obstructive pulmonary disease and 1.99 for upper respiratory disease. Conjunctivitis rose 75%. Adenotonsillectomy produced a 17% relative increase in overall infectious disease.¹⁷

Of the 28 disease groups examined, 78% showed elevated risk after Bonferroni correction, the statistical technique designed to protect against false positives when many comparisons are made.¹⁷ Seventy-eight percent of the disease categories still showed harm after that adjustment.

The Swedish population data extends the Danish. Xiao and colleagues, publishing in JAMA Network Open in December 2024, compared 83,957 Swedish tonsillectomized individuals to 839,570 population-matched controls, drawing on the Swedish Patient Register. Tonsillectomy was associated with a 43% higher risk of stress-related disorders. Post-traumatic stress disorder specifically was 55% higher. The associations held in a sibling-matched analysis of 51,601 exposed and 75,159 unexposed siblings, independent of parental education, sex, age at surgery, and time since surgery.¹⁸

Liang and colleagues, publishing in BMC Medicine in May 2023, drew on 4,953,583 individuals in Sweden with follow-up from 1980 to 2016. Tonsillectomy, adenoidectomy, or adenotonsillectomy carried a modest but consistently elevated risk of cancer of any type, with a population hazard ratio of 1.10 and a sibling hazard ratio of 1.15. Excess risk was observed specifically for cancer of the breast, prostate, thyroid, and for lymphoma, in both the population and sibling comparisons.¹⁹

Murugesan and colleagues, publishing in the Indian Journal of Pediatrics in May 2024, compared 36 children who had undergone adenotonsillectomy with 27 sibling controls during the COVID-19 pandemic. The tonsillectomized children showed a COVID-19 positivity rate of 80.5% compared to 44% in siblings, and a symptomatic infection rate of 68.9% compared to 16%. The relative risk of contracting COVID-19 was 1.8 times higher; the relative risk of symptomatic infection was 4.14 times higher.²⁰

The evidence has been in the peer-reviewed literature for years. The surgical consultation does not include a summary of it.

7. Two Historical Loops

The removal of tonsils has been performed for at least 2,000 years and has never been shown, before or after the current outcome data, to produce improved health.²¹ Two twentieth-century episodes indicate what the operation actually does when studied under specific conditions.

In 1971, Pearay Ogra published in the New England Journal of Medicine the results of a study measuring pharyngeal antibody titers in children before and after tonsillectomy. He found substantial multi-fold decreases in pharyngeal antibody to type 2 poliovirus, both IgA and IgG, in the months following surgery. The decrease persisted for the duration of the follow-up period.²² The organ that was removed had been producing the proteins the establishment identifies as the front-line pharyngeal antibody response. Its removal produced a durable reduction in that response. The Ogra data was published, cited, and clinically ignored.

In 1943, G. W. Anderson published in the American Journal of Public Health his analysis of a Utah polio outbreak. Bulbar poliomyelitis, the severe form of polio that damages the brainstem and produces respiratory failure, was strongly associated with recent tonsillectomy. During three months of the ascending part of the epidemic, 43% of bulbar and bulbospinal cases had been preceded by tonsillectomy within thirty days of onset.²³ A separate study of a 1947-48 outbreak in South Australia by R. V. Southcott reported that 35 of 39 bulbar polio cases in that outbreak had a history of prior tonsillectomy.²⁴ The surgical removal of Waldeyer’s ring appeared to open the anatomical pathway to the tissue that produced the most severe form of the disease. The Anderson and Southcott findings, published in leading medical journals, did not alter surgical practice.

Both studies used establishment methodology and produced findings that the establishment could not integrate. Both were, in effect, buried by not being cited in surgical practice guidance. The tonsillectomy rate continued to climb through the postwar decades, driven by school health programs and pediatric guidance that treated the operation as routine.

The 1920 Rochester Dental Dispensary tonsil clinic remains the historical high-water mark. Between July 26 and September 10 of that year, 1,470 children under 16 were operated on for tonsils and adenoids in the space of seven weeks, funded through philanthropic subsidies from George Eastman of Eastman Kodak and organized by Harvey J. Burkhart and Albert D. Kaiser. Kaiser’s preliminary surveys claimed that 87% of the children in the city of Rochester needed such operations.²⁵ Between 1919 and 1921 the same program operated on approximately 15,000 Rochester schoolchildren. The medical culture in which such a program could be organized without institutional objection is the same culture in which the current rate of pediatric tonsillectomy is treated as normal practice.

8. The Contagion Test the Tonsils Failed

If the tonsils are immune sentinels standing guard against invading pathogens, their removal should measurably increase susceptibility to what the establishment calls infection. The contagion experiments provide a decisive test.

In 1957, H. F. Dowling, G. G. Jackson, and T. Inouye published in the Journal of Laboratory and Clinical Medicine the results of a large-scale attempt to transmit colds by direct inoculation of respiratory mucus from sick donors into healthy recipients. The experiment tracked outcomes in 827 people. Three hundred and sixty-three of the recipients had previously undergone tonsillectomy. Four hundred and sixty-four had intact tonsils.²⁶

Of the 363 tonsillectomized participants, 123 (34%) developed colds. Of the 464 participants with tonsils intact, 148 (32%) developed colds.²⁶

The rates are statistically identical. The removal of the tissue framed as the front-line immune sentinel against upper respiratory infection produced no measurable difference in susceptibility to a direct nasal inoculation of the alleged infectious agent.

The finding sits in tension with the germ-theory framework and dissolves inside the terrain framework. Bacteria and viruses have not been demonstrated to cause disease by invasion. The alleged transmission of respiratory infection has never been reliably demonstrated in human-to-human challenge experiments across more than a century of attempts, as Daniel Roytas has documented in extensive review of the primary literature.²⁶ The tonsils were never sentries against invaders because there are no invaders in the germ-theoretical sense. They were doing something else. The Dowling data confirms that whatever the tonsils were doing, it was not filtering out contagious agents. The tissue that Byars, Stearns, and Boomsma demonstrated is essential to long-term respiratory health does that work by a different mechanism, one that does not require the germ theory framework to describe.

9. What the Body Was Attempting

Weston Price documented fourteen traditional populations across the globe with virtually no chronic disease, no dental caries, and no evidence of the conditions that lead modern children to the pediatric ENT office. The populations ate wildly different diets. The common element was that the food was whole, unprocessed, produced within traditional foodways, and unaccompanied by industrial pharmaceutical intervention.²⁷ None of the populations vaccinated. None consumed the ultra-processed food that constitutes the majority of the modern pediatric diet. Chronic tonsillar inflammation of the sort that leads to tonsillectomy was not observed in these populations because the loads that produce it in modern children were not present.

Tilden described the acute presentation more than a century ago. Tonsillitis appears in “toxemic subjects with gastro-intestinal indigestion from a surfeit of food, in which animal substances, possibly only milk, predominated.”²⁸ The body draws head and neck lymphoid tissue into service when the ordinary digestive and eliminative channels can no longer handle the accumulated burden. Removal of the tissue does not address the burden. It removes the accessory channel while the burden continues to accumulate, forcing the body to eliminate through the remaining organs at higher intensity. The chronic disease that follows tonsillectomy in the Byars data is what the body’s continued attempt at elimination looks like when the accessory channel has been closed.

The clinical evidence that children resolve chronic tonsillitis without surgery when the terrain drivers are addressed is not confined to the historical literature. Parents who remove wheat, sugar, seed oils, and industrial dairy from their children’s diets frequently report that recurrent tonsillar inflammation resolves. One mother, whose son was recommended for tonsillectomy for sleep apnea, cut wheat from his diet after finding a physician who recommended it, and reported the apnea resolved. A man in his late fifties, recommended for tonsillectomy at age eighteen for chronic tonsillitis, read a herbal medicine book identifying heavy greasy and starchy meals as the cause, changed his diet, and reported no further episodes across the following four decades. A woman with chronic tonsil stones canceled her ENT consultation after beginning daily high-polyphenol olive oil.²⁹ These accounts are anecdotal. Their significance is that they reproduce Tilden and Williams independently from the ground up in people who have never read either.

Cowan’s clinical framework holds. The task is to identify and remove the insult, then support the tissue while it clears the accumulated burden.³⁰ The insult is rarely singular. In the child presenting with chronic tonsillitis in 2026, the load includes the cumulative aluminum body burden from the injection schedule, the antibiotic-driven bacterial pleomorphism from prior treatment, the industrial food supply, and the ambient chemical and electromagnetic environment. The tonsils are inflamed because they are attempting to process what they are being asked to process.

10. The Two Operations

The first operation is repeated across the years the child’s head and neck lymphoid tissue is developing. Aluminum is injected into the muscle. White blood cells traffic the metal through the lymphatic system. The tissue that concentrates lymphocytes concentrates the aluminum. The concentrated tissue inflames. The manufacturer’s own package insert lists the outcome. The pediatric visit records it as evidence of an infectious process requiring antimicrobial treatment.

The second operation is performed when the inflammation has recurred often enough to convince the family that the tissue itself is the problem. The tissue is removed. The metal that accumulated in it continues to be delivered by scheduled injections. The scar tissue occupies a region where cranial drainage depended on unobstructed motion. The accessory eliminating channel that Ulric Williams named a century ago is sealed. The load the body was attempting to process through it moves to deeper channels. Thirty years of Danish outcome data document what happens next.

Neither operation asks what is causing the inflammation. Both accept that the tissue is the enemy and that removing its function through antibiotic suppression, or removing the tissue itself through surgery, is the appropriate response. A century of medical practice has been organized around the wrong question. The right question is the one Ulric Williams answered in a single line before the aluminum-adjuvanted schedule existed. The tissue is drainage. The load has changed.

How To Explain It To A 6 Year Old

Imagine your house has a filter on the front door. The filter catches dust and dirt so nothing bad gets inside. Every day the filter does its job. Sometimes it gets a bit dirty and needs cleaning. That’s what filters are for.

Now imagine that every few weeks someone comes to the house and throws a handful of sticky glitter at the door. The filter catches the glitter, because that’s what filters do. After a while the filter gets clogged. It looks red and swollen. It doesn’t work as well as it used to.

Someone looks at the clogged filter and says, “The filter is the problem. Let’s take it off.”

They take the filter off. The person keeps throwing glitter. Now the glitter goes straight into the house and gets stuck in the carpet, the furniture, and the walls. The house gets dirtier and dirtier over the years. Everyone inside starts getting sick.

The filter was never the problem. The glitter was the problem. The people looking at the filter never asked who was throwing the glitter or why. They just took the filter off.

Your tonsils are the filter. That’s the whole story.

References

1. Christopher Exley, “The toxicity of aluminum in humans,” Morphologie 100, no. 329 (June 2016): 51–55. https://doi.org/10.1016/j.morpho.2015.12.003

2. Forrest Maready, Crooked: Man-Made Disease Explained (2018), footnote 187 in the chapter on Crohn’s disease. See also Maready, The Moth in the Iron Lung: A Biography of Polio (Feels Like Fire, 2018).

3. Ulric Williams with Samantha Bailey, Terrain Therapy: How To Achieve Perfect Health Through Diet, Living Habits & Divine Thinking (2022), section “The Tonsil and Appendix Racket,” originally published in Hints on Healthy Living (1934).

4. Aaron Siri, “Development of the U.S. Childhood Vaccine Schedule,” ACIP Meeting presentation, December 5, 2025, drawing on CDC schedule archives at https://www.cdc.gov/vaccines/hcp/imz-schedules/resources.html. See also HHS Fact Sheet, “CDC Childhood Immunization Recommendations” (2025), documenting the 2024 schedule at 17 vaccines and 88 doses through childhood.

5. Thomas Cowan and Sally Fallon Morell, The Contagion Myth (Skyhorse Publishing, 2020), chapter 8. See also CDC excipient table, “Excipients Included in U.S. Vaccines, by Vaccine,” https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/b/excipient-table-2.pdf

6. Russell Blaylock, Health and Nutrition Secrets (Health Press, 2002), cited in Dawn Lester and David Parker, What Really Makes You Ill? Why Everything You Thought You Knew About Disease Is Wrong (2019). See also The Vaccine Reaction, “How Aluminum in Vaccines Affects Your Health,” June 2016. https://www.thevaccinereaction.org/2016/06/how-aluminum-in-vaccines-affects-your-health/

7. Informed Consent Action Network, Freedom of Information Act request to the National Institutes of Health, 2019. NIH response letter documenting that no records responsive to the request could be located across the Office of Intramural Research, NIAID, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Cited in Mark Gober, Samantha Bailey, and Mark Bailey, An End to Upside Down Medicine (Waterside, 2023).

8. Heather Fraser, The Peanut Allergy Epidemic: What’s Causing It and How to Stop It, third edition (Skyhorse, 2017). Fraser documents the correspondence between the 1988–1994 vaccine schedule expansion and the surge in pediatric otitis media and recurrent ear infections.

9. Anthony R. Mawson, Brian D. Ray, Azad R. Bhuiyan, and Binu Jacob, “Pilot comparative study on the health of vaccinated and unvaccinated 6- to 12-year-old U.S. children,” Journal of Translational Science 3, no. 3 (2017): 1–12. https://doi.org/10.15761/JTS.1000186

10. Thomas Cowan, clinical observations across four decades of pediatric practice, discussed in Vaccines, Autoimmunity, and the Changing Nature of Childhood Illness (Chelsea Green Publishing, 2018).

11. Merck & Co., M-M-R II package insert, revised November 2024. Adverse reactions section listing regional lymphadenopathy, parotitis, pneumonia, pneumonitis, otitis media, sore throat, cough, rhinitis, and bronchial spasm. Available at DailyMed and Merck’s product information portal.

12. Centers for Disease Control and Prevention, Epidemiology and Prevention of Vaccine-Preventable Diseases (Pink Book), 14th edition (August 2021), Chapter 15 (Mumps) and Chapter 20 (Rubella). https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-15-mumps.html and https://www.cdc.gov/pinkbook/hcp/table-of-contents/chapter-20-rubella.html

13. Merck & Co., RotaTeq package insert. Adverse reactions section documenting otitis media (14.5% vs 13.0%), nasopharyngitis (6.9% vs 5.8%), and bronchospasm (1.1% vs 0.7%) in vaccine versus comparator groups. https://www.merck.com/product/usa/pi_circulars/r/rotateq/rotateq_pi.pdf

14. Lida H. Mattman, Cell Wall Deficient Forms: Stealth Pathogens, third edition (CRC Press, 2000).

15. Andreas E. Zautner, Merit Krause, Gerhard Stropahl, Silva Holtfreter, Hagen Frickmann, Claudia Maletzki, Bernd Kreikemeyer, Hans Wilhelm Pau, and Andreas Podbielski, “Intracellular Persisting Staphylococcus aureus Is the Major Pathogen in Recurrent Tonsillitis,” PLoS ONE 5, no. 3 (March 2010): e9452. https://doi.org/10.1371/journal.pone.0009452

16. Herbert M. Shelton, quoted in Dawn Lester and David Parker, What Really Makes You Ill? (2019).

17. Sean G. Byars, Stephen C. Stearns, and Jacobus J. Boomsma, “Association of Long-Term Risk of Respiratory, Allergic, and Infectious Diseases With Removal of Adenoids and Tonsils in Childhood,” JAMA Otolaryngology–Head and Neck Surgery 144, no. 7 (July 2018): 594–603. https://doi.org/10.1001/jamaoto.2018.0614

18. Xue Xiao, Fen Yang, Li Yin, Josef Isung, Weimin Ye, David Mataix-Cols, Zhe Zhang, Unnur Valdimarsdóttir, and Fang Fang, “Stress-Related Disorders Among Young Individuals With Surgical Removal of Tonsils or Adenoids,” JAMA Network Open 7, no. 12 (December 2, 2024): e2449807. https://doi.org/10.1001/jamanetworkopen.2024.49807

19. Jinfeng Liang, Yi Huang, Li Yin, Fatemeh Sadeghi, Yanping Yang, Xue Xiao, Hans-Olov Adami, Weimin Ye, Zhe Zhang, and Fang Fang, “Cancer risk following surgical removal of tonsils and adenoids: a population-based, sibling-controlled cohort study in Sweden,” BMC Medicine 21, no. 1 (May 24, 2023): 194. https://doi.org/10.1186/s12916-023-02902-x

20. Ramaneeshwaran Murugesan, Prem Sagar, Rajeev Kumar, Sushil Kumar Kabra, Prem Kumar Chaturvedi, Maroof Ahmad Khan, Chirom Amit Singh, Rajeev Kumar, and Alok Thakar, “Long Term Impact of Adeno-tonsillectomy on Immunity Against Respiratory Viral Infections; Evidence Deduced During COVID-19 Pandemic,” Indian Journal of Pediatrics (May 7, 2024). https://doi.org/10.1007/s12098-024-05125-x

21. Robert S. Mendelsohn, Confessions of a Medical Heretic (Contemporary Books, 1979).

22. Pearay L. Ogra, “Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus,” New England Journal of Medicine 284, no. 2 (January 14, 1971): 59–64. https://doi.org/10.1056/NEJM197101142840201

23. G. W. Anderson, “Tonsillectomy and Poliomyelitis,” analysis of the 1943 Utah polio outbreak documenting that 43% of bulbar and bulbospinal cases were preceded by tonsillectomy within thirty days of onset. Historical documentation of the association is summarized in Kate F. Hurst and Marya S. Zilberberg, “Tonsillectomy and poliomyelitis: Development of causality,” Journal of Clinical Virology Plus (2022), https://doi.org/10.1016/j.jcvp.2022.100113

24. R. V. Southcott, “Studies on a Long Range Association Between Bulbar Poliomyelitis and Previous Tonsillectomy,” Medical Journal of Australia 2 (August 1953): 281.

25. Harvey J. Burkhart, “The Dental and Tonsil-Adenoid Clinics,” Dental Register 74, no. 11 (November 1920). See also Edwin S. Ingersoll, “Surgical Phase of the Tonsil-Adenoid Clinic,” and Albert D. Kaiser, “Medical Phase of the Tonsil-Adenoid Clinic,” in the same issue. Historical overview of the 1919–1921 Rochester program in Pediatric Research abstract 647, “Tonsilmania and Outcomes Research in Rochester NY, 1919–1930.” https://www.nature.com/articles/pr1998795

26. H. F. Dowling, G. G. Jackson, and T. Inouye, “Transmission of Experimental Cold in Volunteers. II. The Effect of Certain Host Factors upon Susceptibility,” Journal of Laboratory and Clinical Medicine 50, no. 4 (October 1957): 516–525. Documented as Experiment 44.2 in Daniel Roytas, Can You Catch a Cold? Untold History and Human Experiments That Prove Contagion Is Not Real (2024). Roytas’s compilation of more than 200 human-to-human contagion experiments is the primary secondary source.

27. Weston A. Price, Nutrition and Physical Degeneration, originally published 1939. Current edition available through the Price-Pottenger Nutrition Foundation.

28. John H. Tilden, Toxemia Explained: The True Interpretation of the Cause of Disease, originally published 1926 (FQ Classics reprint, 2007).

29. Reader correspondence and public comment threads in response to mainstream ENT commentary on pediatric tonsillectomy, 2024–2025.

30. Thomas Cowan, Wednesday Webinar series (2024–2026) and clinical framework documented in Human Heart, Cosmic Heart and Cancer and the New Biology of Water (Chelsea Green Publishing).

Additional Sources

Suzanne Humphries and Roman Bystrianyk, Dissolving Illusions: Disease, Vaccines, and the Forgotten History (2013). Extended treatment of the historical context in which tonsillectomy and the childhood vaccine schedule expanded together, including detailed reconstruction of the twentieth-century tonsillectomy-polio literature.

Mark Bailey, A Farewell to Virology, expert edition (2022).

Samantha Bailey and Mark Bailey, The Final Pandemic: An Antidote to Medical Tyranny (2024).

Dawn Lester and David Parker, What Really Makes You Ill? Why Everything You Thought You Knew About Disease Is Wrong (2019).

Daniel Roytas, Can You Catch a Cold? Untold History and Human Experiments That Prove Contagion Is Not Real (2024).

Mark Gober, Samantha Bailey, Mark Bailey, and Stefan Lanka, An End to Upside Down Medicine (Waterside Productions, 2023).

Torsten Engelbrecht, Claus Köhnlein, Samantha Bailey, and Stefan Lanka, Virus Mania: How the Medical Industry Continually Invents Epidemics, Making Billion-Dollar Profits at Our Expense, third edition (2021).

Forrest Maready, Crooked: Man-Made Disease Explained (2018) and The Moth in the Iron Lung: A Biography of Polio (2018).

Herbert M. Shelton, Natural Hygiene: Man’s Pristine Way of Life.

Henry Bieler, Food Is Your Best Medicine (1965).

The parking lot was full for a Tuesday morning, which Diane took as a good sign. Practices that ran busy tended to run well. She parked in a visitor space near the entrance, checked the time (10:52), and gathered her tote bag and tablet from the passenger seat. A brief drizzle had come through on the drive over. She stepped around a puddle at the curb.

Inside, the waiting room was warm, half-full, mostly mothers with toddlers, one older boy paging through a book on the floor. A cardboard cutout of a giraffe stood by the reception window with a taped sign reading FLU CLINIC SATURDAYS. The front-desk staff knew she was coming. A young woman named Kelsey looked up, smiled, and said, “Ms. Halloran, right? Dr. Marston said to come on back whenever you got here.”

Diane thanked her and followed Kelsey through the side door into the clinical corridor. The practice occupied a single-story building that had been thoughtfully renovated, she noted, with sound-dampening panels on the ceilings and warm wood accents on the exam-room doors. She heard a child’s brief cry from one of the rooms and then a mother’s soothing voice.

Kelsey brought her to a small back office next to what looked like a supply room. “This is ours for however long you need it. Dr. Marston will be with you in a minute; he’s just finishing up with a family. Can I get you coffee?”

“That would be lovely,” Diane said. “Just black, thank you.”

The office was tidy. A round table, four chairs, a whiteboard with staff initials and shift patterns, a small window looking out onto a strip of grass and the neighboring parking lot. Diane took a seat, set down her tote, and pulled out her tablet. She opened the cover, and the lockscreen came up with the photograph she had chosen last month: her two boys in matching red jackets at the pumpkin patch, Ben grinning without his front teeth, Charlie holding up a gourd almost too heavy for him. She looked at it for a beat and then swiped in her passcode.

The IQIP dashboard loaded, and the practice’s data populated across the top of the screen. Coverage assessment complete: 94.1%. Twelve-month change: +2.3 points. Missed opportunities identified: 47 across the review sample. She scrolled through the highlighted charts and read the notes she had prepared last night from her hotel room. The 94.1% put this practice comfortably in the upper quartile for the region. Her target for the twelve-month follow-up was 97%, well within reach.

Dr. Marston came in with two mugs of coffee and set one down in front of her. He was in his early fifties, gray at the temples, a stethoscope slung around his neck over a soft blue cardigan. He shook her hand warmly and sat down across from her.

“Diane, thanks so much for coming out today. We’ve been looking forward to this. I blocked the whole two hours, so we shouldn’t have any interruptions worth speaking of.”

“Thank you for making the time, Dr. Marston. And your numbers look terrific.”

“Peter, please. And thank you. We’ve been working hard on it.” He glanced at the tablet screen. “That two-point-three, I have to say, I’m a little proud of. Last cycle we were flat, and I really wanted to see us move.”

“You should be. Practices at your size usually don’t see that kind of gain without a lot of workflow change.”

“Well,” he said, “we did some things. I want to walk you through them.”

They spent the first forty minutes on his side of the story. He had built a set of prompts into the EMR that flagged any patient coming in for a well-child visit whose immunizations were more than two weeks behind schedule. The prompt fired at the top of the encounter note and again at the discharge screen. Sick visits used to be dead zones for coverage, he told her; his MAs now asked about immunization status at every encounter, and it had picked up a surprising number of catches. The standing orders were rewritten so any nurse could pull and prepare a vaccine without waiting for physician sign-off. That last one had shaved minutes off each encounter and, more importantly, removed a friction point where families sometimes changed their minds.

Diane listened, took notes, asked clarifying questions. Everything he described was exactly what IQIP encouraged. She would be citing this practice in her regional summary as an example of successful strategy adoption.

“Now,” she said, moving into the second phase of the review, “let me walk you through the missed opportunities I flagged from the sample.”

She turned the tablet so he could see, and they went through the charts one by one. A four-month-old whose parents had asked to delay Hep B and never rescheduled. A fifteen-month-old whose MMR had been deferred because of a low-grade fever, with no follow-up call to bring the family back once the fever resolved. A three-year-old who had come in for an ear infection and left without her overdue DTaP catch-up. A ten-year-old who had aged out of the earlier schedule slot without receiving the second varicella dose. An eleven-year-old whose HPV series had been started and then dropped after the first dose because, the note said, “family wants to discuss further.”

Peter nodded through each one, occasionally making a small sound of recognition. “Yeah. Yeah, we saw that pattern too when we went back through internally. The deferrals are the killer. Once they walk out without the dose, the odds of catch-up drop by half.”

“That’s the national data too,” Diane said. “Which is why the scheduling strategy is so important. If you can get them booked for the next visit before they leave the building, you’re not relying on them to call back in six weeks. You’re not relying on your recall system to find them. The appointment is already in the calendar.”

“We’ve been doing that with the well-child schedule for about six months,” Peter said, “but I don’t think we’ve been consistent with the catch-ups. That’s a good catch. Marisol handles most of the front-desk scheduling; I’ll have her build it into the checkout protocol.”

“That’s exactly the kind of change that moves the needle.”

He smiled. “We want to get to 97 next year.”

“You will.”

They worked through a few more charts. Diane pointed out three cases where the EMR prompt had fired but the encounter had ended without the vaccine being given, and Peter said he would review those with the individual providers to see what was happening in the room. She noted his response in her observation field. This was a physician who took ownership of his data, which she would flag in the qualitative section of her report.

Around 12:15, the sounds of the practice shifted. She heard the phone at the front desk ring less often, and the general bustle in the corridor thinned. Peter mentioned that most of the staff took their lunch in shifts starting at noon, and the last morning slot was usually a fifteen- or thirty-minute cushion so that the doctors could catch up on notes.

There was a light knock on the doorframe. A woman in her thirties in dark blue scrubs, a stethoscope around her neck, leaned into the room.

“Sorry, Dr. Marston. Real quick. It’s about the Ellis family.”

“Come on in, Jenna. This is Diane Halloran, she’s with the state, we’re doing our IQIP review. Diane, Jenna is one of our MAs, she’s been here longer than I have.”

Jenna smiled, then turned back to Peter. “So I got Sarah Ellis on the phone this morning about scheduling Nolan’s fifteen-month. He’s due for the next set. And she said she doesn’t want to do it. She said after the last round he wouldn’t stop crying for like two days and she’s just, she doesn’t want to put him through it again. I didn’t push. I told her I’d talk to you and call her back this afternoon.”

Peter nodded slowly, thinking. “Okay. The inconsolable crying thing, that’s actually pretty common, and it’s almost always benign. It’s just the immune response and sometimes the site tenderness. It resolves on its own. But for mom, obviously, it was scary.”

“She was pretty upset about it.”

“Right. So here’s what I’d say to her. Tell her that what she saw is a known and expected reaction, it’s the body doing exactly what we want it to do, and it doesn’t indicate anything is wrong. Then remind her that the fifteen-month is a really important visit because that’s where we get the MMR and the varicella and the Hib booster, and these are the ones that carry the child through the preschool years. If she wants, we can space them out. She doesn’t have to do all of them the same day. But we do want to get him back in.”

Jenna nodded, taking it in. “So offer to split them up.”

“Offer to split them up. And if she’s still hesitant, tell her I’d be happy to hop on a quick call with her, just five minutes, before the appointment. Sometimes hearing it from the doctor helps.”

“Okay. That’s really helpful. Thank you.”

“Anytime, Jenna. And nice work not pushing on the phone. That was the right instinct.”

Jenna smiled and left. Diane heard her footsteps go back down the corridor toward the front.

“That’s such a good example,” Diane said, turning slightly in her chair. “The families that come back with concerns after a reaction, those are the highest-risk drop-offs, and how you handle that first call is everything. Your staff clearly knows what to do.”

“They’re good,” Peter said. “Jenna especially. She’s got a way with parents. She’s been calling back all our hesitancy cases herself for about a year now.”

“Do you have a written script, or is it something you’ve trained her on more informally?”

“More informal, honestly. We’ve talked through the common concerns, and she knows my general approach. I keep thinking I should write it up so the newer MAs have something to work from.”

“That would be a great addition. It’s actually one of the optional strategies in the IQIP framework. If you want, I can send you some template language from other practices in the region that have built out scripts.”

“That would be great. Thank you.”

Diane made a note in the follow-up field. She would email him the scripts and the coverage-comparison data from the peer practices before the end of the week. This was the kind of engaged provider who would actually implement what she sent, which was not always the case.

They worked another twenty minutes, wrapping up the chart review and moving to the summary section. Peter walked her through the practice’s plans for the next quarter, including a Saturday flu clinic he was hoping to expand, and a partnership with the local school district on adolescent catch-up. Diane made encouraging observations and jotted a few final notes. When they had covered everything, she turned back to the tablet and pulled up the site-visit summary form.

She entered the updated coverage data, ticked the boxes for strategies implemented since the last visit, and typed her qualitative notes into the observation field. Strong physician engagement. Effective use of EMR prompts. Front-desk scheduling protocols well established for well-child visits, opportunity for expansion to catch-up visits. Excellent hesitancy management by clinical support staff, potential model for regional dissemination. She reviewed the form, signed the acknowledgment, and submitted it. The screen refreshed and the practice’s file updated in the state system. Twelve-month projection: 96.8%. Well within the target range.

Peter walked her back through the corridor to the front. The waiting room had filled up again with the early-afternoon slots. Kelsey waved from behind the reception window. At the door, Peter shook her hand.

“Really, thank you, Diane. This was useful. We’ll get to 97.”

“I have no doubt. Talk soon.”

She stepped out into the parking lot. The drizzle had cleared, and the sun was breaking through in patches. She walked to her car, set the tablet on the passenger seat, and started the engine. The dashboard clock read 1:14. Her next visit was on the other side of the county, a smaller practice, less prepared, more of a lift. She checked her mirrors and pulled out of the lot.

Inside, at the front desk, Jenna was on the phone with Sarah Ellis, working out a new date for Nolan. The appointment went into the system for a Tuesday morning three weeks out. The reminder call was queued for twenty-four hours before.

The IQIP program depicted in this story is real. Its full name is Immunization Quality Improvement for Providers, and it is administered by the CDC through state health departments. It is described in the CDC's Pink Book (Epidemiology and Prevention of Vaccine-Preventable Diseases).

A note from the author. This essay is written from the terrain paradigm. Disease is the body’s response to dietary, toxic, electromagnetic, and psychological insult. Microorganisms and blood clots appear at sites of tissue breakdown rather than cause it. Within conventional cardiology’s plaque-theory framework, the twelve practices that follow are standard clinical care. From the terrain side, they are deceptions. Two registers operate here. When the essay engages material framed in establishment terms (ejection fraction, atherosclerosis, autoimmune arteritis, the “immune” system, genetic susceptibility, vitamins as discrete nutrients), the establishment vocabulary appears in quotation, attribution, and reference titles. The terrain paradigm operates in the author’s own analytical voice. Readers who have not made the shift from germ theory and mechanistic biology to terrain may find the conclusions inverted from what they expect.

What Was Done to Kilmer McCully

In 1968, Kilmer McCully, an assistant professor of pathology at Harvard Medical School, examined tissue from an eight-year-old boy who had died of a stroke. The child had homocystinuria, a metabolic condition producing massive elevations of the amino acid homocysteine. His coronary arteries looked like those of an elderly man with advanced atherosclerosis. His cholesterol level was normal.⁴

McCully had seen tissue like this before, from a two-month-old infant with the same condition. Two children with arteries destroyed by an amino acid the medical literature had barely discussed. His 1969 paper in the American Journal of Pathology proposed a mechanism. Elevated homocysteine damages the endothelium directly, generates free radicals in the arterial wall, impairs the production of nitric oxide, and promotes clotting. The biochemical cofactors that clear homocysteine (folate, B6, B12) are systematically stripped from the industrial food supply. Restore the cofactors, clear the homocysteine, protect the artery. The proposal was simple, testable, and cheap.

Harvard’s response was not scientific rebuttal. Harvard denied him tenure. Massachusetts General Hospital, where he held a joint appointment, moved his laboratory to the basement. His research funding evaporated. He was told his work was “not of sufficient interest” to the institution. For two years no medical institution would hire him. Colleagues who had praised his work stopped returning his calls. He eventually secured a position at the Veterans Administration hospital in Providence, Rhode Island, and continued his research quietly, publishing steadily, waiting for the profession to catch up.⁴ He died on February 21, 2025, at his home in Winchester, Massachusetts, aged 91. The mechanism he identified is beyond dispute. The test he proposed is still not part of routine cardiology practice.

What was done to McCully in the early 1970s was not a mistake. It was a structural response. The mechanism he found could not be commercialized. B vitamins are cheap and unpatentable. Statins were about to be launched and would generate over a trillion dollars in sales. A profession whose training, income, and institutional standing depended on the cholesterol hypothesis had to choose between the man and the market. It chose the market. Every subsequent choice the specialty has made about what to test, what to prescribe, and what to teach has followed the same structural logic.

An interventional cardiologist earns between $500,000 and $1,000,000 annually, most of it from procedures performed in the cath lab.¹ Hospitals depend on cardiac procedure revenue. Device manufacturers spend billions marketing their products to the specialists who implant them. The ACC/AHA guidelines that govern clinical decisions are written by committees dominated by members with financial ties to the drug and device companies whose products the guidelines recommend. When the 2004 National Cholesterol Education Program guidelines lowered LDL targets in a way that would put millions of additional Americans on statins, most panel members had undisclosed pharmaceutical ties. The Washington Post reported the conflicts. Critics demanded disclosure. The guidelines were not changed.²

The specialty’s foundational hypothesis was itself a selection artifact. Ancel Keys had data available for twenty-two countries when he published his 1953 graph correlating fat consumption with heart disease mortality. He selected six that fit his hypothesis. When the full twenty-two were subsequently analyzed by Yerushalmy and Hilleboe in 1957, the correlation vanished.³ The diet-heart hypothesis that emerged from Keys’ selection became the framework for the entire preventive apparatus of American cardiology, its dietary guidelines, its diagnostic categories, and its drug portfolio.

What follows are twelve specific things the specialty has decided not to say. Each is documented in the specialty’s own trials, its own registries, or its own admissions. What the twelve share is a common cause: the profession’s incentive structure selects for what generates procedures and prescriptions, and against what threatens them. McCully’s story is the pattern. The twelve items are its effects.

Two More Buried Figures

McCully was not the only researcher whose work threatened cardiology’s foundations. Two others deserve mention because their work is drawn on throughout what follows.

Uffe Ravnskov (born 1934), Danish physician and independent researcher, published The Cholesterol Myths in 1991 in Sweden and in 2000 in English. The book documented, with citations to the primary literature, the fraudulent foundation of the diet-heart hypothesis. During a live Swedish television broadcast in 1992, a copy of the book was burned on air.⁵ Ravnskov co-founded The International Network of Cholesterol Skeptics. Their 2016 systematic review in BMJ Open, finding that high LDL was inversely associated with mortality in people over sixty, was the most-read article on the journal for six consecutive months. Their 2018 review in Expert Review of Clinical Pharmacology became the second-most-downloaded paper from Taylor and Francis.⁶ Statin prescribing continued to rise.

Thomas Cowan (born 1957), American physician, spent forty years reframing the organ itself. His Human Heart, Cosmic Heart (2016) makes the case that the heart’s primary function is to organize vortex patterns in blood flow, rather than to generate the pressure that pushes blood through the vessels. Blood moves via the properties of structured water lining the endothelium, described by Gerald Pollack’s laboratory work at the University of Washington.⁷ Cowan also preserved knowledge of strophanthus in English after German cardiology abandoned it. His framework will surface at Items 11 and 12.

Malcolm Kendrick, the Scottish general practitioner whose two books on the cholesterol hypothesis and the thrombogenic alternative anchor much of the evidence in what follows, provides the master documentation across the twelve items.

1. Cholesterol does not cause heart disease.

The teaching: elevated LDL causes atherosclerosis. Lowering it prevents heart attacks and strokes. Statins are the primary tool. Prescribe widely.

The specialty’s own longest-running study contains the confession. The Framingham Heart Study, launched in 1948 and specifically designed to establish the cholesterol-heart-disease link, published its thirty-year data with a finding buried in the report. For each 1 mg/dl drop in cholesterol, there was an 11 percent increase in coronary and total mortality.⁹ People whose cholesterol fell over the follow-up period died at higher rates than those whose cholesterol rose. William Castelli, former director of Framingham, admitted publicly that in Framingham, the more saturated fat and cholesterol a person ate, the more calories a person ate, the lower their serum cholesterol.⁹ The Multiple Risk Factor Intervention Trial, following 361,662 men, found that those with cholesterol below 170 mg/dl had double the death rate from cerebral hemorrhage compared to those with higher levels. Below 160, the death rate quadrupled.¹⁰

The most damning fact requires no biostatistics to state. Most people who have heart attacks do not have elevated LDL. Most people who have elevated LDL do not have heart attacks.¹¹ A causal agent absent from most cases and present without effect in most other cases is a marker of something else, or of nothing at all.

Merck knew. Statins block HMG-CoA reductase, an enzyme in the mevalonate pathway that produces both cholesterol and coenzyme Q10. The two share a biosynthetic route. Q10 is the primary electron carrier in the mitochondrial respiratory chain. The heart, the organ with the highest energy demand in the body, contains the highest concentration of Q10 in the body.¹² Statins deplete plasma Q10 by 16 to 54 percent.¹³ Before launching lovastatin, Merck filed two patents in 1990 for combinations of their statin with Q10 supplementation. US Patent 4,929,437 and US Patent 4,933,165. The second patent named Nobel laureate Michael S. Brown as inventor. Its stated rationale: “since CoQ10 is of benefit in congestive heart failure patients, the combination with HMG-CoA reductase inhibitors should be of value in such patients who also have added risk of high cholesterol levels.”¹⁴ Neither combination was ever marketed. Kendrick asked the operative question: could statins be totally innocent if they required a built-in antidote?¹⁵

For the full development of the cholesterol argument, see The Wrong Enemy and Cholesterol and Statins: An Essay on the Most Successful Unfalsifiable Claim in Medicine.

2. Stents do not prevent heart attacks in stable disease.

Roughly a million stents are placed in the United States annually, at about $30,000 per procedure. The rationale offered to patients is that opening a narrowed artery prevents the heart attack the narrowing would otherwise cause.

The COURAGE trial, published in the New England Journal of Medicine in 2007, randomized 2,287 patients with stable coronary disease to stenting plus optimal medical therapy or to optimal medical therapy alone. Follow-up averaged 4.6 years. No difference in death or myocardial infarction between the two groups.¹⁶ The ORBITA trial, published in The Lancet in 2017, went further. It used a sham-controlled design in which some patients received a real stent and others received a simulated procedure without a stent placed. Neither the patients nor the assessing physicians knew who had received which. The primary endpoint was exercise time. There was no difference. Sham stenting produced the same result as real stenting.¹⁷ The ISCHEMIA trial, published in the New England Journal of Medicine in 2019, tested an invasive strategy (angiography followed by revascularization) against conservative medical management in 5,179 patients with moderate to severe ischemia. No mortality benefit. No reduction in myocardial infarction.¹⁸

Three trials in the specialty’s own flagship journals. Nothing changed in practice. Stent placement did not decline. The revenue continued.

3. Bypass surgery does not extend life for most patients who receive it.

Approximately 400,000 coronary artery bypass grafting procedures are performed in the United States annually, at roughly $100,000 each. Surgical mortality is 1 to 2 percent from the procedure itself.

The Coronary Artery Surgery Study, the VA Cooperative Study, and the European Coronary Surgery Study collectively established in the 1970s and 1980s that bypass surgery extends life only in the narrow subgroup of patients with left main coronary disease or three-vessel disease with impaired left ventricular function. For everyone else, which is most patients who undergo the procedure, no mortality advantage over medical management.¹⁹ The MASS-II trial, published in Circulation in 2010, compared bypass surgery to medical therapy in stable multi-vessel disease over ten years of follow-up. No difference in overall mortality.²⁰ Vein grafts harvested from the leg develop atherosclerosis faster than the native coronary arteries they were meant to replace. Many patients need repeat procedures.

4. The artery they open is rarely the artery that later kills you.

Coronary angiography identifies the biggest visible narrowings. The specialty then treats the biggest narrowings on the assumption that the biggest are the most dangerous.

Autopsy studies contradict the assumption. Giorgio Baroldi, the Italian pathologist whose autopsies of heart attack victims Cowan cites, found that 80 percent of people dying of a heart attack showed no arterial blockage sufficient to explain the event.²¹ Many had extensive stable plaques compensated by collateral circulation and had lived symptom-free for years. Others died from vessels the angiogram would have called minor. Vulnerable plaques, the ones most likely to rupture and produce the acute event, tend to be small, non-obstructive, and invisible on angiography. Large stable plaques calcify and reinforce themselves. Coronary calcium scores, marketed as advanced screening, measure the healed plaques rather than the dangerous ones and correlate with lower heart attack risk, not higher.²³

Angiography is also less reliable than the specialty presents it as. Different cardiologists reading the same angiogram reach different conclusions on the significance of a given lesion 30 to 40 percent of the time.²² A two-dimensional shadow of a three-dimensional structure viewed from a single angle can look like a 50 percent stenosis or a 90 percent stenosis depending on which projection is chosen. The specialty’s most confident intervention rests on the least reliable diagnostic image in cardiology.

5. Blood pressure targets keep dropping to sell more drugs.

The threshold for hypertension has moved down repeatedly across the specialty’s history. 160/95 became 140/90. 140/90 became 130/80. The 2017 ACC/AHA guidelines lowered it again, capturing roughly thirty million additional Americans into a new drug-eligible category overnight.

The trial that drove the last drop was SPRINT, published in the New England Journal of Medicine in 2015. SPRINT compared intensive blood pressure control (systolic target below 120) to standard control (target below 140) in 9,361 patients. The trial excluded diabetics, who had been studied separately in the ACCORD trial with a negative result the guidelines then ignored. SPRINT used automated unattended blood pressure measurement, which reads approximately 10 mmHg lower than standard office measurement, so patients meeting the “120” threshold in the trial were actually running closer to 130 by conventional office readings. The trial was stopped early on the basis of interim analysis, a technique known to inflate apparent effect size.²⁴ Cochrane reviews of tight blood pressure control in the elderly have not found mortality benefit and have documented increased falls, kidney injury, and syncope.²⁵

Each guideline revision brings in millions of patients who were told the previous year that their numbers were fine.

6. Saturated fat was rehabilitated by the specialty’s own meta-analyses.

For fifty years the specialty told the population that saturated fat causes heart disease. The advice reshaped the food supply. Households pulled butter and lard from their cupboards; institutional cafeterias substituted margarine and vegetable oil.

The specialty’s own meta-analyses have overturned the advice. Siri-Tarino in 2010, pooling twenty-one prospective studies covering 347,747 subjects, found no association between saturated fat intake and cardiovascular disease.²⁶ Chowdhury in 2014, pooling seventy-two studies covering over six hundred thousand subjects, found the same.²⁷ De Souza in 2015, pooling seventy-three studies, found no association between saturated fat and total mortality, cardiovascular mortality, coronary disease, or ischemic stroke.²⁸ Three large meta-analyses in the mainstream cardiovascular literature. The specialty’s dietary advice has not been updated.

The intervention trials tell a sharper story. The Sydney Diet Heart Study, run from 1966 to 1973, replaced saturated fat with vegetable oil in the treatment group. The full data was buried until Christopher Ramsden, working at the National Institutes of Health, recovered it and reanalyzed it in 2013. The men who replaced saturated fat with vegetable oil had a 62 percent higher death rate.²⁹ The Minnesota Coronary Survey, hidden for four decades and recovered by Ramsden’s team in 2016, showed that for every 30 mg/dl reduction in cholesterol in the treatment group, mortality increased by 22 percent.³⁰ Teicholz’s The Big Fat Surprise documents the institutional history of how the advice came to be given despite the evidence that contradicted it.³¹

7. Salt restriction raises mortality in most people.

The teaching is that salt raises blood pressure, blood pressure causes heart disease, therefore restrict salt. The specialty targets 2,300 mg of sodium per day for the general population and 1,500 mg for anyone with hypertension or over the age of fifty.

James DiNicolantonio, cardiovascular researcher and author of The Salt Fix, has assembled the data the guidelines do not cite. About 80 percent of people with normal blood pressure are salt-insensitive, meaning their blood pressure does not rise with increased salt intake. Among those with prehypertension, roughly 75 percent are insensitive. Even among those diagnosed with hypertension, about 55 percent are insensitive.³² The optimal sodium intake range for healthy adults sits between 3 and 6 grams per day, well above the guideline target. The relationship between sodium intake and cardiovascular mortality follows a J-curve. The lowest sodium intake groups, which is to say those meeting or beating the guideline target, have the highest cardiovascular and all-cause mortality. The PURE study, following 101,945 people across seventeen countries, confirmed the pattern.³³

The Korean paradox. Koreans consume among the highest sodium intakes in the world, over 4,000 mg per day. They have one of the world’s lowest rates of hypertension and cardiovascular disease.³² Low-salt diets increase heart rate, activate the renin-angiotensin-aldosterone system the antihypertensive drugs are designed to block, contribute to insulin resistance, and elevate the risk of hyponatremia in the elderly.³² The advice to restrict salt is not supported by the evidence used to give it.

8. Ancel Keys built the diet-heart hypothesis by discarding data.

The 1953 graph. Six countries on a straight line. Fat consumption on one axis, heart disease mortality on the other. Elegant. Persuasive. The image on which the entire diet-heart hypothesis was constructed.

The countries not shown. Data was available for twenty-two nations at the time Keys drew his graph. He selected the six that fit his hypothesis. When Jacob Yerushalmy and Herman Hilleboe reanalyzed the full twenty-two-country dataset in 1957, publishing in the New York State Journal of Medicine, the correlation vanished. Countries with similar fat intakes had heart disease rates that varied by factors of three and four. Keys’ clean line was an artifact of his selection.³ Kendrick performed a version of the same exercise using the seven European countries with the lowest saturated fat intake and the seven with the highest. The high-fat countries had lower heart disease rates. Every one of them.¹¹

Even within Keys’ own selected data, the internal inconsistencies were visible. In Finland, the region of Karelia had five times the coronary mortality of Turku despite nearly identical cholesterol levels. On the Greek islands, Corfu had five times the cardiac deaths of Crete despite lower cholesterol.¹¹

The Sugar Research Foundation, faced with emerging evidence linking sucrose to coronary disease in the 1960s, paid Harvard researchers the equivalent of $50,000 in today’s money to write a review attacking the sugar research and promoting the fat hypothesis instead. The researchers assured the sugar industry that they were “well aware of your particular interest” and would “cover this as well as we can.” The review appeared in the New England Journal of Medicine in 1967 without disclosure of the funding source. The documents establishing the payment and the intent surfaced decades later in the archives of Cristin Kearns and were published in JAMA Internal Medicine in 2016.³⁴

The specialty’s founding hypothesis is a selection artifact underwritten by a documented industry payment. Its diagnostic categories, dietary guidelines, and drug portfolio all descend from this base.

9. Homocysteine, and the test the specialty still refuses to run.

Cardiologists do not routinely test homocysteine. It is not in the ACC/AHA lipid panel. Most insurance plans do not cover it. Most patients have never heard of it. Fifty years after McCully identified the mechanism, the specialty’s silence on the topic is the loudest ongoing indictment in this list.

The observational data assembled in the interval has been consistent. The Framingham data showed that people with the highest homocysteine levels had twice the heart disease risk of those with the lowest.³⁵ The European Concerted Action Project showed that elevated homocysteine increased heart disease risk by 200 percent.³⁶ The Nurses’ Health Study, following over 80,000 women, found that those with the highest folate and B6 intake had 45 percent less heart disease than those with the lowest, an effect independent of other risk factors.³⁷

The randomized trials of B-vitamin supplementation for cardiovascular events have been mixed. HOPE-2 in 2006 gave folic acid, B6, and B12 to 5,522 patients with vascular disease and reduced stroke by 25 percent as a secondary endpoint, though the composite primary endpoint did not reach significance.³⁸ NORVIT and VISP were negative for the composite endpoint.³⁹ The subsequent debate has largely been about whether the trials used the right forms (folic acid, which requires enzymatic conversion, rather than methylfolate, which does not) and the right populations (patients already on statins and aspirin whose damage patterns may mask the intervention).⁴⁰ The observational marker data has not been meaningfully disturbed. Cardiology’s response to the marker has been to ignore it in daily practice.

The compounds involved (folate, methylcobalamin, pyridoxal-5-phosphate) are the biochemical cofactors the methylation cycle requires to clear homocysteine. They are present in whole foods (organ meats, eggs, leafy greens, legumes) and stripped from processed foods. White flour has 90 percent of its B6 removed in processing. A diet of industrial food combined with clinical silence on homocysteine testing produces the endothelial injury the specialty then treats with drugs that address neither the cofactor depletion nor the mechanism.

For the fully worked case on the homocysteine mechanism, see The Wrong Enemy.

10. The teeth and the heart are the same problem.

The teaching is silence. Cardiologists do not ask about dental history. Periodontal disease is a problem for the dentist, not the internist. Root canals are considered dental infrastructure with no bearing on cardiac risk. The specialty separated the mouth from the heart around 1950, when the American Dental Association reversed the focal-infection position it had held since the 1920s.

Weston Price, the founding director of the American Dental Association’s research section and its chairman from 1914 to 1928, spent twenty-five years documenting the systemic effects of root-canal-treated teeth. He worked with a sixty-person research team and over five thousand animals. He extracted root-filled teeth from patients with specific systemic diseases and implanted fragments under the skin of rabbits. Rabbits inoculated from patients with heart disease developed heart disease. Rabbits inoculated from patients with kidney disease developed kidney disease. In one endocarditis case, cultures from a fifteen-year-old’s infected molar were injected into thirty rabbits. Twenty-eight died of endocarditis. Ground root-canaled teeth were then sterilized to remove all bacteria and injected in minute quantities. The rabbits still developed heart disease and died. The toxins produced by the anaerobic organisms colonizing the dead tooth were more potent than the organisms themselves.⁴¹ Price’s own son had died of a heart attack shortly after Price performed a root canal on him. That was the research’s origin.

The modern data confirms the pattern. Willershausen and colleagues, publishing in the Journal of Endodontics in 2009, compared 125 patients hospitalized with acute myocardial infarction to matched controls and found significantly higher rates of chronic endodontic infection in the infarction group.⁴² Larger observational studies have found that endotoxemia from periodontal disease and root canals correlates with cardiovascular events more tightly than cholesterol does.⁴³ A textbook of periodontal medicine states that the evidence is “strong enough to establish oral infections as an independent risk factor for CVD.”⁴⁴

The cardiologist does not ask about the dentist. The dentist does not ask about the cardiologist. Two specialties treating the same disease from opposite ends of the same organism, neither acknowledging the other.

For the extended treatment of the dental side of this problem, see 12 Things Your Dentist Was Trained Not to Tell You.

11. Ejection fraction measures a function the heart does not primarily perform.

Ejection fraction is the master metric of modern cardiology. The percentage of blood in the left ventricle expelled with each beat. Normal is 55 to 70 percent. Below 40 percent is called “reduced” and triggers escalating pharmaceutical intervention. Below 35 percent is the threshold for implantable defibrillator placement, a device costing $50,000 to $100,000 with ongoing surveillance costs. Below 20 percent puts a patient on the transplant list. The number governs decisions about defibrillators, transplants, drugs, prognosis, and the conversation the cardiologist has with the family.

The number measures the volume percentage expelled per beat under the founding assumption that the heart is a pressure-propulsion pump and that the ejection percentage is a meaningful index of that function. As a pressure-propulsion pump, the heart is only about 30 percent efficient. Leon Manteuffel-Szoege, working in Warsaw in the 1940s, demonstrated that blood continues to circulate for up to two hours after the heart stops, and concluded that blood has its “own motor energy” independent of cardiac contraction.⁴⁵ Blood begins flowing in the developing embryo before the heart has formed. Rivers of blood move through primitive vessels while what will become the heart is still an unstructured cluster of cells.⁴⁶ These are not observations the pump model can accommodate.

The specialty’s own diagnostic category called heart failure with preserved ejection fraction (HFpEF) makes the case for the metric’s inadequacy on the specialty’s own terms. HFpEF now constitutes more than half of all heart failure cases. The heart contracts normally. The ejection fraction is preserved, sitting in the 55 to 70 percent range. And the patient is still dying. Every major trial of the cardiovascular drug classes the specialty had built its practice on, applied to HFpEF, has failed to reach its primary endpoint. CHARM-Preserved with candesartan (3,023 patients). PEP-CHF with perindopril (850 patients). I-PRESERVE with irbesartan (4,128 patients, death rates essentially identical between drug and placebo at 52.6 versus 52.3 per 1,000 person-years). TOPCAT with spironolactone (3,445 patients).⁴⁷ The 2023 JACC Heart Failure Scientific Statement conceded that “the pathophysiologic mechanisms driving HF progression in HFpEF remain poorly understood.”⁴⁸ Two SGLT2 inhibitors imported from diabetes practice have shown modest reductions in heart-failure hospitalizations in HFpEF through mechanisms that are still debated, without clear all-cause mortality benefit. What has not appeared inside the pump-model framework is a drug that fixes the physiology the ejection fraction claims to measure.

Peter Langsjoen’s 2019 study demonstrates what happens when the actual cause is addressed. 142 heart failure patients with mean 6.8 years of statin exposure. 94 percent had HFpEF. Treatment protocol: stop the statin, start Q10 at 300 mg per day. NYHA Class I improved from 8 percent to 79 percent. In the subgroup with reduced ejection fraction, mean EF improved from 35 percent to 47 percent. One-year mortality: zero. Three-year mortality: 3 percent.⁴⁹ The metric moves when the treatment addresses the actual injury. The Q-SYMBIO trial confirmed the direction with 420 patients across 17 centers, randomized placebo-controlled: Q10 halved cardiovascular mortality over two years. Number needed to treat to prevent one death: ten.⁵⁰

The metric governs decisions the specialty cannot justify from the physiology. A cheap unpatentable molecule outperforms every major HFpEF drug trial in the specialty’s literature and has not entered guideline care.

For the fully worked case, see Congestive Heart Failure: The Modern Beriberi.

12. The heart is not a pump.

The teaching is old and universal. The heart is a muscular pump that pushes blood through roughly 60,000 miles of vessels. Every downstream intervention on this list, from the drugs that support contractility to the mechanical devices that assist it to the transplants that replace the organ altogether, sits inside this frame.

The mathematics do not close. The heart weighs about 300 grams. The vascular network it supplies extends across sixty thousand miles of vessels. Most of that network is capillaries, so narrow that red blood cells must deform and pass through single file. The pressure required to push blood through this network against the documented resistance exceeds by orders of magnitude what a 300-gram organ could produce. Athletes increase cardiac output by 600 percent during intense exercise. The heart muscle mass does not multiply sixfold in the process. The energy available does not multiply sixfold. Blood continues moving through capillaries even in tissue surgically isolated from cardiac pressure.

The alternative comes from Gerald Pollack’s laboratory at the University of Washington. Pollack demonstrated that water adjacent to hydrophilic surfaces (which include the interior walls of blood vessels) forms a structured layer, distinct from bulk water in liquid or solid phase, that he named the fourth phase of water. This layer carries a negative charge, excludes solutes, and grows when the surface is illuminated by infrared light. In tubes, it generates flow without any pumping. The mechanism can be replicated on a bench.⁵¹ Applied to the vasculature, the model gives blood its own motor. The negatively charged exclusion zone lining the vessel walls repels the negatively charged red blood cells, propelling them along the vessel.

The heart’s actual function, on this model, is to organize the flow into specific vortex patterns. Frank Chester discovered that a specific seven-sided geometric figure, which he named the chestahedron, sits at exactly 36 degrees when nested inside a cube. This is precisely the angle of the heart in the chest. When the chestahedron is spun in water, it generates vortex patterns that match those seen in echocardiograms of the ventricles.⁷ Francisco Torrent-Guasp, working over several decades in Spain, demonstrated that the ventricular muscle fibers form a helical spiral, wrapping around themselves in a figure-eight pattern.⁵² That arrangement is far more complex than a pump wall would need to be, and is exactly what vortex generation would require.

Blood begins flowing in the developing embryo before the heart forms. Rivers of blood move through primitive vessels via the properties of structured water in those vessels, weeks before there is a heart to pump them. When the heart forms, it forms at a bend in an already-flowing stream, the way a hydraulic ram is inserted into an existing river.⁴⁶

What the specialty calls heart failure is not, on this model, primarily pump failure. It is systemic energy deficit, autonomic dysregulation, and the failure of structured water dynamics in the vasculature. The interventions cardiology performs (drugs to force the pump to work harder, mechanical devices to assist pumping, transplants to replace the pump) are all built on a model that misidentifies the organ’s primary function.

The buried medicine confirms the model by working through it. Strophanthus, a cardiac glycoside derived from the seeds of an East African vine, was used in German cardiology for over fifty years for angina, heart failure, and prevention of heart attacks. Coal miners in 1970s Germany died at approximately thirty per year of heart attacks in a workforce of 1,800. After the introduction of strophanthus extract, deaths dropped to two per year. Professor Kern documented the 93 percent reduction.⁵³ A Berlin hospital’s twelve-year series reported that 99 percent of chest pain patients became complaint-free within two weeks on oral strophanthus. A survey of practicing German physicians found that 98 percent reported high effectiveness. The remaining 2 percent described it as “within limits positive.” Not one physician reported negative assessment.⁵³ The mechanism operates through Gilbert Ling’s cellular framework, in which the sodium-potassium pump the specialty was taught to believe in mathematically cannot exist. Ling calculated that the pump would require thirty times more ATP than cells actually produce.⁸ Cells maintain the sodium-potassium distribution through the structure of intracellular water, which forms a gel that geometrically excludes sodium while accommodating potassium. Ouabain, the active compound in strophanthus, supports the formation of that gel.

Strophanthus disappeared from mainstream medicine in the 1970s. Digoxin, the other cardiac glycoside in use, remained. Digoxin is fat-soluble, accumulates in tissue, has a narrow therapeutic window, causes roughly eight thousand US hospital visits annually for toxicity, and produced no mortality benefit in the DIG trial.⁵⁴ The safer medicine, requiring less monitoring, disappeared. The dangerous one, requiring continuous physician supervision and blood tests, survived.

For the extended treatment of the strophanthus story and the cellular biology beneath it, see The Gift from Paradise: Strophanthus and the Heart Medicine That Disappeared, and my summary of Human Heart, Cosmic Heart.

The Cardiologist’s Waiting Room

The next appointment is on the calendar. You have not canceled it. It is Tuesday at 3:15.

You will sit down. The nurse will take your blood pressure. A phlebotomist will draw blood for a lipid panel. Twelve electrodes will go on your chest, wrists, and ankles for the ECG. The cardiologist will study the numbers, find something above threshold, present a treatment plan. You will schedule the next appointment, pick up the prescription, and come back in six months.

Nothing in the sequence will ask about the six years of grief since your husband died, about the antidepressants you were put on after that, about the electrical hum in the house since the smart meter was installed, about the sixteen root canals in your extended family, about the decades of industrial food that stripped the cofactors from your methylation cycle before the homocysteine that will not be tested for climbed to whatever it is now. None of it will be asked because the visit is not structured to ask it.

Cardiology in its current form is a repair industry positioned at the end of a long causal chain. The chain begins in the kitchen, the workplace, the bedroom, the electromagnetic environment, the dentist’s chair, the medicine cabinet, and the accumulated psychological weight the patient carries into the six-month appointment. A cardiology that addressed those upstream causes would be a smaller cardiology, less remunerative, with fewer specialists. The market did not select for that cardiology. The insurance codes do not pay for the diet conversation, the stress conversation, the dental conversation, the medication-review conversation.

The knowledge exists. McCully documented the mechanism in 1969. Ravnskov dismantled the diet-heart hypothesis across three decades of publication. Cowan reframed the organ itself. Kendrick assembled the evidence into two books that any interested reader can obtain. The work was done, and published, and translated into English, and left there. It has been the specialty’s choice not to integrate it.

What remains is the redirected gaze. Toward the food on the table. Toward the water in the glass. Toward the sunlight, the ground, the sleep, the community. Toward the dentist who will remove the root canal that has been leaking anaerobic toxins into the systemic circulation for twenty years. Toward the electromagnetic environment that no cardiologist has ever asked about. Toward strophanthus, still available from a small number of practitioners, still working through the mechanism the specialty walked away from, still ignored.

You will go to the appointment on Tuesday. You will ask the questions the appointment is not structured to handle. What the cardiologist says, or does not say, is the diagnostic finding you take home.

What This Means for the Next Appointment

Before any statin prescription, ask for the absolute risk reduction and the number needed to treat, not the relative risk reduction the promotional materials use. The two numbers can differ by a factor of thirty.

Before any stent recommendation for stable disease, ask about the COURAGE trial and the ORBITA trial by name. The cardiologist knows what they are.

Before any bypass for stable disease, ask about MASS-II.

Before accepting an ejection fraction as a prognosis, ask about the Langsjoen 2019 study and whether Q10 depletion by statins might have contributed to the number.

Ask what homocysteine testing shows. If it has not been performed, ask why not.

Ask whether the specialist has read McCully’s The Heart Revolution, Kendrick’s The Great Cholesterol Con, Ravnskov’s The Cholesterol Myths, or Cowan’s Human Heart, Cosmic Heart. The answer, or the manner of the answer, will tell you what to do next.

Ask about the dentist. Ask what percentage of your teeth are root-canaled or crowned. Ask whether the cardiologist has ever asked a patient about their dentist. If the answer is no, ask why not.

A cardiologist who has read the sources will not be threatened by the questions. One who has not will treat them as obstruction, as internet misinformation, or as denialism. Either response is useful information. The appointment has shifted from a procedure being done to a procedure being negotiated.

For patients already deep in the cascade, on the statin for the third decade, with the stent placed or the bypass performed, told the ejection fraction leaves them with a limited window: the terrain is still upstream. Reversible cardiomyopathy is a recognized category in the specialty’s own literature. Alcoholic cardiomyopathy resolves in 42 percent of cases with abstinence. Tachycardia-induced cardiomyopathy normalizes with rate control. What made the damage produced the damage. Removing what made the damage removes some fraction of the damage.

How to Explain It to a Six-Year-Old

Your heart is like the gardener at the center of a big garden. The gardener does not water every plant one by one. That would be impossible, because the garden is huge and the gardener is small. What the gardener does is stir the water in the pond into a special swirling pattern. The swirling pattern makes the water move through all the little channels in the garden by itself. Every plant gets watered because the swirl keeps going.

The doctors who take care of hearts do not know about the swirl. They were taught in school that the gardener pushes the water through the channels by squeezing very hard. So when the plants start to droop, the doctors give the gardener drugs to make him squeeze harder, or they put in mechanical arms to help him squeeze, or they cut open the channels and put in metal tubes to help the water get through the tight spots. None of it works very well. The plants keep drooping. The gardener gets tired.

What is actually happening is that the water in the garden has stopped swirling properly, because too many bad things have gotten into the garden and messed up the swirl. Bad food. Bad water. Bad worry that never stops. Bad electric humming from the machines everywhere. Bad teeth that are leaking poison into the pond. When you fix those upstream things, the swirl comes back. The plants stop drooping. The water starts flowing through the little channels by itself again.

Once, a long time ago, doctors in Germany used a special medicine that helped the swirl. It came from a plant that grows in Africa. Most heart doctors today have never heard of it. The heart is a gardener. The pump is the story the doctors were taught. The swirl is what actually keeps you alive.

References

1. Interventional cardiologist compensation data, MGMA Physician Compensation Survey, and Medscape Cardiologist Compensation Report 2023.

2. Washington Post, “Statins Committee Members Had Ties to Drug Firms,” October 15, 2004, documenting undisclosed pharmaceutical ties among National Cholesterol Education Program panel members. See also Malcolm Kendrick, The Great Cholesterol Con: The Truth About What Really Causes Heart Disease and How to Avoid It (London: John Blake Publishing, 2008).

3. Yerushalmy, J. and Hilleboe, H.E. “Fat in the Diet and Mortality from Heart Disease: A Methodologic Note.” New York State Journal of Medicine 57 (1957): 2343–2354.

4. Kilmer S. McCully, The Heart Revolution: The Extraordinary Discovery That Finally Laid the Cholesterol Myth to Rest (New York: HarperPerennial, 1999). McCully's original paper: McCully KS, "Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis," American Journal of Pathology 56 (1969): 111–128. Biographical details and the account of the Harvard/Mass General basement banishment are drawn from Michelle Stacey, "The Fall and Rise of Kilmer McCully," New York Times Magazine (August 10, 1997); and the New York Times obituary, "Kilmer McCully, Pathologist Scorned for Heart Disease Theory, Dies at 91" (March 21, 2025). McCully lived December 23, 1933 – February 21, 2025.

5. Uffe Ravnskov, The Cholesterol Myths: Exposing the Fallacy That Saturated Fat and Cholesterol Cause Heart Disease (Washington, DC: NewTrends Publishing, 2000). The book burning incident on Swedish television is documented in Ravnskov’s public writings and in various profiles of THINCS.

6. Ravnskov U et al., “Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review,” BMJ Open 6 (2016): e010401. Ravnskov U et al., “LDL-C does not cause cardiovascular disease: a comprehensive review of the current literature,” Expert Review of Clinical Pharmacology 11 (2018): 959–970.

7. Thomas Cowan, Human Heart, Cosmic Heart: A Doctor’s Quest to Understand, Treat, and Prevent Cardiovascular Disease (White River Junction, VT: Chelsea Green Publishing, 2016).

8. Gilbert Ling, Life at the Cell and Below-Cell Level (New York: Pacific Press, 2001), and Gilbert Ling, A Revolution in the Physiology of the Living Cell (Malabar, FL: Krieger Publishing, 1992). Ling’s calculations of the ATP requirement for the sodium-potassium pump and his stripped-membrane experiments are summarized in Cowan, Human Heart, Cosmic Heart, and in the strophanthus literature at newbiologyclinic.com.

9. Framingham Heart Study, 30-year follow-up data, discussed extensively in Ravnskov, The Cholesterol Myths, and Kendrick, The Great Cholesterol Con. William Castelli’s admission on saturated fat and serum cholesterol appears in Castelli WP, “Concerning the possibility of a nut...,” Archives of Internal Medicine 152 (1992): 1371–1372.

10. Multiple Risk Factor Intervention Trial (MRFIT) Research Group, various publications 1982–1996, discussed in Ravnskov, The Cholesterol Myths.

11. Malcolm Kendrick, The Clot Thickens: The Enduring Mystery of Heart Disease (Columbus Publishing, 2021).

12. Peter Langsjoen and Alena Langsjoen, “The clinical use of HMG CoA-reductase inhibitors and the associated depletion of coenzyme Q10,” BioFactors 18 (2003): 101–111. See also Karl Folkers et al., “Lovastatin decreases coenzyme Q levels in humans,” Proceedings of the National Academy of Sciences 87 (1990): 8931–8934.

13. Marcoff L, Thompson PD, “The role of coenzyme Q10 in statin-associated myopathy: a systematic review,” Journal of the American College of Cardiology 49 (2007): 2231–2237. Qu H et al., “Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis,” European Journal of Medical Research 23 (2018): 57.

14. United States Patent 4,929,437, “Coenzyme Q10 with HMG-CoA reductase inhibitors,” issued May 29, 1990. United States Patent 4,933,165, “Coenzyme Q10 with HMG-CoA reductase inhibitors,” issued June 12, 1990 (Michael S. Brown, inventor). Both assigned to Merck & Co.

15. Malcolm Kendrick, The Great Cholesterol Con, chapter on statin side effects.

16. Boden WE et al. (COURAGE Trial), “Optimal medical therapy with or without PCI for stable coronary disease,” New England Journal of Medicine 356 (2007): 1503–1516.

17. Al-Lamee R et al. (ORBITA), “Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial,” The Lancet 391 (2018): 31–40.

18. Maron DJ et al. (ISCHEMIA), “Initial invasive or conservative strategy for stable coronary disease,” New England Journal of Medicine 382 (2020): 1395–1407.

19. Coronary Artery Surgery Study (CASS) Principal Investigators, “Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery,” Circulation 68 (1983): 939–950, and related follow-up publications.

20. Hueb W et al., “Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study II (MASS II),” Circulation 122 (2010): 949–957.

21. Giorgio Baroldi, “Coronary heart disease: significance of the morphologic lesions,” American Heart Journal 85 (1973): 1–5, and subsequent autopsy series. Discussed in Cowan, Human Heart, Cosmic Heart, and Stephen Hussey, Understanding the Heart (White River Junction, VT: Chelsea Green Publishing, 2022).

22. Zir LM et al., “Interobserver variability in coronary angiography,” Circulation 53 (1976): 627–632, and subsequent replications.

23. Blaha MJ et al., “Coronary artery calcium scoring: is it time for a change in methodology?” JACC Cardiovascular Imaging 10 (2017): 923–937. Discussion of the paradox that calcification indicates stability rather than danger appears throughout Kendrick, The Clot Thickens.

24. SPRINT Research Group, “A randomized trial of intensive versus standard blood-pressure control,” New England Journal of Medicine 373 (2015): 2103–2116. Critique of the unattended BP measurement protocol appears in Kjeldsen SE et al., “Unattended blood pressure measurements in the Systolic Blood Pressure Intervention Trial: implications for entry and achieved blood pressure values compared with other trials,” Hypertension 67 (2016): 808–812.

25. Diao D et al., “Pharmacotherapy for mild hypertension,” Cochrane Database of Systematic Reviews 8 (2012): CD006742.

26. Siri-Tarino PW et al., “Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease,” American Journal of Clinical Nutrition 91 (2010): 535–546.

27. Chowdhury R et al., “Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis,” Annals of Internal Medicine 160 (2014): 398–406.

28. de Souza RJ et al., “Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies,” BMJ 351 (2015): h3978.

29. Ramsden CE et al., “Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis,” BMJ 346 (2013): e8707.

30. Ramsden CE et al., “Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73),” BMJ 353 (2016): i1246.

31. Nina Teicholz, The Big Fat Surprise: Why Butter, Meat and Cheese Belong in a Healthy Diet (New York: Simon & Schuster, 2014).

32. James DiNicolantonio, The Salt Fix: Why the Experts Got It All Wrong and How Eating More Might Save Your Life (New York: Harmony Books, 2017).

33. Mente A et al. (PURE), “Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies,” The Lancet 388 (2016): 465–475.

34. Kearns CE, Schmidt LA, Glantz SA, “Sugar industry and coronary heart disease research: a historical analysis of internal industry documents,” JAMA Internal Medicine 176 (2016): 1680–1685.

35. Selhub J et al., “Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis,” New England Journal of Medicine 332 (1995): 286–291 (Framingham data).

36. Graham IM et al., “Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project,” JAMA 277 (1997): 1775–1781.

37. Rimm EB et al., “Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women,” JAMA 279 (1998): 359–364.

38. Lonn E et al. (HOPE-2), “Homocysteine lowering with folic acid and B vitamins in vascular disease,” New England Journal of Medicine 354 (2006): 1567–1577. Stroke as a secondary endpoint: hazard ratio 0.75 (95% CI 0.59–0.97, p=0.03). The primary composite endpoint (cardiovascular death, MI, stroke) did not reach statistical significance.

39. Bønaa KH et al. (NORVIT), “Homocysteine lowering and cardiovascular events after acute myocardial infarction,” New England Journal of Medicine 354 (2006): 1578–1588. Toole JF et al. (VISP), “Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial,” JAMA 291 (2004): 565–575. Both trials were null for their composite cardiovascular endpoints.

40. Debreceni B, Debreceni L, “The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease,” Cardiovascular Therapeutics 32 (2014): 130–138. Discussion of methylation-cycle bioavailability differences between folic acid and methylfolate appears in Scaglione F, Panzavolta G, “Folate, folic acid and 5-methyltetrahydrofolate are not the same thing,” Xenobiotica 44 (2014): 480–488.

41. George E. Meinig, Root Canal Cover-Up (Bion Publishing, 1998), documenting Weston Price’s twenty-five-year research program, the rabbit-implantation studies, the endocarditis case in which 28 of 30 rabbits died, and the sterilized-powder experiments demonstrating that the toxin remained potent after bacterial removal.

42. Willershausen I et al., “Association between chronic dental infection and acute myocardial infarction,” Journal of Endodontics 35 (2009): 626–630.

43. Stephen Hussey, Understanding the Heart: Surprising Insights into the Evolutionary Origins of Heart Disease and Why It Matters (White River Junction, VT: Chelsea Green Publishing, 2022), chapter on dental-cardiac connections.

44. Louis F. Rose et al., eds., Periodontal Medicine (Hamilton, ON: BC Decker, 2000), cited in Hussey, Understanding the Heart.

45. Manteuffel-Szoege L, “Remarks on the circulation of the blood following stopping of the heart,” Journal of Cardiovascular Surgery 7 (1966): 201–208. Discussed in Hussey, Understanding the Heart, chapter 6.

46. Embryological observations on pre-cardiac blood flow are documented in Branko Furst, The Heart and Circulation: An Integrative Model (London: Springer, 2013), and discussed in Cowan, Human Heart, Cosmic Heart.

47. Yusuf S et al. (CHARM-Preserved), The Lancet 362 (2003): 777–781. Cleland JGF et al. (PEP-CHF), European Heart Journal 27 (2006): 2338–2345. Massie BM et al. (I-PRESERVE), New England Journal of Medicine 359 (2008): 2456–2467. Pitt B et al. (TOPCAT), New England Journal of Medicine 370 (2014): 1383–1392.

48. Desai AS et al., “2023 JACC Heart Failure Scientific Statement on heart failure with preserved ejection fraction,” JACC Heart Failure (2023).

49. Langsjoen PH et al., “Statin-associated cardiomyopathy responds to statin withdrawal and administration of coenzyme Q10,” The Permanente Journal 23 (2019): 18.257.

50. Mortensen SA et al. (Q-SYMBIO), “The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial,” JACC Heart Failure 2 (2014): 641–649.

51. Gerald H. Pollack, The Fourth Phase of Water: Beyond Solid, Liquid, and Vapor (Seattle: Ebner and Sons Publishers, 2013).

52. Torrent-Guasp F et al., “The structure and function of the helical heart and its buttress wrapping. I. The normal macroscopic structure of the heart,” Seminars in Thoracic and Cardiovascular Surgery 13 (2001): 301–319, and Torrent-Guasp F et al., “Towards new understanding of the heart structure and function,” European Journal of Cardio-Thoracic Surgery 27 (2005): 191–201.

53. German clinical literature on strophanthus compiled by Dr. Knut Sroka and Dr. Rolf-Jürgen Petry, archived at strophantus.de and in the Internet Archive. Coal miners data from Professor Kern, 1970s Germany. Berlin hospital twelve-year series and the survey of German physicians documented in “The Gift from Paradise: Strophanthus and the Heart Medicine That Disappeared,” Lies Are Unbekoming, February 4, 2026.

54. Digitalis Investigation Group, “The effect of digoxin on mortality and morbidity in patients with heart failure,” New England Journal of Medicine 336 (1997): 525–533. Digoxin toxicity hospital visit data from Patel N et al., “Digoxin Toxicity,” in StatPearls (2024).

All the blood in the body passes through the thyroid gland every seventeen minutes, and during each passage the gland’s iodine kills weak germs and weakens strong ones — provided iodine is present. Eighty-five sterilisation cycles in twenty-four hours, running automatically, costing nothing, requiring only that the chemical agent be there to do the work. Folk Medicine: A Doctor’s Guide to Good Health, published in 1958 by D. C. Jarvis, documents this mechanism alongside a more uncomfortable observation: chlorinated drinking water and table salt strip iodine from the body through the halogen displacement law, because lighter halogens displace heavier ones from biological tissue. Chlorine displaces iodine. Fluorine displaces all three. The seventeen-minute cycle continues running, but empty.

Jarvis was a fifth-generation Vermonter who trained in organised medicine at Burlington, served as an ear-nose-throat physician in Barre for over fifty years, and conducted a twenty-year correspondence study with fifty nationally known doctors — many of them faculty members at medical schools — across thirty-two states. The letters went out Tuesdays and Fridays, basing their findings on cumulative observations from his clinical practice. He came to the work as a trained specialist who recognised, on arriving in Barre, that he would need to learn the indigenous medicine of the back-road farms if he hoped to gain the confidence of the people he served. The book is the testable residue of that fifty-year practice — protocols followed in dairy herds and human patients, urine reactions recorded over two years by twenty-four “human guinea pigs,” milk-production tables across multiple seasons.

By 1958 the pharmaceutical model was well established and the older nutritional traditions were being displaced from medical training. Sulphanilamide had been tried on the Jersey cow with chronic mastitis “for two years” and had failed; vinegar resolved it. Penicillin was being used to save seriously sick cows in herds not receiving iodine. Chlorination of municipal water supplies was treated as settled public health, the halogen-displacement consequence unmentioned. Honey, which Sackett had documented at Colorado Agriculture College as killing typhoid germs in forty-eight hours and dysentery germs in ten, was being replaced on American tables by manufactured corn syrup. Jarvis was writing into a moment when what farm communities had known for generations was being stripped from clinical practice and replaced with patented substitutes that suppressed symptoms while leaving the underlying terrain unaddressed.

The framework sits within the older terrain tradition that Béchamp and Bernard articulated and that Shelton extended into the suppression-to-chronic-disease pathway: the soil determines what grows, the symptom is the body’s intelligent response, the suppression of the symptom drives the acute toward the chronic. The full summary unpacks the bacterial pH table supplied to Jarvis by a medical-school bacteriology department — every pathogenic organism on the list grows on alkaline media, every one — alongside the 23 boarder cows whose pregnancies started within four months on apple-cider vinegar, the eight-year-old boy whose five-month head cold cleared within five minutes of his first chew of honeycomb, and Cavanaugh’s demonstration at Cornell that kelp reduces fracture healing time by twenty per cent. The Andean Peruvians at 16,000 feet make the month-long round trip to the Pacific to fill little bags with kelp, which they carry carefully. They use it, they say, to guard the heart.

Read more

In 1924, Arm & Hammer distributed a twenty-eight-page booklet to physicians describing sodium bicarbonate as clinical medicine — for influenza, kidney disease, gastric distress, uric acid disturbances, respiratory illness, and the general support of the body’s cleansing processes. Arm & Hammer, as the manufacturer, could not distribute that booklet today. The substance is unchanged. What changed is the regulatory environment, which now restricts what manufacturers of unpatentable compounds can say about them.

Two of those compounds are the subject of the two books out today. Both were in every kitchen. Both were routine medicine for generations. Both were quietly written out of the professional conversation as the drug model took over. Neither has stopped working. Neither is expensive. Neither is new. What they are is recovered.

Baking Soda: The Terrain Book on the Compound Medicine Forgot

Buy on Lulu → · 289 pages · USD $19.99

This is a brand new book, available now for the first time.

Baking Soda locates sodium bicarbonate inside the terrain framework that industrial medicine buried. It maps what the compound does at the level of the blood, the kidneys, the lungs, the digestion, the mouth, the skin, and the acidic tissue that industrial modernity produces. It is honest about what bicarbonate cannot do, and about what must accompany it — hydration, minerals, breath, the removal of what is driving the acidity in the first place — for the framework to actually work.

Across eighteen chapters and three Q&A appendices, the book covers the physiology, the historical burial of the terrain framework, and the specific applications: respiratory, kidney, digestive, athletic, dental, transdermal baths, and cancer — where bicarbonate is documented in research on altering the tumour microenvironment.

The compound is cheap. The compound is in every grocery store. The compound is one of the safest substances in general medical and household use. And it has been progressively excluded from the professional medical conversation while remaining freely available to any reader willing to acquire it and understand what it does.

For the family that wants a single reference on a compound they already own. For the reader who has heard terrain mentioned and wants to see it in practice on a substance they can hold.

A word on the second edition

The next book, Castor Oil, first appeared as a digital edition earlier this year. Readers of that first edition should know that the print edition is substantially different — not a reprint, but a second edition, revised and expanded.

The revision is substantial — restructured from the ground up. The clinical record of Dr. William McGarey’s A.R.E. Clinic — the largest single body of documented castor oil practice in modern medicine — is now integrated throughout rather than referenced. Barbara O’Neill’s contemporary teaching from her retreat in the New South Wales mountains sits alongside it. Ulric Williams’s surgical observations from 1930s New Zealand, Edgar Cayce’s Palma Christi tradition, D.C. Jarvis’s Vermont folk practice, and the terrain framework as taught by Tom Cowan are all woven in.

Ten appendices give you the pack construction, the McGarey survey, companion kitchen remedies, sourcing and quality, protocols for the first month, frequently asked questions, and the Vermont tradition. A full index sends you to what you need. If you have the first edition on your screen, this is the version you keep on the shelf.

The Castor Oil Book: The Kitchen Medicine That Nearly Disappeared

Buy on Lulu → · 220 pages · USD $19.99 · Second Edition, Revised and Expanded

Castor oil is the medicine mainstream healthcare quietly stopped talking about. Not because it stopped working — it didn’t. Because a two-dollar bottle from the pharmacy doesn’t sit well in a system built on prescriptions and procedures. So it faded into the background, and with it, four thousand years of documented practice.

This book recovers that practice.

Twenty-two chapters cover kidney stones, appendicitis, liver congestion, fibroids, adhesions, breast conditions, chest conditions, the male terrain, and pediatric applications. The clinical observations behind each are documented. The protocols are given in full. The limitations are stated honestly. The reader is trusted to read the record and decide what to do with it.

For the household that wants one honest reference on a compound already in the cupboard. For the person who has been told there is nothing to be done and wants to see what four thousand years of practice actually documents.

The shelf

Ten books now. More coming.

The first five took on specialisms trained not to see the thing they treat — motherhood, vaccination, dentistry, veterinary medicine, psychiatry. The next three took on suppressed remedies and the germ-theory question underneath — DMSO, chlorine dioxide, and No Contagion (co-authored with Jamie Andrews). These two take on something quieter and closer to home: the compounds already in the kitchen, and the framework that makes them make sense.

That framework has a name. Terrain. It is what medicine looked like before the drug model, and what medicine will need to look like again if it is going to address the chronic disease that the drug model has produced. Each of these books is a piece of that recovery.

The books are printed to order and shipped worldwide from Lulu. The full shelf is at lulu.com/spotlight/unbekoming.

A note of thanks

None of this shelf would exist without the people carrying it. Those of you who bought one book to try it, then came back for a second. Those buying two or three at a time. Those buying the full set, sometimes more than one copy of the same title to give to a friend or a parent. I see every order. Each one is a real person deciding that this work is worth space on their shelf and dollars from their week. Thank you. I do not take that lightly.

— Unbekoming

Feargus O’Connor Greenwood’s 180 Degrees: Unlearn The Lies You’ve Been Taught To Believe ran to 700 pages of citations, footnotes, and cross-referenced sources — 15,000 hours of research designed to move readers gradually from unquestioning belief in official narratives to critical scepticism. Its follow-up, Spiritual War: Tales of the Unexpected — Part 1, opens with the author lying in bed being “spooned” by an invisible presence in a locked, empty house, his nervous system firing as if hooked to a low-voltage socket. This is not a sequel. Greenwood calls it “a radical departure,” and he means it. Where 180 Degrees was engineered to slide readers from A to Z, Spiritual War “starts at Z and then tosses them off the cliff. This is Sparta.” The earlier book was aimed at nudging “the herd” into questioning the official narrative; this one targets the “sceptical independent thinkers” who already got out, and asks them to consider what lies beyond materialism itself. Where 180 Degrees addressed what Greenwood terms “fifth generation warfare — the war for your mind,” Spiritual War addresses “tenth generation warfare — the war for your soul.”

Full disclosure. I read 180 Degrees at a moment when I badly needed it. After Kennedy’s The Real Anthony Fauci had cracked the AIDS narrative open for me, and Liam Scheff’s Official Stories and Joe Plummer’s Tragedy & Hope 101 had shown me the wider architecture of manufactured reality, 180 Degrees arrived and sat above all of them. It taught me more than any book I have ever read. When I interviewed Greenwood in October 2023, he told me his next book would be on “a more spiritual tip” — the least and most spiritual book the reader would ever encounter, combined into one. Spiritual War is that book, and it delivers on the promise.

Greenwood chose humour as his “main vector of attack” — an unusual choice for material this heavy, but a deliberate one. Dialogue is set in script format. Personal anecdotes carry the argument. Part I contains no formal bibliography, only inline references and QR codes; Greenwood didn’t want an academic feel because “many of the ‘tales’ are not citable.” The reader is dropped into a series of scenes: a psychic lodger sketching a French spirit guide named Elena; an 81-year-old friend named Abner who has been astral-travelling since he was five; a woman who describes herself as a “walk-in” who possessed her own body after a suicide attempt; a 75-year-old channelling a Hopi Indian who clears a chronic throat blockage in thirty seconds. The method sounds indefensible on paper. It works on the page because Greenwood is a genuinely funny writer and because the anecdotes cluster into patterns rather than sitting as isolated oddities.

The book’s spine is Greenwood’s own conversion. A London maths graduate and self-described committed rationalist, he documents his own left-brain favouritism and the atomically slim odds of ever going “inter-dimensional.” The turning point is the bedroom encounter, followed by what he calls his “T-system” — a full-body tingle response that begins triggering at unpredictable moments. In the Victoria & Albert Museum, it fires at the coffin effigy of Eleanor of Aquitaine. Through his lodger Tales, whose sketches and channelled messages he treats as data rather than décor, he identifies two persistent spirit guides. Greenwood is careful throughout to state what he cannot prove and to let the reader adjudicate. The framing is closer to field notes than to revelation.

The theoretical backbone comes from Jerry Marzinsky, the psychologist whose four decades of work with schizophrenic patients led him to conclude that “the voices” are not internal at all. When patients asked the voices who they were, the answer was always “we are you.” Marzinsky’s clinical position — that the voices lie systematically about their origin in order to keep the host identified with them — sits alongside Robert Falconer’s argument in The Others Within Us that minds are porous, and the assumption of the mind as a sealed private fortress is catastrophically wrong. Greenwood layers in the Catholic three-stage model of oppression, obsession, possession, and the observation that looped negative memories generate the emotional charge non-human entities are said to feed on. The material is presented as testable rather than doctrinal: revisit a bad memory; if the associated emotion no longer fires, the shadow work on that item is complete.

Chapter 9 is where the book earns its keep as a practical manual. Greenwood sets out eight defence protocols in sequence: shadow work, awareness, cleaning the temple, discernment, verbal dismissal, command and control, psychic weapons for quiet wars, and leveraging the herd. The section on shadow work draws on Bert Hellinger’s Family Constellations therapy and includes a lengthy first-person account from Ben Hawkes — the man who narrated the 180 Degrees audiobook — describing how the resolution of a past-life debt cleared both a chronic marital conflict and a set of business obstacles that had been moribund for years. “Clean the temple” addresses fluoride, GMO food, EMFs, blue-light overload, and physical decluttering. “Psychic weapons” covers intuition, mental strength, non-attachment, fearlessness, and the transmutation of anger into determination. Whatever the reader makes of the ontology, the protocols read as sane hygiene practice for anyone under sustained psychological pressure.

Greenwood’s case for why this book exists now runs through the final chapter. Ancient prophecies across multiple traditions describe a coming bifurcation — a great split in humanity — with what the esoteric literature calls “8th Sphere soul capture” as the losing outcome. Rudolph Steiner, in an October 1917 lecture, described a future in which people would be inoculated against their disposition towards spiritual ideas and materialistic physicians would be entrusted with expelling the souls from mankind. The current push toward what David A. Hughes calls Omniwar — “a stealth war waged against cognition and rationality, across every domain of life” — is, in Greenwood’s reading, the surface layer of something older. Transhumanism and bio-digital convergence are presented as the operational endpoint, with the book citing academic papers advocating what their authors term “anti-love biotechnology” — the search for a chemical cure for love. Greenwood’s preferred term for the whole is not Omniwar but Spiritual War, because that frame focuses attention on where the actual battle lies and what it is aimed at.

180 Degrees was a book you handed to people who still believed the mainstream account. Spiritual War is a book you hand to people who have already burned that account and are looking for what comes next. It will lose some readers early — the opening bedroom scene will end it for a certain kind of sceptic — and Greenwood knows it. He is not writing to convert anyone. He is laying out testimony, patterns, and protocols, and letting the reader do the work. Part II is coming, and he signals it will “go for the Demiurge’s jugular” — a sharper, darker book on the war for the soul proper. This one is the on-ramp: personal, funny, unnerving, and structurally serious under the levity. For anyone who found 180 Degrees to be a master key, Spiritual War is what the key was for.

SPIRITUAL WAR: Tales Of The Unexpected: Part I: Greenwood, Feargus O'Connor: Amazon.com: Books

Author’s note: This essay continues my work on remedies that cannot be patented and have been displaced by ones that can. Jarvis’s iodine protocol sits at the clearest end of that pattern: documented in two published books, prescribed to named patients, almost entirely absent from mainstream practice today. It costs a few dollars a year. The territory it opens onto, the modern management of anxious and dysregulated children, is contested; I have kept my focus on what Jarvis observed and how it was displaced. My thanks to the paid subscribers who make this work possible.

“Dr Jarvis, what am I going to do? One of these girls is a racehorse and the other is a farm horse.”

The mother had five-year-old twin daughters. One was nervous, highly-strung, irritable, always ready to fight. The other had a calm, even disposition, peaceful and quiet. The racehorse twin kept her sister and her mother in a permanent state of upset. Spanking made it worse. She blew up. The mother had no idea how to live with the child.

Jarvis’s answer was two drops of Lugol’s solution of iodine plus a teaspoon of apple cider vinegar in a glass of water. Given any time the child’s temper shifted into high gear. Two weeks later the mother reported that her racehorse daughter had quieted within two hours of the first dose. With continued use, the child could be managed. By the time she graduated high school the tantrums of her early years were behind her. She married. She kept her home. If she ever again felt her constitution slip into high gear, she knew what to do about it.¹

That five-year-old, today, would be evaluated for attention-deficit hyperactivity disorder or oppositional defiant disorder, prescribed a Schedule II controlled substance (methylphenidate or amphetamine), and monitored for years. The CDC now reports that roughly one in nine American children between the ages of three and seventeen has been diagnosed with ADHD, and a majority of them take a prescription stimulant.²

Two treatments. Two therapeutic worlds. Between them sits a constitutional framework that used to be recognized and a set of industrial and pharmaceutical decisions that made it invisible.

Audio Deep Dive (for Paid Subscribers)

The Second Case

Jarvis did not stop with the twin. In the same chapter he describes a second child, unrelated to the first. Her mother had been a professor at a women’s college before her marriage; her father was a university graduate. The elder daughter was even-tempered and easy to live with. The second was the racehorse type. The mother came to Jarvis with the same complaint. Jarvis prescribed the same remedy. Within two hours the child was different. She grew into a successful college student who developed her mind and her artistic ability and made friends easily.¹

Two cases is not a trial. Jarvis did not claim it was. What he claimed was a reproducible pattern: a constitutional type that responded, on a specific timeline, to a specific intervention. He also ran a two-year observational study of twelve small children under the age of five, testing whether children became ill on an alkaline urinary background and recovered when the urine returned to acid. That was the study the twins came from. The dosing responses were repeatable enough that Jarvis wrote, of the calming effect on nervous children, “I have never seen it fail to calm down a nervous child.”³

A Constitutional Category

The racehorse type is not a metaphor Jarvis reached for once. It is a working clinical category running through both books. Some children come into the world with their sympathetic nervous system dominant. The human motor idles in high gear. Sleep is difficult, attention scattered, emotional reactivity high. The body is organized for combat when combat is not required.

Jarvis attributed the pattern in part to the parents’ diet before conception, particularly the mother’s, and to the diet the child was raised on. He described the two divisions of the autonomic nervous system as the two gears of a motor. Sympathetic dominance produces the racehorse constitution. Parasympathetic dominance produces the farm horse. The mapping onto the autonomic system is standard physiology. What Jarvis added was the observation that the gear could be shifted.

He tested it on animals first. Pugnacious bulls calmed down within a month or two on a daily dose of apple cider vinegar poured over the ration. The same intervention shifted cross dogs, irritable horses, and mastitis-prone dairy cows toward docility. In humans, two teaspoons of vinegar and two of honey in a glass of water, taken at each meal, produced the same shift.⁴ When that was not enough, when the constitutional pull toward high gear was strong, Jarvis added iodine.

The pattern itself is not what modern medicine disputes. What is disputed is where it comes from and what to do about it. Current practice treats the pattern as neurodevelopmental, largely fixed, requiring pharmaceutical management often for the whole of childhood and increasingly into adult life. Jarvis treated it as a state, produced and sustained by daily nutrition, correctable through the same channel.

What Iodine Does

Jarvis attributed three functions to iodine, none mystical, all anchored in observable outcomes.

The first was energy. Depleted energy and endurance, he wrote, are commonly a sign of low iodine intake. He asked, of any patient presenting with fatigue, whether the soil of the state they lived in was iodine-poor and whether any dietary source of iodine was in place. The thyroid gland concentrates iodine and produces the hormones that set the basal rate of energy production in every cell. Insufficient iodine means insufficient thyroid hormone, which means insufficient cellular energy.³

The second was the calming of nervous tension. “When nervous tension runs high,” Jarvis wrote, “there is irritability and difficulty in sleeping well at night, and the body is continually on a combat basis, organised for fight and flight.” His observation was that iodine, in small doses, shifted the body out of that continuous combat organization and into rest. Thyroid function affects the metabolism of adrenaline and the tone of the autonomic nervous system. What Jarvis had was the clinical observation and the reproducible dose.³

The third was clear thinking. “The mind simply works better,” he wrote, “when the body is supplied the iodine it needs.”³ Sally Fallon, four decades later, cataloged corroborating findings: iodine depletion has been linked to cognitive impairment, mood disturbance, and delayed mental development.⁵ Paul Bergner cataloged the same set of findings. Anxiety, depression, hyperactivity, and insomnia cluster with depletions in iodine, magnesium, zinc, and B-group nutrients, especially in populations eating industrial food.⁶

The picture Jarvis drew is coherent. A child running in permanent high gear, unable to settle at night, irritable and hard to discipline by day, is a child whose energy-regulating machinery is being asked to run without a critical mineral input. Add the mineral back and the machinery can regulate.

The two-hour timeline Jarvis reports across cases is not what pharmacology would predict from correcting a nutritional shortfall. Restoring the thyroid’s iodine stores takes weeks. The rapid calming effect points to a different mechanism, and the protocol itself suggests what it is.

Apple cider vinegar has documented effects on postprandial glucose. Acetic acid slows gastric emptying and blunts the glucose spike that follows a carbohydrate-heavy meal, in some studies by twenty to thirty percent.¹¹ Honey provides a lower and slower glycemic curve than refined sugar. Sipped through a meal, the mixture flattens the spike-and-crash pattern that follows standard modern eating.

That pattern is where the racehorse child gets hit. When blood sugar crashes an hour or two after a high-glycemic meal, the body compensates with a surge of adrenaline. In an adult this feels like the mid-afternoon jitters. In a sympathetic-dominant child it presents as irritability and the classic pre-dinner meltdown. Flatten the glucose curve and the adrenaline surge does not fire.

Iodine works on a slower clock. Rebuilding thyroid stores and shifting autonomic tone takes weeks, which is why Lugol’s has been used therapeutically for over a century in doses larger than what current guidelines call sufficient. Jarvis’s protocol is a compound intervention: vinegar and honey give the fast calming, iodine gives the sustained shift. He was not choosing between them. He was giving both, at every meal, and he saw the fast effect first.

The Halogen Displacement

Iodine’s chemistry makes it structurally vulnerable. It sits at the bottom of the halogen group, the column containing fluorine, chlorine, bromine, and iodine, with the highest atomic weight of the four. Within the halogen group, lighter elements displace heavier ones from the biological sites they compete for. Fluorine displaces chlorine, bromine, and iodine. Chlorine displaces bromine and iodine. Bromine displaces iodine. Iodine displaces none of them.³

Jarvis names this in Folk Medicine and draws the practical conclusion: chlorinated drinking water strips iodine from the thyroid. So does excess sodium chloride. He does not name fluoride because in 1961 municipal fluoridation was a new program. Fluorine sits at the top of the displacement hierarchy, a stronger iodine-stripper than chlorine, and now enters daily consumption through both municipal water and toothpaste. He does not name bromine as a dietary contaminant because the industrial substitution that would put bromine into the daily bread of every American child had not yet happened. But he lays out the chemistry that predicts both.

This is the mechanical backbone of the suppression story. Iodine is not stolen from the body by malice. It is displaced by lighter halogens introduced into daily consumption. Fluoridate the water, chlorinate it, switch the flour additive from an iodine compound to a bromine compound, and the child eating and drinking will lose iodine at every meal. The thyroid gland, which the entire blood volume passes through every seventeen minutes, gets scrubbed of the mineral it depends on.

Wolff-Chaikoff

In 1948, two researchers at Berkeley, Jan Wolff and Israel Chaikoff, published a study showing that rats given large doses of iodide showed a temporary suppression of thyroid hormone production. The effect was transient. The rats adapted within days and thyroid function resumed normally. What the paper described was the thyroid’s own homeostatic regulation.⁷

The paper was cited for something else. Over the following decades, medical practice absorbed the study as evidence that therapeutic iodine dosing was dangerous. The transient nature of the effect in rats, its subsequent full reversal, its irrelevance to the doses used in clinical practice, none of this made it into standard teaching. What made it into standard teaching was: iodine in doses larger than trace amounts is thyroid-suppressive and should be avoided. Guy Abraham, the endocrinologist who spent decades documenting iodine’s clinical history, described the interpretation as a misreading that acquired the status of received truth and was cited thereafter without re-examination.⁸

Before Wolff-Chaikoff, iodine at therapeutic doses had been a standard medical intervention for nearly a century. Jarvis in 1961 was still working in that tradition. Every pharmacist knew how to make Lugol’s, every drugstore carried it in stock, and the doses he prescribed for adults were larger than what current guidelines call the upper safe limit. Nothing had changed about iodine. What had changed was the willingness of physicians to prescribe it. A paper became the reason a therapy that had worked for a century was progressively withdrawn from mainstream practice.

The Bromate Swap

The second structural change happened in commercial baking. Bread had been the major dietary source of iodine for American children through most of the twentieth century, first because iodized salt was used in commercial baking and then, from the 1940s onward, because potassium iodate was routinely added to bread as a dough conditioner. A single slice contained roughly 150 micrograms of iodine, the amount now designated as the full daily RDA.⁹

Beginning in the 1980s, commercial bakers replaced potassium iodate with potassium bromate. The stated reason was that bromate produced a better dough: higher rise, better texture, longer shelf life. What was accomplished at the same time was two changes running in opposite directions. The largest single dietary source of iodine for American children was removed. A halogen that displaces iodine in the thyroid was introduced in its place. Every slice of commercial bread now contains not the mineral the child needs but the mineral that flushes what remains.

Median urinary iodine concentrations in the United States, tracked by NHANES, dropped by roughly half between the early 1970s and the mid-1990s and have not fully recovered.¹⁰ The population is more iodine-depleted than it has been at any point since the pre-iodization era.

The substitution is documented. It appears in food-industry technical literature. The population depletion that followed appears in NHANES. Neither triggered any regulatory reversal.

What Filled the Space

Between 1961 and now, Lugol’s solution left the counter of the neighborhood pharmacy. Iodine as a therapeutic tool for fatigue and the anxious constitution left routine medical practice. In its place a new therapeutic category grew: pharmaceutical management of the same constitutional pattern Jarvis was correcting with two drops in a glass of water.

Methylphenidate was patented in 1954. Its use expanded slowly through the 1960s and 1970s, mostly for what was then called minimal brain dysfunction. The category was renamed attention-deficit disorder in 1980 and attention-deficit hyperactivity disorder in 1987. Prescriptions climbed. Amphetamine formulations were reintroduced for the same category through the 1990s. By the late 2010s, roughly 3.5 million American children were taking a prescription stimulant daily. The figure has continued to grow.² Market analyses put global ADHD medication sales at approximately twenty billion dollars annually.¹²

The diagnostic naming has fragmented what Jarvis treated as one thing. Both of his cases, the tantrum twin and the professor’s daughter, would today move through evaluations that split the racehorse constitution across several separate labels: ADHD for the inattention and restlessness, oppositional defiant disorder for the fighting and the tantrums, disruptive mood dysregulation disorder for the outbursts, generalized anxiety for the underlying tone. Each label carries its own medication protocol. Each of those medications has its own patent, its own manufacturer, its own marketing budget, its own physician-education pipeline. The racehorse constitution is not in the DSM.

Iodine cannot be patented. Neither can apple cider vinegar or honey. The protocol Jarvis prescribed to the mother of the twin costs a few dollars a year. There is no commercial infrastructure with an interest in that protocol being recovered, and there is a large commercial infrastructure with an interest in the constitutional pattern it treats being permanently renamed and permanently medicated. Neither observation is a conspiracy claim. Both are visible in the disclosed financial statements of the companies involved.

The suppression argument does not require malice. It requires only an accurate description of what happens when therapies with revenue attached to them can afford research, marketing, regulatory attention, and physician education, and therapies without revenue attached to them cannot afford any of those things. The second category becomes invisible to the first, then absent from medical training, then forgotten by all but the small number of practitioners who read outside the current literature. Every mother who takes her difficult child to a pediatrician today is met by a physician trained inside a knowledge system from which the racehorse constitution and its two-drop remedy have been erased.

Two Children

Jarvis’s twin, five years old, was given two drops of Lugol’s solution and a teaspoon of vinegar in a glass of water. Within two hours she was calmer. Over the years, as needed, she took the remedy again. By the time she left high school her early temperament was a memory. She married. She kept her home. She was, by every measure Jarvis reported, well.

A five-year-old with the same constitution today, brought to the evaluation her mother would be told to seek, moves down a different path. She is observed for six weeks and diagnosed. She is started on a Schedule II controlled substance, methylphenidate at a low dose, increased in steps. Her sleep changes. Her appetite changes. If the first drug is not tolerated, she is switched to a second. If additional symptoms are identified, an SSRI or an atypical antipsychotic is added. By adolescence she is likely on more than one medication. The prescriptions typically continue into adulthood.

Both children began with the same constitution. What differs is the framework that met them and the therapy that framework had available. In Jarvis’s framework, the constitution was a state: real, observable, correctable through mineral repletion and dietary adjustment, not requiring lifetime pharmaceutical management. In the current framework, the same constitution is a disorder: a neurodevelopmental condition of unclear origin, requiring accurate diagnosis and appropriate pharmaceutical treatment, typically for years.

Jarvis’s approach worked. The evidence is thin by modern trial standards. Two named cases, a twelve-child observation study, decades of clinical practice reports. Not zero. And the therapy costs almost nothing to try. Lugol’s is still sold. Apple cider vinegar and honey are still sold in every supermarket. Any parent watching a child at the edge of a diagnostic pathway that leads to fifteen years of amphetamine prescriptions can, before consenting to that pathway, try the intervention Jarvis prescribed for the same constitutional presentation in 1961. Two drops of Lugol’s, two teaspoons of vinegar, two teaspoons of honey, a glass of water. Sipped through a meal. Repeated as needed.

The twin quieted within two hours. The professor’s daughter did too. It is possible that the same intervention, offered before the diagnostic pathway begins, would produce the same result today. It is also possible that a generation of children could grow up as Jarvis’s patients did: not permanently labeled, not carrying prescriptions into adult life, but recognizably themselves, in their own particular temperaments, brought out of permanent high gear by a mineral their bodies were built to use.

The bottle every pharmacist once kept in stock is still available. It costs a few dollars. What is not available in the current framework is the recognition that the racehorse twin’s mother was two weeks away from having a different child.

Note on Dosing

Lugol’s 5% solution delivers roughly 6.25 mg of elemental iodine per drop. Jarvis’s protocol was two drops for adults, one drop for children, in a glass of water made acid with a teaspoon of apple cider vinegar, sipped through a meal. In the United States, 5% Lugol’s is regulatory-restricted to 1 oz bottles and can be harder to find; 2% Lugol’s is more widely available on Amazon and elsewhere. The equivalence is straightforward: five drops of 2% delivers the same iodine as two drops of 5%. Compounding pharmacies remain a reliable source for both.

This is Lugol’s solution, not povidone iodine. Lugol’s is elemental iodine plus potassium iodide in water, formulated for internal use. Povidone iodine is iodine bound to a polymer for external wound care and should not be substituted.

Anyone with an existing thyroid condition, particularly Hashimoto’s, should read Guy Abraham’s and David Brownstein’s work before starting therapeutic doses. Introducing iodine into an inflamed thyroid can produce a transient worsening before improvement. Selenium is the essential companion mineral, roughly 200 micrograms per day, obtainable from three Brazil nuts.

How I’d Explain It to a Six-Year-Old

Some children come into the world wound up like a racehorse. Others come into the world calm like a farm horse. Both kinds are normal.

A long time ago, a country doctor noticed that the wound-up children became calmer, within about two hours, when they drank a glass of water with a spoonful of vinegar, a spoonful of honey, and two tiny drops of a medicine called iodine. He tried it many times. It kept working.

Iodine is a mineral that comes from the sea. It helps a small gland in your neck do its job. Without enough iodine, some children stay wound up all the time.

Bread used to have iodine in it. Then bakers stopped putting it in and started using a different chemical, called bromine, that actually pushes iodine out of the body. So children now get less of what they need and more of what steals it.

When a wound-up child sees the doctor today, they are usually given a very strong medicine that changes how the brain works, often for many years.

The old drink is still around. Vinegar and honey are in every kitchen. Iodine is at the drugstore. A day of the drink costs less than a piece of candy. That is what this essay is about.

References

1. Jarvis DC. Arthritis and Folk Medicine. Pan Books; 1962. Chapter 12: The Usefulness of Lugol’s Solution of Iodine.

2. Centers for Disease Control and Prevention. Data and Statistics on ADHD. National Survey of Children’s Health, 2022. Approximately 11.4% of US children aged 3–17 have been diagnosed with ADHD; a majority of those currently diagnosed take a prescription medication for the condition.

3. Jarvis DC. Folk Medicine: A Doctor’s Guide to Good Health. Pan Books; 1961. Chapters on iodine, the halogen displacement law, and the racehorse type.

4. Jarvis DC. Arthritis and Folk Medicine. Pan Books; 1962. Chapter on apple cider vinegar and the calming of pugnacious bulls, cross dogs, and mastitis-prone dairy cows.

5. Fallon S, Enig MG. Nourishing Traditions. NewTrends Publishing; 2001. Section on iodine.

6. Bergner P. The Healing Power of Minerals, Special Nutrients, and Trace Elements. Prima Publishing; 1997. Chapter 13 (Iodine) and Table 25.1 (nutrients associated with functional depletion states).

7. Wolff J, Chaikoff IL. Plasma inorganic iodide as a homeostatic regulator of thyroid function. Journal of Biological Chemistry 1948; 174: 555–564.

8. Abraham GE. The safe and effective implementation of orthoiodosupplementation in medical practice. The Original Internist 2004; 11: 17–36.

9. Pearce EN, Pino S, He X, Bazrafshan HR, Lee SL, Braverman LE. Sources of dietary iodine: bread, cows’ milk, and infant formula in the Boston area. Journal of Clinical Endocrinology and Metabolism 2004; 89: 3421–3424.

10. Caldwell KL, Makhmudov A, Ely E, Jones RL, Wang RY. Iodine status of the U.S. population, National Health and Nutrition Examination Survey, 2005–2006 and 2007–2008. Thyroid 2011; 21: 419–427.

11. Johnston CS, Kim CM, Buller AJ. Vinegar improves insulin sensitivity to a high-carbohydrate meal in subjects with insulin resistance or type 2 diabetes. Diabetes Care 2004; 27(1): 281–282. See also Östman E, Granfeldt Y, Persson L, Björck I. Vinegar supplementation lowers glucose and insulin responses and increases satiety after a bread meal in healthy subjects. European Journal of Clinical Nutrition 2005; 59(9): 983–988.

12. Grand View Research. ADHD Therapeutics Market Size, Share & Trends Analysis Report. Global ADHD medication market estimated at approximately $20 billion USD as of 2023, with continued projected growth.

Author’s Note

Parts of what follows are documented and verifiable. Other parts are interpretive reconstructions built on that documentation. And some parts, by the framework's own structure, cannot be adjudicated on evidence at all. I am not making a claim about which is which for every element of the argument. I am attempting something narrower: to produce a working definition of a term that has begun showing up with real frequency in podcasts, interviews, and long-form writing on hidden power, and that most readers who encounter it have no clear idea what to do with.

The framework is not mine. It belongs to Joseph Farrell, developed across roughly seven books and a long-running conversation with Catherine Austin Fitts on the Solari Report. My job here is to explain what he means so that the next time you hear the phrase used, you understand what is being pointed at. Whether the thing being pointed at exists, and in what form, is a separate question the essay does not adjudicate.

If you have never read Farrell, this is your entry point. If you have read some of him, this may organize what you already know. If you reject the framework, this may at least let you reject the version he actually holds rather than a caricature.

The essay brackets Farrell’s claims about exotic technology (the Bell, directed energy, weather engineering) so the definitional work stays clean. Those claims are important to his larger body of work and may get their own treatment separately.

A term that is used without being understood is a term that does work in the culture without accountability. This essay is an attempt to make one such term accountable to its actual meaning.

The check was cleared in Buenos Aires. It was drawn on Manufacturers Hanover and on Chase Manhattan. The signature was Martin Bormann’s. The year was somewhere in the early 1960s.

Bormann is supposed to have died in a Berlin bunker on May 2, 1945. Remains recovered in Berlin were identified as his through dental records in 1972; mitochondrial DNA testing conducted in 1998 was, by German authorities, treated as final confirmation. On the standard account, the man was dust for two decades before the check was written.

Paul Manning, a CBS journalist who had worked closely with Edward R. Murrow, spent years investigating an alternative account. He published his findings in a book called Martin Bormann: Nazi in Exile. In it, he documented the check.¹

You may believe Manning was wrong. You may believe the check was cleared under a false signature or that Manning was deceived. Some other explanation is available if you want one. What the documentary evidence will not let you do, if you take it seriously, is treat the postwar period as settled history where the visible surface is the whole story.

The check is a small piece of evidence for a very large claim. The claim is that a substantial part of what actually happened after 1945 has never made it into the standard account. Joseph Farrell has spent roughly the last twenty years assembling the case for that claim, book by book, cross-reference by cross-reference. The framework he built to organize what he found borrows its central term from another writer: the UFO historian Richard Dolan, who in the second volume of UFOs and the National Security State used a phrase that has since escaped into the wider culture without most of the people using it knowing what it means.²

Dolan called it a breakaway civilization.

This essay explains what he meant, what Farrell built on top of it, and why the concept, once you have it, does not easily leave.

What Dolan noticed

Dolan’s insight came near the end of a long historical study of the U.S. government’s postwar handling of the UFO phenomenon. He was working the archival record and reading the classified budget history. He noticed something the material forced on him whether or not he wanted it.

Continuous secret spending compounds.

Fund a black project for a year and you have a project. Fund it for a decade and you have a program. Fund it for two generations at scale, and you no longer have a program. You have institutions. Then facilities. Then personnel who spend their careers inside those facilities and never leave. Then their children, some of whom follow them in. Then a body of accumulated knowledge that exists nowhere else, held by people who cannot describe what they know.

At some point in this accumulation, the group ceases to be an offshoot of the society funding it. The technology it works with changes what its members consider possible. The information it has access to changes what its members consider real. The rules it operates under diverge from the rules its parent society thinks are in force. It becomes its own thing.

Dolan’s word for it was civilization. He chose the word carefully. He meant it literally.

Farrell’s question

Joseph Farrell read Dolan and took the concept as a hypothesis to test. His question was not whether the idea was aesthetically appealing. It was operational. If Dolan was right, what would such a thing have needed in order to come into existence? Where would those needs have been met? What footprints would it have left in the visible record?

The answer he arrived at, across a series of books published between 2004 and 2015, is what people are pointing to now when they use the term. The Nazi series (Reich of the Black Sun, SS Brotherhood of the Bell, Nazi International, The Third Way) traces the historical origins. The breakaway trilogy (Saucers, Swastikas and Psyops, Covert Wars and Breakaway Civilizations, Covert Wars and the Clash of Civilizations) develops the framework and applies it.³

The core of the framework is this. A breakaway civilization, if it exists, requires a hidden system of finance sustained across decades and insulated from any political process that could shut it down. The origin of that system, in the western half of the postwar world, was the strategic situation the United States faced as the war closed. And the operational architecture that emerged from that situation is still running.

What such a thing has to eat

The financing requirement is more restrictive than it sounds. Ordinary appropriations turn over with elections. Even a classified budget under congressional oversight is exposed to periodic scrutiny. Congress writes checks and Congress can un-write them.

What a genuinely breakaway operation needs is money that is not subject to any of that. A pool sustained across decades, kept off the public books, insulated from the visible economy. The pool has to be large enough to build and maintain a hidden infrastructure. It has to be structured so that no elected official can find the string that unravels it. And it has to keep growing, because the operations it funds keep growing.

Farrell’s contention is that such a pool exists and has existed since 1945. His reconstruction of how it was built runs in three movements.

The three movements of the money

First movement: the seed capital, 1945 through the late 1950s

At the end of the war the United States confronted three problems simultaneously, each of which required secret means and none of which could be addressed publicly. The Communist bloc, against which American intelligence had almost no human network. The surviving Nazi apparatus, which had spent the last two years of the war planning a strategic evacuation of personnel, capital, and technology from Europe. And, in Farrell’s reading, a persistent phenomenon of unidentified craft over sensitive military installations severe enough to be one of the driving concerns behind the reorganization of the entire national security apparatus under the National Security Act of 1947.

Each problem demanded money that Congress could not know about. The Americans built the plumbing.

Nazi capital, laundered through the Bank for International Settlements and Swiss banks, flowed into major western banks after the war and gave them off-balance-sheet reserves large enough to underwrite the postwar credit expansion.⁴ Japanese plunder from occupied Asia, discovered by American forces at the end of the war, was authorized by Truman as a slush fund for the National Security Council.⁵ The Exchange Stabilization Fund at the New York Fed, sitting outside the normal budgetary bureaucracy, became one of the primary vehicles for postwar covert operations, including the rigging of the 1948 Italian elections. The National Security Act of 1947 and the CIA Act of 1949 gave the American government the statutory ability to appropriate money for one purpose and shift it into unaccountable classified accounts. This is the origin of what is now called the black budget.

By the late 1950s the seed capital was in place. It was hidden. It was large. It answered to no one who could be voted out.

Second movement: industrialization, 1960s through 1980s

The seed money grew, and the machinery around it hardened. The postwar restructuring of the international narcotics trade in the 1960s and 1970s, documented by the Danish journalist Henrik Krüger, displaced the French Connection and inserted postwar fascist networks as on-the-ground operators for what became a joint enterprise with American intelligence in Latin America.⁶ Drug revenue fed the black budget. The black budget was laundered through mortgage securities and government securities fraud.

Then came the decisive institutional shift. Under the incoming Reagan administration, an executive order qualified private corporations to perform secret and highly classified functions paid for by the U.S. government.⁵ This turned the trillion-dollar black budget into a mechanism by which private corporations, not government agencies, could own and control the most advanced technology in the world on a non-transparent, non-accountable basis. The classified work moved outside the direct chain of command of the elected government. The corporations doing the work were themselves privately held, or subsidiaries of privately held entities, and answered to boards no voter had heard of.

By the end of the 1980s the breakaway civilization, if that is what it was, had a permanent industrial base. It was funded by a mixture of appropriated black budget, criminal revenue, and hidden financial reserves inherited from the war. It operated through private corporations under sovereign immunity. It employed hundreds of thousands of cleared personnel. And its output was, by design, indistinguishable from the outside from ordinary defense contracting.

Third movement: consolidation, 1990s to present

In the spring of 1995 a mortgage banker walked into Catherine Austin Fitts’ office in Washington carrying a database. His family had been in the mortgage banking business for three generations. His core competency was tracking every FHA-insured mortgage issued in the United States. He had a message. The number in the newly published federal financial statements, 400 billion dollars of outstanding FHA insurance, was wrong. The real figure, he said, was several multiples higher.⁷

Fitts, who had been Assistant Secretary of Housing under the first Bush administration, initially dismissed the claim. She refused to take his database, on the reasonable calculation that whoever accepted it would probably not live to publish it.

She was wrong to dismiss it. Her later litigation with the federal government forced her back to the numbers. Independent research by Professor Mark Skidmore at Michigan State, published in 2017, established that the U.S. Treasury, the Department of Justice, the Department of Housing and Urban Development, JP Morgan Chase, and the New York Fed had been engaged in coordinated undocumentable adjustments to the federal accounts running to 21 trillion dollars between fiscal 1998 and fiscal 2015.⁸ The number has been revised upward since.

This is where Fitts and Farrell converge. Farrell had proposed the architecture. Fitts documented its footprint in the accounts. Twenty-one trillion dollars leaving the visible budget between 1998 and 2015 is the size of the entire U.S. economy for a year. It went somewhere. Whatever the breakaway civilization is, that is roughly what it has been paid.

In October 2018, the Federal Accounting Standards Advisory Board issued Statement 56, effective for federal fiscal year 2019 onward. Statement 56 permits federal entities to modify or omit financial information from their published reports on grounds of national security.⁹ In Fitts’ reading, this is the moment the hidden system stopped running alongside the visible one and began subsuming it. The books were legally darkened. The consolidation was complete.

Two constituencies

Farrell distinguishes two players in the western half of this arrangement, and refusing to collapse them into one is central to what he has been arguing.

The first he calls the Post-War Nazi International. His starting distinction is that the German government surrendered in 1945; the Nazi Party did not. During the last years of the war, senior party leadership had established a network of corporate fronts, moved capital through Switzerland and the Bank for International Settlements, and prepared operational continuity plans that included evacuation to Latin America and elsewhere. American counter-intelligence identified and shut down roughly 750 of these fronts. Farrell’s argument is that the operation was much larger than what was shut down, that it survived, and that it continued its wartime research programs as an extraterritorial entity using corporations and nations as cut-outs.

The evidence is specific. The postwar fusion project run in Argentina under Juan Perón by the German scientist Ronald Richter, the same Richter who had worked on the same physics inside the Third Reich. The 1945 deal, recorded in Reinhard Gehlen’s memoirs, in which the head of Nazi military intelligence for the East handed over his entire espionage network to Allen Dulles on terms that preserved German interests where they clashed with American interests, and kept Gehlen himself in operational command.¹⁰ The Gehlen organization became the Bundesnachrichtendienst, modern Germany’s federal intelligence service, which meant the CIA’s Soviet analysis on the day the agency was chartered was being produced by former Nazi intelligence officers. And the Bormann check, cleared in Buenos Aires over his own signature, sixteen years after his officially recorded death.

The second constituency is the American deep state. Not the phrase as it is used in mainstream political commentary, but the specific postwar nexus Farrell traces: Wall Street law firms, prime banks, intelligence agencies, defense contractors, and the corporations that had done business with IG Farben and its counterparts before the war. Sullivan & Cromwell, the Dulles brothers, Standard Oil, and the Rockefeller interests on the American side; Hermann Josef Abs at Deutsche Bank and Prince Bernhard of the Netherlands, a wartime IG Farben manager and SS officer, on the European side. These names recur in the historical record with a frequency Farrell treats as diagnostic.

Operation Paperclip supplied the technical staff. Von Braun, Rudolph, Dornberger, and hundreds of others took positions across American universities, foundations, and defense contractors, their wartime records sanitized. Farrell notes that American counter-intelligence assessments in the late 1940s established that these scientists were maintaining contact with each other through Latin America. That is, they operated as a coherent network within the host country. Farrell’s term for what this implied is a Nazi extraterritorial state already functioning inside the American system by the late 1940s.

The two constituencies cooperated where cooperation served them. They competed where it did not. Together they constituted the western wing of what would become the breakaway.

Why the word “civilization”

Dolan chose the word carefully, and Farrell has been insistent that it be taken literally rather than as metaphor. Once you enumerate the properties a civilization has, the argument about whether one exists becomes tractable.

A civilization has infrastructure, hard and soft. The soft infrastructure is the hidden financial system already described. The hard infrastructure is a network of underground facilities. Fitts, working with a researcher and drawing on the published work of Richard Sauder, arrived at an estimate of over 140 such facilities in the United States alone. Add the tunnel systems Farrell attributes to the postwar Nazi presence in Latin America, the Soviet and Russian underground network, the Antarctic installations, and whatever exists under China, and the picture is of a global system of hidden physical plant under continuous construction for eighty years.

A civilization has borders. In this case the borders are security perimeters and cleared-access requirements that separate the classified world from the ordinary one.

A civilization has a legal system. Fitts’ term for it is sovereign immunity: the layered legal shields placing national security operations, intelligence agencies, central banking arrangements, and their contractor networks beyond the reach of ordinary courts. Members of the breakaway civilization are above the law with respect to the visible society and operate under their own internal system of adjudication with respect to each other.

A civilization has personnel: the cleared workforce that lives and works inside the security perimeter and whose work cannot be described outside it.

And a civilization, Dolan argued, eventually has its own way of thinking. Access to technology no one else has changes what its holders consider possible and necessary. Decisions get made inside the perimeter that make no sense outside it, because they are being made on the basis of information the outside does not have. This is the specific sense in which the group ceases to be an offshoot and becomes something distinct.

Farrell’s larger body of work extends into claims about what the classified research has actually produced: exotic propulsion systems, directed-energy weapons, technologies for manipulating weather and seismic events, and physics derived from Nazi wartime research on a device called the Bell. Those claims are outside the scope of this essay. Readers who want to pursue them can begin with Reich of the Black Sun and SS Brotherhood of the Bell.³ For present purposes the point is narrower: money on the documented scale, sustained across decades within the institutional architecture already described, produces something. Whatever that something turns out to be, it exists.

The mafia war

Farrell is careful not to describe this as a single unified entity. If the model is correct, every major power that has run significant black research over the postwar period has developed some version of it. Russia has one. China has one. Farrell suspects France and India do as well. The Nazi International was itself extraterritorial rather than tied to any single state.

What sits at the top, in his current framing, is a set of factions in intermittent cooperation and increasingly open conflict. He calls it the mafia war. The postwar arrangement between the surviving Nazi structure and the American financial oligarchy is coming apart. Markers are being called in. Bank bailouts function as signals between factions. Recent disruptions of the visible international order, including the move toward multipolarity and the visible decay of American institutional capacity, Farrell reads as surface manifestations of a struggle among hidden formations for control of what remains.

The mafia war framing is not metaphorical. In Farrell’s account, the factions have real weapons developed with the hidden money, and they use them. Insider positions taken against a country’s sovereign debt in the week before a natural disaster wipes out its territory. Bank bailouts demanded with the specific stipulation that there be no oversight, which in Farrell’s reading looks like the behavior of someone acting under duress. When these factions fight each other, they do not use conventional weapons. They use what the classified research has produced. The collateral damage falls on the visible civilization, on the people who did not know the hidden one existed.

Fitts has extended the framework with a historical parallel. In the feudal system, a serf or minor noble owed allegiance to a local lord, but might also owe allegiance to another lord higher up. When two lords demanded his obedience against each other, the concept of ligeancy determined which loyalty was ultimate. In Fitts’ reading, we have not quite reached the stage where the modern equivalent has crystallized. But the visible signs are there: sovereign immunity claims multiplying, and a widening gap between what officials say and what officials do as different classes of decision-maker respond to different sets of orders. When ligeancy becomes explicit, the mafia war stops being a phrase and becomes a fact on the ground.

What the concept lets you see

There is a moment in Fitts’ account of the 2004 Indian Ocean tsunami that is worth stopping on.

She had been managing a portfolio for a private client. She had put a portion of it into a world bond fund, and 15 percent of the fund’s holdings were in Indonesian sovereign debt. In the week after her client bought in, the fund dropped 15 percent overnight on massive insider selling. There was no interest rate move. There was no news. Nothing in the visible information environment explained what she was seeing.

A week later the tsunami arrived. It killed at least 227,000 people across fourteen countries.

Someone had known. Not by luck. Not by market intuition. They had known specifically enough, and confidently enough, to move a significant amount of capital against a specific country’s debt with a specific timing that only made sense if they knew, in advance, what was about to happen to that country’s coastline.

You can dismiss this observation as anecdotal. You can construct alternative explanations. What you cannot do, once you have looked at it seriously, is put it back where you found it. Because if what Fitts saw was what it looks like, then some things follow.

If some party can induce a tsunami, that party has a weapon no elected government has publicly disclosed. If that weapon exists, the money to develop it has been spent. If the money has been spent, it left a trail. And the trail, when you look for it, is where Fitts and Farrell have been telling you to look.

Once the concept of a breakaway civilization is in your working vocabulary, certain features of the visible world become legible that were not before.

Missing federal money in the tens of trillions is not an accounting error and is not evidence that the government is broke. It is the visible footprint of a hidden system of finance funding something.

Political leadership that appears to be following orders no ordinary voter would recognize as coming from any electoral mandate is not a mystery. It is the visible footprint of a hidden actor whose decisions are made inside the security perimeter and communicated outward.

The persistent inability of qualified financial analysts to make sense of the visible economy, the “nothing about this makes sense from any angle” reaction Farrell has described repeatedly in his conversations with Fitts, is not their failure of analysis. It is what happens when you try to reconcile a set of accounts that has, by design, been separated from another set of accounts you do not know exists.

What you have to decide

None of this requires accepting the specific technology claims Farrell makes elsewhere. The structural argument stands independently. If a hidden system of finance of the documented scale has been operating for eighty years, it has bought something. Something has been built. Someone runs what has been built. Those people, across decades, become distinct from the people funding them in their information, their assumptions, their loyalties, their sense of what is possible.

That distinctness, accumulated across generations, is what the term breakaway civilization names.

The reason the term does not easily leave once you have it is that the alternative is worse. The alternative is to keep reading the news as if the visible surface is the whole story. To treat the missing trillions as a curiosity that will presumably be reconciled at some future audit. To treat the odd trades before disasters as coincidences. To treat leadership decisions that make no visible sense as the ordinary confusion of politics. To treat the widening gap between what the world officially is and what the world actually seems to be doing as, essentially, nothing.

Once you have the concept, that reading is no longer available. Every anomaly you notice is either evidence that the concept applies or evidence that it does not, and the ordinary tools for adjudicating which is which are, by the concept’s own logic, the ones that have been captured.

One further thing the reader should know before deciding. The framework has structural features that make it partially self-sealing. Once you have it, evidence for it accumulates and evidence against it can be reinterpreted as successful concealment. Absence of documentation becomes evidence of effective secrecy. Rejection by credentialed historians becomes evidence of the institutional capture the framework predicts. This is a feature of the framework you should hold in mind whether you accept it or reject it. It does not by itself refute the framework — real hidden systems would produce exactly this epistemic shape — but it does mean the framework cannot be adjudicated purely on evidence, and any reader who tells you otherwise, in either direction, is selling you something.

This is not a problem the essay can solve for you. Farrell built the framework. Fitts documented the footprint. What is on the table, now that you have looked at it, is on you.

How to explain it to a 6 year old

Imagine your parents give you a small allowance every week for eighty years. Most of it you spend on things everyone can see. But some of it you put in a secret jar in the garage that no one ever looks in.

After a very long time there is enough in the jar to buy a bicycle. Then a shed. Then a small workshop, because you have started to build things. Then you hire a friend. Then a bigger workshop, then another friend, then a fence, then rules about who is allowed inside the fence.

Your parents still think you are the kid who buys candy. They do not know about the workshop or the fence. When they ask what you did with the money, you say “not much.” They believe you, because the jar has been in the garage the whole time and they have never looked.

After eighty years the workshop is bigger than your parents’ house. The kids inside the fence do not follow your parents’ rules anymore. They have their own school, their own kitchen, and things your parents do not know exist. They are still your parents’ kids, technically. But if your parents called them in for dinner, they would ignore it, because they have their own dinner, in their own kitchen, in the workshop your parents do not know is there.

That is what a breakaway civilization is. The parents are the ordinary country. The kids behind the fence are the people who spent the secret money. The fence is why we cannot see what they built.

References

1. Paul Manning, Martin Bormann: Nazi in Exile, Lyle Stuart, 1981.

2. Richard M. Dolan, UFOs and the National Security State: The Cover-Up Exposed, 1973–1991 (Volume II), Keyhole Publishing, 2009.

3. Joseph P. Farrell, the “Nazi series”: Reich of the Black Sun (2004), SS Brotherhood of the Bell (2006), Nazi International (2008), The Third Way (2015); and Saucers, Swastikas and Psyops (2011), Covert Wars and Breakaway Civilizations (2012), Covert Wars and the Clash of Civilizations (2013). Adventures Unlimited Press.

4. Christopher Simpson, Blowback: America’s Recruitment of Nazis and Its Effects on the Cold War, Weidenfeld & Nicolson, 1988.

5. Joseph P. Farrell and Catherine Austin Fitts, Solari Report interview, “Covert Wars and Breakaway Civilizations,” September 6, 2012; and Solari Report, “Who Is Mr. Global?” with Joseph P. Farrell, November 11, 2021.

6. Henrik Krüger, The Great Heroin Coup: Drugs, Intelligence and International Fascism, South End Press, 1980.

7. Catherine Austin Fitts, Solari Report publications and presentations on federal finance, missing money, and the hidden system of finance. Primary source of the FHA mortgage insurance fraud documentation and the 2004 Indonesian sovereign debt insider trading observation. See in particular the Missing Money archive at solari.com.

8. Mark Skidmore et al., research on undocumentable adjustments in U.S. federal financial reporting, Michigan State University, 2017; and subsequent Solari Report documentation.

9. Federal Accounting Standards Advisory Board, Statement of Federal Financial Accounting Standards 56, “Classified National Security Activities,” issued October 2018.

10. Reinhard Gehlen, The Service: The Memoirs of General Reinhard Gehlen, World Publishing, 1972.

Author’s Note

For a thousand years, leprosy meant exile: the bell tied to the wrist, the door barred against the sick, the priest reading the office of the dead over a living body. The disfigurement was real. What caused it was another question, and it was never asked seriously until 1873, when a Norwegian physician named Gerhard Armauer Hansen looked into a microscope and decided he had the answer. The essay below examines what he actually found, what he never demonstrated, what actually made people sick in the places called leprous, and what made the disease disappear from Europe centuries before any medicine existed for it. The paradigm is the target. The suffering was always real.

On November 3, 1879, at the Bergen leprosy hospital in western Norway, a physician named Gerhard Armauer Hansen ordered a thirty-three-year-old patient into his office. Her name was Kari Nielsdatter Spidsøen. She had lived with a mild form of leprosy for seventeen years. Hansen held a cataract knife tipped with material he had scraped from an active lepromatous nodule on another patient. In front of colleagues, without warning her, without her consent, he attempted to inoculate the material under her conjunctiva. She fought him off. She reported the assault to the hospital pastor. The pastor reported it to civil authorities. Hansen was tried and convicted the following year.

Six years earlier, in 1873, Hansen had observed a rod-shaped bacillus in the tissue of another Bergen patient and named it as the cause of the disease. The Bergen assault was his attempt to prove the causation he had already claimed. It produced no transmission. Spidsøen did not develop the more severe form of the disease. And 152 years after Hansen’s initial observation, no laboratory anywhere in the world has ever grown Mycobacterium leprae in a culture dish. Every claim that followed, that leprosy is an infectious disease caused by M. leprae, that it spreads by droplet or contact, that antibiotics cure it, that a vaccine will finish it off, rests on the assumption Hansen tried and failed to demonstrate in Kari’s eye.

“Axenic media” is the technical term: a defined nutrient preparation, free of other organisms, in which a bacterium can be reproducibly divided and passaged. Every standard medical bacterium meets this test. M. leprae does not. The most recent comprehensive review, published in Frontiers in Microbiology in May 2025, opens with the confession: the bacterium “remains uncultivable in axenic media, a constraint that continues to hamper leprosy research.”¹ The reviewers examined 78 studies. Every historical claim of successful cultivation on egg-based or synthetic media proved irreproducible, or the organism grown turned out to be a different mycobacterium entirely. The only reproducible method for sustained laboratory growth is inside a live animal: the mouse footpad, or the armadillo. The bacterium the entire modern account rests on cannot be persuaded to divide in a dish.

Robert Koch, whose postulates still define the standard for demonstrating microbial causation, required that the microorganism be isolated from a diseased host and grown in pure culture. The second postulate has never been fulfilled for M. leprae. Not by Hansen, who first observed the bacillus under a microscope in Bergen in 1873. Not by any of the researchers, in any of the 78 studies just reviewed, over the century and a half that followed. The bacterium was named, described, published, cited, and inscribed as the causative agent of leprosy on the strength of an observation and an assumption. The proof was never produced, and the medical account has since built around the missing proof rather than obtaining it.

What sits on top of the missing proof is a cascade of admissions. The CDC’s own transmission page states, plainly: “It is not known exactly how Hansen’s disease spreads between people.”² The same CDC page reports that “more than 95% of all people have natural immunity to the disease.”³ A November 2011 review of leprosy vaccine research, published in Human Vaccines and cited approvingly by the industry, states that “M. leprae infection does not always cause disease, and it is estimated that anywhere between 30–75% of infections are spontaneously cleared without causing significant symptoms.”⁴ The same review describes leprosy as “one of the most renowned, but least understood diseases of man.”⁵ The medical establishment cannot say how the bacterium reaches its host, cannot say why the host resists it in the overwhelming majority of cases, and cannot claim to understand the disease it has spent 152 years attributing to a single cause.

Audio Deep Dive (for Paid Subscribers)

The Disease Before the Bacterium

The word “leprosy” was never a diagnosis in the modern sense. For most of its history, it labeled almost any visible skin disorder that disfigured the sufferer badly enough to warrant exclusion. Herbert Shelton, writing in the natural hygiene tradition, observed that “for ages the term leprosy was applied to a wide variety of skin diseases.”⁶ The medieval European leprosaria housed patients whose actual conditions, by any modern differential, would have included eczema, syphilis, chronic fungal skin conditions, arsenic poisoning, mercurial dermatitis, and tuberculoid skin lesions of every etiology. What united them was appearance, not etiology. The category was social before it was medical.

The biblical category is more revealing than usually noticed. Tsara’ath, translated as leprosy in the King James Bible, encompassed three categories the priest was instructed to examine: skin conditions, mildew on woolen and linen cloth, and damp rot and mold on the walls of houses. Leviticus 14:45 instructs the priest to demolish the affected stones of the house and carry them outside the town. No bacterium infects wool and stone. Whatever tsara’ath was, it was a category of visible surface degradation across biological and non-biological materials, and the remedy for household tsara’ath was mold remediation as still practiced. The uniting principle was not one causative agent. It was a class of visible outcome: surface breaking down under environmental stress. Skin, cloth, and wall respond to their environments in analogous ways, and the ancient category captured all three under one label.

The medieval response was exile. Cities passed leprosy statutes; the sick were declared civilly dead, stripped of property rights, made to carry a rattle or bell so that healthy citizens could avoid them. Priests read the Missa pro mortuis over living patients as they entered the leprosarium. This was the terrain in which the diagnosis operated for a thousand years: not laboratory confirmation, but visible disfigurement, judged by clergy and civil authorities against a standard set by scripture and custom.

Then leprosy left Europe. It began to fade from most of the continent in the fifteenth century, four centuries before Hansen would observe the bacillus in his microscope. It was rare across most of Western Europe by the seventeenth century. By the eighteenth it was essentially gone, well before the germ theory existed. Even the Leprosy Mission’s own historical account admits that “the reason for this decline is not well understood,” and speculates about improvements in living conditions.⁷ Whatever removed leprosy from Europe operated without any specific medical intervention against it. The decline was already essentially complete when Hansen arrived to explain it.

Norway was the striking exception. On the wet, crowded, malnourished western coast, in the closed fjord communities of Vestland, the disease re-emerged in the eighteenth century and peaked in the mid-nineteenth. By the 1850s, some Bergen districts recorded prevalence of 25 per 1,000 population.⁸ These are the conditions Hansen worked in. His fame rests on the coincidence that the last European stronghold of leprosy happened to be the country where he lived.

The Bacterium That Cannot Be Grown

Hansen was appointed medical officer for leprosy in Norway in 1875, two years after his initial observation of the bacillus. He knew, and his contemporaries knew, that the observation alone did not establish causation. Koch, corresponding with Hansen from Breslau, had already begun formalizing what would become the postulates. Hansen understood that he needed to transmit the disease. He tried, and failed, in twelve consecutive animal experiments.⁹ The bacillus he had observed refused to cause the disease he claimed for it. The 1879 assault on Spidsøen was his thirteenth attempt and his last.

The court case that followed is remembered for its ethical narrative. What is not usually reported alongside it is what the failed experiment demonstrated. Hansen conceded, in court, that he had neither obtained her consent nor informed her of his purpose. The judgment, published in 1880 and reproduced in the historical record by Vogelsang, found him guilty of injuring the patient without cause.¹⁰ ¹¹ He lost his post at the leprosy hospital, though in a political compromise he retained his position as chief medical officer for leprosy in Norway. Spidsøen already carried the mild tuberculoid form of the disease. Hansen was attempting to induce the more severe lepromatous form by direct inoculation of active lepromatous material under her conjunctiva. No nodule developed. No lepromatous transformation occurred. The most direct human transmission attempt in the historical record, conducted by the discoverer of the bacillus, on a patient already believed susceptible, produced no transmission.

The bacillus he could not grow, he could not transmit either. And in the 146 years since, the situation has not improved. The 2025 Frontiers review, cited above, documents that the only sustained growth of M. leprae in a laboratory remains growth inside a live animal host. Mouse footpad inoculation was developed by Charles Shepard in 1960. The armadillo model, exploited because armadillos have a lower core body temperature than most mammals, was developed by Waldemar Kirchheimer in the early 1970s. Both require whole living animals. Neither is a fulfillment of Koch’s second postulate. Neither has produced a definitive causation experiment that would satisfy the third.

The armadillo model has been turned into something stranger. When wild armadillos in Louisiana and Texas were found to carry M. leprae, the CDC reversed the direction of inference: not that armadillos had been inoculated from human sources during the mid-twentieth-century research programs at the National Hansen’s Disease Center at Carville, but that armadillos are a natural reservoir from which humans acquire the disease.¹² A bacterium that cannot be grown in the laboratory is now described, on the CDC’s own page, as passing from armadillo to human in the southern United States, though the mechanism, once again, is left unspecified. Growing a bacterium in a live animal is not the same as culturing it. The vast majority of M. leprae-positive armadillos are asymptomatic. Attributing human cases to armadillo contact does not demonstrate transmission; it identifies a correlation of unknown direction. The armadillo is a workaround for a bacterium that fails every direct test, not an answer to the question the establishment claims to have answered.

The Cascade of Confessions

The establishment position on leprosy, when its own statements are laid side by side, is internally incoherent. The CDC and HRSA both state that around 95 percent of the human population, in the paradigm’s phrasing, has “natural immunity” to the bacterium and cannot be made to develop the disease even under prolonged exposure.¹³ ¹⁴ The observation is real. The label is the establishment’s attempt to explain away the observation without confronting what it implies: if the bacterium fails to produce the disease in 95 percent of those it reaches, the bacterium is not the cause. The IDRI review of vaccine development, funded by the Bill and Melinda Gates Foundation, notes that 30 to 75 percent of “infections” resolve spontaneously without any treatment.¹⁵ The WHO fact sheet reports an incubation period ranging from one to twenty years and states, without further explanation, that this anomaly exists.¹⁶ The CDC concedes that the mode of transmission is not known.¹⁷ The reviewers of the vaccine literature, writing in Human Vaccines, describe the condition as one of the least understood diseases in medicine.¹⁸

Koch’s first postulate requires that the microorganism be found in all those with the disease, and not in those without. Both criteria are violated. M. leprae is found in armadillos, in soil samples, in nasal secretions of healthy contacts, in patients who never develop symptoms, and is absent, or undetectable, in a fraction of clinical cases. Peter Duesberg’s dictum applies: “A single exception would be enough to pronounce the microbe innocent of creating that disease.”¹⁹ The exceptions here are not single. They are the majority.

The establishment’s response to these violations has been to elaborate rather than to reconsider. The concept of “natural immunity” was retrofitted onto the observation that most exposed people do not become ill. The concept of an “asymptomatic carrier state” was retrofitted onto the observation that the bacterium is found in healthy people. The concept of “spontaneous clearance” was retrofitted onto the observation that most people who develop the bacterium eliminate it without any treatment. Each addition preserves the causation claim while explaining why the causation cannot be observed. What the additions cannot preserve is the claim that Koch’s postulates have been met. They have not been. The vaccine literature admits this openly, then continues to develop the vaccine.

The pattern operates in real time. A 2023 case report in the CDC’s own Emerging Infectious Diseases journal documented a Central Florida man with no travel history, no immigration background, and no known armadillo contact, who nonetheless received a leprosy diagnosis. The authors declared central Florida an endemic zone and appealed for expanded surveillance, then reproduced the standard cascade: transmission mechanism unclear, most people naturally immune, incubation possibly exceeding a decade, further study needed. The case adds a leprosy diagnosis to a state whose environmental toxicity profile, from mercury deposition in the Everglades to agrochemical exposure in the citrus belt, is documented and, once again, not investigated as a leprosy factor.²⁰

The medical literature concedes a further point that undermines its own model. M. leprae is acknowledged in the mainstream literature to be pleomorphic: it changes form in response to the conditions of its environment, appears as bacillary rods under some conditions and as coccoid or cell-wall-deficient variants under others, and cannot be assigned the fixed morphology and pure-culture identity Koch required.²¹ This is what an environmental caretaker organism looks like. It is not what a specific pathogen with a stable causal identity looks like.

What is being protected here is not the science. It cannot be the science, because the science, on its own admissions, does not support what is claimed. What is protected is the institutional structure that names the disease, that trains the specialists, that manufactures and distributes the antibiotics, that operates the national leprosaria (Carville, until 1999) and international programs, and that funds the coming vaccine. The bacterium never grown supports a global industry that requires it to exist as an infectious agent.

Norway: The Natural Experiment That Ran for Fifty Years

The cleanest data set on leprosy transmission in the historical record comes from Norway. The National Leprosy Registry, established in 1856, tracked every diagnosed case in the country by name, address, date of onset, hospital admission, death, and emigration. It is the oldest disease registry of its kind in the world. It was analyzed most rigorously by Meima, Irgens, and Habbema in a paper published in the International Journal of Epidemiology in 2002.²² Their conclusion, using conventional epidemiological modeling: “The decline cannot be explained fully by the Norwegian policy of isolation of patients; an autonomous decrease in transmission, reflecting improvements in for instance living conditions, must also be assumed.”²³

The Norwegian caseload fell from 1,800 known cases in 1875 to 575 in 1901 to essentially zero by 1920. The Leprosy Acts of 1877 and 1885 mandated isolation of cases the acts labeled infectious, but the modeling shows that the decline began before the acts and continued at a pace the isolation policy alone cannot account for. Something else was working. Living conditions, in Norway during this period, meant food security, indoor space per person, ventilation, reduced dampness, and less industrial toxicity. The disease tracked those conditions more closely than it tracked the isolation policy.

The Minnesota data are more striking. Between 1857 and 1895, roughly 5,053 new cases of leprosy occurred in Norway. Approximately 170 of the patients emigrated to the American Midwest, settling primarily in the Norwegian farming communities of Minnesota, Iowa, and Wisconsin.²⁴ The 1942 US Public Health Service report on the episode noted the finding: “Although no new cases of leprosy developed in the Scandinavian settlement during the first 50 years, seven cases occurred between 1895 and 1916, most of them in families of the imported cases. None have occurred since then.”²⁵

Between 160 and 200 Scandinavian leprosy patients settled among Norwegian-American immigrant communities living in close family and cultural contact. In fifty years, no secondary cases appeared. Seven appeared in the second half-century, all in the families of the original patients. Then the disease stopped. If leprosy were meaningfully contagious in the sense germ theory claims, some measurable fraction of the Norwegian-American community should have contracted it from prolonged close-quarters contact with the imported cases. None did. The disease did not travel.

Dr. J.H. Holmboe, the Bergen leprosy hospital surgeon, visited the Minnesota settlements in 1864 to assess exactly this question. He found twelve cases, one of which had recovered entirely after arrival. His conclusion, on returning to Norway, was that the patients’ condition of health was better in America than it would have been at home.²⁶ Professor William Boeck of Christiania made a follow-up visit in 1869–70 and confirmed the general pattern: transplanted patients did well, some improved dramatically, and where new cases appeared they appeared almost entirely within the families of the original imported patients, not among the wider community.²⁷ The controlling factor was not exposure to the bacterium. The controlling factor was the terrain the exposed people were living in.

The Norwegian data, taken as a whole, dismantle the contagion hypothesis on the paradigm’s own historical record. Same people. Same bacterium. Same close contact. Different terrain, different food, different housing, different work. No transmission. This is a natural experiment of a rigor the establishment cannot ordinarily obtain, and its result is that the disease disappeared without any specific medical intervention against it and did not follow the exposed populations to a healthier place.

Dr. Gerhard Buchwald, writing in Vaccination: A Business Based in Fear, captures the wider pattern: “Leprosy was a constant guest in the times when increasing numbers of people lived together in the most cramped spaces as the city walls made the expansion of cities difficult. As soon as the cities grew beyond the city walls and people had more space available, leprosy disappeared.”²⁸ The gap between the retreat of leprosy from Europe and the introduction of any specific medical intervention against it is five hundred years. Whatever removed the disease from Europe operated in the absence of any germ-theoretic understanding of what it was, and without any deliberate targeting of the alleged causative organism.

The Toxicological Convergence

If the bacterium is not the cause, the symptoms attributed to leprosy require an explanation. The medical literature provides one, hidden in the sections marked “differential diagnosis” and “other causes.” Every major symptom the establishment attributes to M. leprae has a well-documented chemical origin that the treating physician is trained to consider only after the bacterium has been excluded.

Peripheral neuropathy, the numbness and eventual disfigurement of the hands and feet that defines the most feared form of leprosy, is a textbook consequence of arsenic, lead, and mercury poisoning. A 2017 review in the Annals of Indian Academy of Neurology on the epidemiology of peripheral neuropathy in India, where nearly 60 percent of the world’s leprosy cases occur, catalogs the neurotoxic exposures that cause the identical clinical picture: arsenic, lead, mercury, and a range of pharmaceutical chemotherapeutic agents “with a propensity to affect peripheral nerves.”²⁹ The Indian subcontinent has extensive arsenic contamination of groundwater. West Bengal and Bihar carry some of the highest measured arsenic exposures in the world. The distribution of peripheral neuropathy across the region maps more accurately onto arsenic contamination than onto any bacterial transmission model.

The skin symptoms of leprosy are similarly overdetermined by chemical exposure. A 2000 study in the International Journal of Dermatology, titled High prevalence of vitiligo in lepromatous leprosy, reported that pigment loss frequently co-occurs with leprosy but is rarely reported in the literature.³⁰ A 2010 review in the Indian Journal of Dermatology, on chemical leucoderma, identifies the responsible substances directly: “Chemical leucoderma is an industrial disorder in developed countries and the common causative chemicals are phenols and catechols.”³¹ Phenols and catechols are petrochemical derivatives. The list of chemicals known to be toxic to melanocytes, the pigment-producing cells whose destruction produces the depigmenting skin lesions of leprosy, includes mercury, arsenic, phenols, catechols, and azo dyes, the last a family of synthetic industrial colorants used in textile, leather, food, and cosmetic manufacture across the Indian subcontinent.³²

The physical toxins are documented. So is the pharmaceutical toxicology. From the 1300s until the twentieth century, the standard treatment for leprosy skin lesions was mercury ointment. Dr. Carolyn Dean, in Death by Modern Medicine, records the assessment: “Mercury is second only to plutonium in toxicity. When it first began to be used, centuries ago, nobody really knew its dangers. Mercury ointment was a treatment for the skin lesions of leprosy, beginning in the 1300’s.”³³ For six hundred years the treatment was itself neurotoxic, dermatotoxic, and nephrotoxic. Every mercury-treated patient added mercury poisoning to whatever else was producing the symptoms. Chronic mercury exposure produces peripheral neuropathy, cognitive decline, skin lesions, and progressive breakdown of the body’s cleansing and repair capacity. The treatment was capable, on its own, of producing every symptom of the disease it was applied to.

The pattern extends to smallpox vaccination, in which mercury and calf lymph and other biologically foreign material were introduced directly under the skin of nineteenth-century populations. Eleanor McBean, writing in Swine Flu Expose, cites the observation that had circulated among sanitarians throughout the period: “Many vaccines also cause other diseases besides the one for which they are given. For instance, smallpox vaccine often causes syphilis, paralysis, leprosy, and cancer.”³⁴ The claim is easy to dismiss until one considers that the toxic and antigenic loads introduced by nineteenth-century vaccinia inoculation would have been more than sufficient to trigger the sensitization response Charles Richet later documented for the injection of any foreign protein.

The geography of leprosy in the present tense confirms the toxicological reading. According to the WHO’s Global Leprosy Strategy 2016–2020, Brazil, India, and Indonesia together account for 81 percent of new cases globally.³⁵ These are the three largest developing economies where industrial pollution, groundwater contamination with heavy metals, occupational chemical exposure, and persistent malnutrition coexist at population scale. Brazil’s principal endemic zones overlap with the mining regions, particularly the artisanal small-scale gold mining that releases mercury directly into rivers used for drinking water and fishing.³⁶ India’s endemic zones overlap with arsenic-contaminated aquifers, chemical dye industries, and heavy pesticide use. Indonesia’s endemic zones overlap with the industrial pollution of the outer islands, the deforestation-agrochemical corridor, and mining runoff. The disease appears where the terrain is toxic. It disappears where the terrain is clean. The bacterium is the CDC’s marker of last resort, the label placed on a chemical injury for which no other diagnosis has been sought.

On the Body

In its milder tuberculoid form, leprosy leaves patches of skin without feeling. A patient can burn a hand on a stove and not know it until the smell of the burning flesh reaches the nose. Feet develop unnoticed ulcers that eat down to the bone. Thickened peripheral nerves can be felt beneath the skin at the elbows and wrists. In the more severe lepromatous form, the face coarsens: thickened forehead, collapsed nasal bridge, pendulous earlobes. Medicine calls the pattern leonine facies, the face of a lion. Fingers shorten as bone resorbs beneath insensate skin. Feet drop. Eyebrows fall out. This is the presentation that produced the leprosarium, and this is what any honest account of the disease has to explain.

A modern patient placed on multidrug therapy for the twenty-four months of the standard course does not escape the picture. The rifampicin turns urine, tears, and sweat red. The dapsone destroys red blood cells and produces the fatigue and breathlessness of chronic anemia, methemoglobinemia in a fraction of recipients, and, on longer exposure, its own peripheral neuropathy. The clofazimine colors the skin reddish, then brown, then, in some patients, almost black, and adds abdominal pain and diarrhea from crystal deposition in the gut. Two years in, the patient is discolored, exhausted, and, if the drug-induced neuropathy has progressed, losing sensation in the exact pattern the disease is claimed to produce. The regimen is described in the fact sheets as curative.

The Poisons Called Cure

The current WHO-recommended treatment for leprosy is multidrug therapy (MDT), comprising dapsone, rifampicin, and, for multibacillary cases, clofazimine. The regimen is provided free of charge by the WHO through pharmaceutical donations.³⁷ It is described in the fact sheets as curative.

Dapsone (4,4’-diaminodiphenylsulfone) was introduced in the 1940s as a sulfone drug related to the earlier sulfa antibacterials. Its documented adverse effect profile includes dose-dependent hemolytic anemia (the destruction of red blood cells), methemoglobinemia (the conversion of hemoglobin to a form that cannot carry oxygen), agranulocytosis (collapse of the body’s infection-fighting white cell count), hepatotoxicity progressing in severe cases to vanishing bile duct syndrome and acute liver failure, and three severe skin reactions: DRESS syndrome, Stevens-Johnson syndrome, and toxic epidermal necrolysis, each of which produces widespread skin loss, systemic organ involvement, and, at the severe end, death.³⁸ ³⁹ The list is not obscure. It is on the drug’s label, in the standard pharmacology references, and in the NIH LiverTox database.

The most instructive of dapsone’s documented adverse effects, given the disease it is prescribed for, is peripheral neuropathy. Dapsone directly damages the long nerve fibers of the arms and legs, and the damage progresses with the dose.⁴⁰ The principal drug in the treatment of a disease whose defining severe manifestation is peripheral neuropathy causes peripheral neuropathy. A patient diagnosed with leprosy on the basis of nerve damage, then treated with dapsone, will have any subsequent nerve damage attributed to progression of the disease. There is no clinical test that can distinguish drug-induced neuropathy from disease-induced neuropathy in a patient receiving both. The pharmacology literature admits the toxicity. The clinical literature does not credit the drug for the progression.

Rifampicin, the second drug in the regimen, produces liver toxicity in a substantial fraction of recipients. Chronic rifampicin exposure ramps up the liver’s main drug-processing enzymes, altering the metabolism of every other drug the patient is taking and depleting endogenous compounds the liver would otherwise process. Clofazimine, the third, colors the patient’s skin reddish to almost black, produces gastrointestinal disturbances that include nausea, vomiting, and diarrhea, and, at higher doses, forms crystalline deposits in body tissues including the small intestine, where they can cause bowel obstruction.⁴¹ The medication that turns the patient’s skin the color of the disease it is treating is a treatment in name only.

The establishment defends the toxicity of the regimen with the argument of “resistance.” When dapsone monotherapy began to fail in the 1970s, the interpretation was that M. leprae had developed resistance to the drug. The multidrug protocol was introduced to “overcome” this. Every antibiotic used against leprosy has, in due course, produced “resistance” in the same way, requiring the addition of new drugs. The alternative interpretation, that the drugs are not treating what the establishment claims and that continued dosing progressively poisons an already toxin-burdened patient, is not entertained. The failure of the drug is treated as evidence of the cleverness of the bacterium rather than as evidence of the wrongness of the paradigm.

Historically, the same pattern held. Chaulmoogra oil, adopted from Indian medicine by Western physicians in the early twentieth century, produced apparent improvements that medicine attributed to antibacterial activity. Whether the benefit reflected any specific action, or the general effect of removing the patient from active mercury treatment while providing dietary fat in an often malnourished population, is a question the establishment did not ask.

BCG, the Coming Vaccine, and What History Records

The BCG vaccine, developed for tuberculosis, is also deployed against leprosy on the argument that M. leprae and M. tuberculosis are structurally similar. If the two bacteria are similar enough that a vaccine against one protects against the other, they cannot be responsible for two entirely distinct diseases. The medical account holds both positions.

The BCG data are, in any case, unimpressive. A large field trial conducted by the WHO in India between 1968 and 1971 vaccinated approximately 364,000 people across 309 villages, with a comparable unvaccinated area used for comparison. The results showed no protective effect against tuberculosis, and in some age groups more cases occurred in the vaccinated area than in the unvaccinated one.⁴² The vaccine is still administered on the basis that whatever it does, it is better than nothing.

A dedicated leprosy vaccine has been in development for over a decade. The Infectious Disease Research Institute (IDRI), funded by the Bill and Melinda Gates Foundation, moved a candidate called LepVax into Phase I human trials in 2017.⁴³ The vaccine is being developed on the basis that MDT is not working, that “resistance” is spreading, and that a specific leprosy vaccine is needed to close the gap. The reasoning is circular. The MDT protocol was introduced because dapsone monotherapy failed. The vaccine is being developed because MDT is failing. Each failure justifies the next intervention against the same alleged causative organism. Each institutional failure is treated, by the institutions, as evidence that more of the same is needed.

The observation about vaccines and leprosy is not a fringe claim. Vaccinia and other nineteenth-century injections were noted repeatedly in the sanitarian literature to precipitate skin conditions, chronic ill health, and occasional cases of what was diagnosed as leprosy. Charles Richet’s Nobel-winning 1913 work on anaphylaxis established that injection of foreign proteins produces sensitization; subsequent exposure produces escalating and eventually severe response.⁴⁴ Mass injection of biological material into malnourished populations across the nineteenth and twentieth centuries may have precipitated some measurable fraction of the cases the establishment subsequently attributed to bacterial transmission. Investigating this would implicate the vaccine industry in producing the disease the vaccine industry is now developing a new product to prevent.

What Leprosy Actually Is

In a body burdened with mercury from six centuries of medical treatment, arsenic from the groundwater, lead from the roofing, phenols from the workplace, and a diet from which industrial processing has stripped its mineral cofactors, the appearance of M. leprae is not the origin of the disease. It is the arrival of the cleanup crew at a site of terrain collapse. The bacterium is a marker, not a cause. Its presence indicates that the terrain has failed, not that the terrain is under attack.

The disease disappeared from Europe not because the bacterium was killed, but because the terrain improved. Leprosy tracked the terrain, not the bacterium.

Medicine has been here before. Helicobacter pylori was identified in stomach tissue in the 1980s, declared the cause of peptic ulcer disease, and treated with triple antibiotic therapy. Barry Marshall and Robin Warren shared the 2005 Nobel Prize for the identification.⁴⁵ Two decades on, the picture has quietly collapsed into something more complicated. More than half of the world’s population carries H. pylori. Only a small fraction develop ulcers. The bacterium is now positioned as one factor among several, alongside non-steroidal anti-inflammatory drugs, chronic stress, and other terrain conditions. The antibiotic protocol persists as the standard of care, but the specific-cause claim that produced the Nobel Prize is no longer defended in the form in which it was made. Leprosy is on the same trajectory, several decades further along. The bacterium is a marker of something, not the cause of everything the diagnosis names. The paradigm eventually admits this. It does so slowly, without acknowledging how badly it got the story wrong, and it never revisits the interventions it prescribed on the basis of the original error.

The persistence of the paradigm in the face of this record is not a scientific problem. It is an institutional one. The bacterium sustains a global program: the WHO’s MDT distribution, the pharmaceutical companies producing dapsone and rifampicin and clofazimine, the research institutes developing the vaccine, the specialist physicians whose careers depend on the diagnostic category, and the national leprosy programs of the affected countries. A terrain reading of leprosy would dismantle this apparatus. The apparatus has an interest in the bacterium’s continued causal status. The interest is not in truth.

Kari Nielsdatter Spidsøen, whose eye Hansen tried to inoculate, did not develop the more severe form of leprosy after the assault. She had had the mild form for seventeen years and continued to live with it. She remained in the Bergen leprosarium, having been the subject of the most direct transmission attempt the establishment ever conducted, which produced a null result. Her name appears in the historical footnotes because she resisted the knife. The bacterium she was inoculated with was never grown in a laboratory dish. It has not been grown since. The disease she carried, the disease Hansen claimed to have identified the cause of, was made by the terrain Hansen never asked about: the mercury on her skin, the crowding of her village, the water she drank. The microscope was pointed at the wrong thing.

How To Explain It To A 6 Year Old

A long time ago, people were very afraid of a sickness that made spots on the skin. The spots did not go away. Sometimes fingers and toes went numb and stopped working. People with this sickness had to leave their families and live in special houses far away from the town. They had to ring a bell so that everyone would know they were coming and could stay away.

The name of the sickness was leprosy. For a very long time nobody knew what made people sick with it. Some doctors thought it was in the food. Some thought it was in the air. Some thought it was punishment from God. The way they treated the sickness was to put mercury paste on the skin. Mercury is a metal that is very poisonous. So the medicine was making the sickness worse, but the doctors did not know that.

Then a doctor in Norway named Hansen looked into a microscope one day in 1873 and saw a tiny thing in the skin of a sick person. He decided this tiny thing was what made the person sick. He wanted to prove it. He tried to make animals sick with it, twelve times, and could not do it. He tried to grow the tiny thing in a dish. It would not grow. Then, on a day in 1879, he grabbed a woman named Kari who lived in his hospital, held her down, and tried to push some of the tiny thing into her eye with a knife. She fought him off. She told the priest. The priest told the police. Hansen went to court and lost his job at the hospital.

The tiny thing still would not grow in a dish. It still will not grow in a dish today, 152 years later. Nobody has been able to make it grow in a dish, ever. But everyone was told that the tiny thing was what made people sick, and this is still what they are told now.

The leprosy sickness went away from Europe hundreds of years ago, before any doctor had a medicine for it. It went away because the towns got bigger, people had more room to live in, they got more food, they had cleaner water, and they stopped putting mercury paste on their skin. Where the towns are still crowded and the water is dirty and the workers touch bad chemicals, the sickness is still there. Where the towns and water and work are clean, the sickness goes away.

The medicine that doctors give people with leprosy today is called dapsone. One of the things dapsone does to people is make their hands and feet go numb. This is one of the same things leprosy does. So when a person on the medicine gets more numb, the doctor says the sickness is getting worse and gives more medicine. Nobody says the medicine is the reason.

The story people are told about leprosy is not right. The tiny thing Hansen saw is a real tiny thing. But it is not the reason for the sickness. It is like a fire truck that shows up when there is a fire. Nobody thinks the fire truck started the fire. The fire truck is there to help clean up. The tiny thing is there to help clean up too. The fire is the poison in the water and the bad food and the mercury on the skin and the smoke from the factories. Take those things away and the sickness goes away, whether the tiny thing is there or not.

References

1. “Silence on the plate: revisiting the enigma of Mycobacterium leprae cultivation.” (2025). Frontiers in Microbiology. Published May 2025. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1708557/full

2. Centers for Disease Control and Prevention. Transmission: How Hansen’s Disease Spreads. https://www.cdc.gov/leprosy/transmission/index.html

3. Ibid.

4. Duthie MS, Gillis TP, Reed SG. (2011). “Advances and hurdles on the way toward a leprosy vaccine.” Human Vaccines, 7(11):1172-1183. Cited in Lester D, Parker D. (2019). What Really Makes You Ill? Why Everything You Thought You Knew About Disease Is Wrong.

5. Ibid.

6. Shelton HM. Natural Hygiene: Man’s Pristine Way of Life. Cited in Lester & Parker (2019), op. cit.

7. The Leprosy Mission International. The History of Leprosy. https://www.leprosymission.org/what-is-leprosy/the-history-of-leprosy/

8. Grokipedia. History of leprosy, citing Irgens LM et al. on peak prevalence in Bergen c. 1850s reaching approximately 25 per 1,000. https://grokipedia.com/page/History_of_leprosy

9. Høvik LV. (2018). “Armauer Hansen’s Experiment and the Discovery of the Lepra Bacilli.” Historical account reviewing Vogelsang, Blom, and primary Norwegian sources. https://medium.com/@hoevik/armauer-hansens-experiment-and-the-discovery-of-the-lepra-bacilli-b78bb3727fa9

10. Lanska DJ. (2025). “Gerhard Armauer Hansen’s unethical person-to-person leprosy transmission experiment in 1879.” Hektoen International. https://hekint.org/2025/07/10/gerhard-armauer-hansens-unethical-person-to-person-leprosy-transmission-experiment-in-1879/

11. Vogelsang TM. (1963). “A serious sentence passed against the discoverer of the leprosy bacillus (Gerhard Armauer Hansen), in 1880.” Medical History, 7(2):182-186. See also Blom K. (1973). “Armauer Hansen and human leprosy transmission. Medical ethics and legal rights.” International Journal of Leprosy and Other Mycobacterial Diseases, 41(2):199-207.

12. Centers for Disease Control and Prevention. About Leprosy (Hansen’s Disease). https://www.cdc.gov/leprosy/about/index.html

13. Ibid.

14. Health Resources and Services Administration. Frequently Asked Questions About Hansen’s Disease. https://www.hrsa.gov/hansens-disease/frequently-asked-questions

15. Duthie MS et al. (2011), op. cit.

16. World Health Organization. Leprosy Fact Sheet, March 2019 edition, cited in Lester & Parker (2019), op. cit.

17. CDC Transmission, op. cit.

18. Duthie MS et al. (2011), op. cit.

19. Duesberg P. (1996). Inventing the AIDS Virus. Cited in Lester & Parker (2019), op. cit.

20. Bhukhan A, Dunn C, Nathoo R. (2023). “Case Report of Leprosy in Central Florida, USA, 2022.” Emerging Infectious Diseases, 29(8):1698-1700. https://wwwnc.cdc.gov/eid/article/29/8/22-0367_article

21. Pleomorphism of M. leprae documented in the mainstream literature; see Job CK, Karat AB, Karat S. (1966). “The histopathological appearance of leprous rhinitis and pathogenesis of septal perforation in leprosy.” Journal of Laryngology & Otology, 80(7):718-732; and cell-wall-deficient / L-form observations reviewed in Mattman LH. (2001). Cell Wall Deficient Forms: Stealth Pathogens, 3rd ed., CRC Press. Summarized in Lester & Parker (2019), op. cit.

22. Meima A, Irgens LM, Habbema JDF. (2002). “Disappearance of leprosy from Norway: an exploration of critical factors using an epidemiological modelling approach.” International Journal of Epidemiology, 31(5):991-1000. https://pubmed.ncbi.nlm.nih.gov/12435774/

23. Ibid.

24. Public Health Service, US. (1942). Public Health Reports, Vol. 57, No. 18, May 1, 1942. Report on leprosy in Minnesota, Iowa, and Wisconsin. https://stacks.cdc.gov/view/cdc/70218/cdc_70218_DS1.pdf

25. Ibid.

26. Holmboe JH. (1864). Report on Norwegian-American leprosy cases in the Midwest. Cited in Grønvold C. (1879). “Notes of Four Cases of Leprosy in Minnesota.” https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824979/

27. Boeck W. (1870). Investigation report. Nordiskt Medicinskt Archiv, Band III, No. 1. Cited in Grønvold (1879), op. cit.

28. Buchwald G. Vaccination: A Business Based in Fear. Cited in Lester & Parker (2019), op. cit.

29. Trivedi S, Pandit A, Ganguly G, Das SK. (2017). “Epidemiology of Peripheral Neuropathy: An Indian Perspective.” Annals of Indian Academy of Neurology, 20(3):173-184. https://pubmed.ncbi.nlm.nih.gov/28904445/

30. High prevalence of vitiligo in lepromatous leprosy. (2000). International Journal of Dermatology. https://www.ncbi.nlm.nih.gov/pubmed/11123444

31. Bajaj AK, Saraswat A, Srivastav PK. (2010). “Chemical leucoderma: Indian scenario, prognosis and treatment.” Indian Journal of Dermatology, 55(3):250-254. https://pubmed.ncbi.nlm.nih.gov/21063517/

32. Ibid.

33. Dean C. Death by Modern Medicine. Cited in Lester & Parker (2019), op. cit.

34. McBean E. Swine Flu Expose. Cited in Lester & Parker (2019), op. cit.

35. World Health Organization. Global Leprosy Strategy 2016–2020. http://www.searo.who.int/entity/global_leprosy_programme/documents/global_leprosy_strategy_2020/en/

36. Global Burden of Disease of Mercury Used in Artisanal Small-Scale Gold Mining. Environmental Health Perspectives, 2017. https://www.sciencedirect.com/science/article/pii/S2214999616308207

37. WHO Leprosy Fact Sheet, op. cit.

38. National Institutes of Health. Dapsone. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. https://www.ncbi.nlm.nih.gov/books/NBK548936/

39. Dapsone pharmacology summarized in ScienceDirect Topics. https://www.sciencedirect.com/topics/neuroscience/dapsone

40. Ibid. Dapsone-induced peripheral neuropathy documented as axonal, primarily motor, dose-dependent.

41. WHO. Guidelines for the Diagnosis, Treatment and Prevention of Leprosy, adverse effect profiles of clofazimine documented within.

42. WHO field trial of BCG for tuberculosis, Chingleput, India, 1968–1971. Results summarized in Lester & Parker (2019), op. cit.

43. Infectious Disease Research Institute press release, October 2017. Promising New Leprosy Vaccine Moves into Human Trials. https://www.idri.org/promising-new-leprosy-vaccine/

44. Richet C. (1913). Nobel Prize in Physiology or Medicine, awarded for work on anaphylaxis. Background documented in Lester & Parker (2019), op. cit.

45. Marshall BJ, Warren JR. (1984). “Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.” Lancet, 1(8390):1311-1315. Nobel Prize in Physiology or Medicine awarded to Marshall and Warren, 2005. https://www.nobelprize.org/prizes/medicine/2005/summary/

Author’s Note

Two registers operate in this essay. When mainstream science is being examined, the establishment’s language and citations appear. When the terrain framework is being stated, terrain language takes over. The reader should always know which register is operating.

The biogeochemistry described here is not fringe science. It is one of the best-documented planetary systems in the mainstream literature. The paradigm-relevant question is not whether the sulfur cycle exists, but why its practical implications for human health have been quietly removed from public conversation, and what recovering them looks like.

Marine phytoplankton produce roughly one billion tons of dimethylsulfoniopropionate every year.¹ The compound gives the ocean its characteristic smell, seeds the clouds that shape the earth’s radiation balance, and delivers sulfur to plants, animals, and humans on land through a chain that has been mapped in mainstream science for more than fifty years.

A reader mentioned this week that he remembered learning about this cycle from a New Scientist article around 1985. He added, without prompting, that the magazine at that time was “not so narrative driven and more focused on dispensing knowledge.” The article he remembered was almost certainly part of the coverage around James Lovelock’s work, which reached its most influential statement in the 1987 Nature paper by Charlson, Lovelock, Andreae, and Warren titled Oceanic phytoplankton, atmospheric sulphur, cloud albedo and climate.² Lovelock’s foundational observation appeared in Nature fifteen years earlier.³ Between 1972 and 1987, the science press treated this material as knowledge worth transmitting to a lay audience. A reader who kept it in his head for forty years is evidence that the transmission worked.

Today the same material is buried under advertising copy. The compound at the center of the cycle is now sold as a joint supplement in capsules, with no reference to the biosphere-wide chain that used to deliver it into the body without industry mediation.

The Compound the Ocean Makes

Dimethylsulfoniopropionate, or DMSP, is synthesized by marine phytoplankton, several species of coral, some seagrasses, and certain marine bacteria.⁴ Inside the cell it works as an osmolyte, balancing internal salt against surrounding seawater. It also acts as an antioxidant⁵ and as a cryoprotectant. When phytoplankton are grazed by zooplankton, die, or are metabolized by marine bacteria, DMSP is cleaved into a gas: dimethyl sulfide, or DMS.

DMS is what your nose registers as the smell of the sea. At the low concentrations found in coastal air, it is faint and unmistakable. Behind that smell sits the chemistry of trillions of cells across the ocean surface, releasing a gas that has been part of ocean life for as far back as ocean life can be traced.

The gas does not stay dissolved. Roughly 300 million tons of DMS escape into the atmosphere each year, making it the largest natural source of sulfur gas over the global ocean.⁶ Once airborne, DMS reacts with hydroxyl radicals and other oxidants in a stepwise chain:

DMS → DMSO (dimethyl sulfoxide) → DMSO₂ (dimethyl sulfone, also called MSM) → methanesulfonic acid and sulfate.⁷

Each step adds an oxygen atom to the sulfur. The end products act as cloud condensation nuclei, the microscopic particles that let atmospheric water vapor form droplets. Higher DMS emissions produce more of these particles, which produce more clouds, which reflect more sunlight back into space and cool the surface below.

This feedback loop was named the CLAW hypothesis after its authors. The tightness of the climate coupling has been challenged in the mainstream literature; Quinn and Bates published a critical review in Nature in 2011 arguing that the tight feedback cannot be demonstrated.⁸ The underlying chain, however, is not disputed. Phytoplankton make DMSP. Bacteria cleave it to DMS. DMS enters the atmosphere. The oxidation products form cloud nuclei and return to earth in rain. A reader in 1985 could learn this. A reader in 2026 has to hunt for it.

From Ocean to Rain to Table

DMSO and MSM are both water-soluble. When they form in the atmosphere from DMS oxidation, they dissolve in atmospheric moisture and fall in rainfall. Plants take them up through their roots. MSM is retained in plant tissue and delivered into the food chain from there.⁹

Measurements find MSM in most fresh fruits and vegetables at concentrations of roughly 1 to 4 milligrams per kilogram.¹⁰ Raw milk from pastured cows carries 2 to 5 milligrams per kilogram.¹⁰ Breast milk contains it. Whole grains contain trace amounts. Coffee and beer show detectable levels because fermentation and roasting preserve some fraction of what the plant deposited.

The compound is heat-sensitive and volatile. Cooking destroys much of it. Pasteurization eliminates almost all of it from milk. Long storage reduces it. Industrial processing strips it. What survives is what arrives on the plate raw or minimally cooked, or in a glass of untreated milk from a cow that grazed on pasture watered by unpolluted rain.

Sulfur is the seventh most abundant element in the human body.¹¹ It sits in the structure of connective tissue. It powers the methylation cycle. It forms the backbone of the amino acids methionine and cysteine. It is central to glutathione synthesis, to the redox architecture that governs cellular energy, and to hundreds of enzyme systems that cannot operate without it. When sulfur supply falls short, connective tissue lacks material for its structural proteins. Detoxification pathways that depend on sulfur substrate slow down. Cellular energy production falters wherever sulfur-containing cofactors are needed to run the mitochondrial machinery.¹²

The chain runs from ocean surface, through gas emission and atmospheric oxidation, into rainfall, then through soil and plant and animal and food, into the body. Each step has been measured by mainstream biogeochemistry. What the mainstream literature does not do is add up what modern life does to each step of this cycle.

Six Interruptions

Glyphosate. The active ingredient in Roundup and its generics chelates manganese, cobalt, iron, and other minerals in the soil and in the plant.¹³ It also interferes with the shikimate pathway, which plants use to synthesize sulfur-containing amino acids. Sprayed plants have lower sulfur content than unsprayed plants grown in the same soil. This is standard agronomy, not disputed. The result: a food supply that carries less sulfur to the eater, meal by meal, decade after decade.

Industrial agriculture. Soil that has been continuously cropped with synthetic nitrogen fertilizers, without return of organic matter, becomes depleted of the microbial life that mediates sulfur cycling in the root zone. Sulfur deficiency in agricultural soils is now widespread enough that agronomists have begun recommending elemental sulfur applications to restore yields. That recommendation is an admission, not framed as one, that the soil no longer contains what the plant needs, and therefore that the plant no longer contains what the eater needs.

Pasteurization. Raw pastured milk carries MSM at 2 to 5 milligrams per kilogram. Pasteurized milk contains almost none.¹⁰ The heat process regulators claim protects the public also destroys one of the compounds by which the sulfur cycle delivers into human nutrition. The regulatory framework was built as if MSM did not exist. Whether the regulators knew is a separate question. The compound is destroyed regardless.

Cooking and processing. The volatility that lets MSM enter the atmosphere lets it leave a saucepan. Long cooking, high heat, dehydration, and industrial processing all reduce it. A diet composed largely of processed food, restaurant meals, and long-cooked vegetables receives a fraction of what fresh, raw, and minimally cooked produce would deliver.

Organophosphates. Mark Purdey’s work is the clearest terrain reading of a disease the establishment declared infectious. Purdey was a Somerset organic dairy farmer, not an academic, when he refused to apply the government-mandated organophosphate warble-fly treatment to his herd in the 1980s. He took the Ministry of Agriculture to court over the mandate and won. His own cattle stayed BSE-free while herds around him did not. From that observation he began two decades of self-funded international investigation, tracing the same pattern through transmissible spongiform encephalopathy clusters in Colorado, Iceland, Slovakia, and Sardinia.¹⁴

The mechanism he identified: chronic organophosphate exposure combined with excess manganese in supplemental feed and depleted copper in the soil, resulting in the substitution of manganese for sulfur-bound copper at the active site of the prion protein.¹⁵ Organophosphates disrupt sulfur metabolism at the cellular level; manganese loading fills the gap the depleted copper leaves; the prion protein bends into the folded configuration that mainstream researchers then call infectious. Every geographical BSE cluster Purdey investigated showed the same signature of these three factors converging.

The mainstream framing calls BSE an infectious prion disease transmitted through rendered animal feed. Purdey’s terrain reading called it a metabolic disorder driven by sulfur-cycle disruption in specific chemical zones. His analysis appeared in peer-reviewed journals, most consistently in Medical Hypotheses. It was never refuted in the literature. It was simply not funded to continue. Purdey died in 2006 at fifty-two, from a brain tumor, in circumstances his family found questionable. The prion story remains the official account. The industry that manufactures organophosphates has never had to answer for the evidence he assembled.

Air pollution. In heavily polluted urban environments, the ambient DMS signal from the ocean is overlaid with anthropogenic sulfur dioxide from combustion, and the atmospheric chemistry above the city runs on different pathways than the chemistry above a coastline. Sulfur-cycle exposure through the airway is not what it was.

Any one of these interruptions would matter. Six operate simultaneously on the same population, and they compound. A person eating processed, pasteurized, glyphosate-treated food, grown on depleted soil, in a polluted city, receives a fraction of what an intact cycle was configured to deliver. The mainstream health literature does not track this. It tracks isolated nutrients in isolated capsules and calls the resulting picture nutritional science.

The MSM Question

Both DMSO and MSM are now sold as commercial products. DMSO as a topical solvent and therapeutic. MSM as a joint-health supplement in capsules.

The compounds are not inert. Robert Herschler filed the original MSM patents beginning in 1981.¹⁶ Stanley Jacob and colleagues documented clinical use in thousands of patients through the 1980s and 1990s, spanning joint pain, connective tissue disorders, allergy symptoms, and inflammatory conditions.¹⁷ Engelke and colleagues confirmed MSM presence in human cerebrospinal fluid and blood plasma using NMR spectroscopy.¹⁸

The paradigm question is not whether the compound works. The paradigm question is what selling it in isolation, at concentrations no food provides, without reference to the cycle it belongs to, represents.

It represents the same structure this work has criticized elsewhere. A compound is isolated from its biological context, manufactured industrially, marketed as a deficiency correction, and sold in a bottle. What goes unmentioned is that the entire industrial food and water infrastructure has been engineered to remove this compound from the eater’s diet, and that reversing that engineering is the actual solution. The bottle becomes a permanent product because the interruption of the cycle is permanent.

MSM in a capsule and MSM in raw pastured milk are the same molecule. What differs is everything around the molecule: the cofactor matrix, the whole-food delivery, the enzymes that survived the pasteurization that did not happen, the calcium and magnesium and fat-soluble compounds that arrived with it, the microbiome that would have processed it, the entire biological context that arrives when the cycle is intact. The supplement industry sells one molecule. The terrain framework asks for the whole system.

DMSO is a different case. It is not a nutritional compound but a pharmacological and physical agent with specific therapeutic uses documented across the medical literature from the 1960s onward. Applications include pain relief, transport of other substances through the skin, tissue repair, and uses in ophthalmology, dermatology, and musculoskeletal medicine.¹⁹ Its utility does not depend on framing it as a nutrient. Used as what it is, it is a genuine terrain-compatible tool. My book on DMSO covers the clinical applications and the suppression history in full; what belongs in this essay is only its position on the sulfur oxidation chain and the distinction between it and MSM.

The distinction matters. Reject the vitamin-and-supplement paradigm where it applies. Recognize a real pharmacological agent where the evidence supports one.

Practical Restoration

Six items, ranked roughly by strength of effect.

Live near the sea, or visit often. Coastal air carries the ambient DMS signal and its oxidation products in dilute form. Nineteenth-century sanatoria placed tuberculosis and convalescent patients on cliffs and coastlines for reasons the physicians observed clinically even though they could not name the chemistry. Whatever the sea air was doing then, it is still doing now. Coastline is free. A morning walk on wet sand delivers what no capsule ever will.

Eat raw and minimally cooked produce in season. Alliums such as garlic, onion, and leek. Crucifers such as broccoli, cabbage, kale, and Brussels sprouts. Sulfur-rich herbs. These foods deliver the sulfur amino acid backbone the body uses to build every sulfur-dependent structure. Raw or lightly steamed preserves what long cooking destroys.

Drink raw milk from pastured animals where legally accessible. The MSM is there. The living enzymes are there. The fat-soluble compounds are there. The intact matrix is there. Pasteurization removes all of it. This is not a supplement; it is a whole food that was, until very recently, the default form of dairy for most of human history.

Eat sulfur-rich whole foods for the amino acid backbone. Pastured eggs. Organ meats, particularly liver and kidney. Bone-in cuts and bone broth. Wild-caught fish. Grass-fed red meat. These supply methionine and cysteine, the sulfur amino acids that form the structural pool the body draws on. MSM is a delivery vehicle; the amino acids are the building material.

Use DMSO topically for the applications it is documented to serve. Pain, inflammation, tissue repair, transport of other therapeutic compounds through the skin. It is a real therapeutic with a real evidence base going back sixty years. Use it as what it is.

Sulfur springs, mineral baths, and hot springs where geography permits. Traditional healing practice worldwide, ignored by modern medicine, structurally consistent with what the sulfur cycle does. Not a substitute for food-chain delivery, but not nothing either.

None of these requires a bottle, and every one predates the supplement industry by centuries.

What the Reader Noticed

The reader’s aside about the magazine carried more weight than he may have known. He remembered New Scientist treating the sulfur cycle as knowledge to be transmitted, and noticed that the same magazine no longer does that. The chemistry has not changed since 1985. What has changed is what the science press does with knowledge like this. A person searching for information about MSM today finds advertising copy for capsules. A person searching for DMS finds either climate policy debates or industrial safety data sheets. The connective tissue is missing. The story of how the ocean feeds the land through the atmosphere, and how modern life has interrupted every step of that delivery, has been removed from public view.

The information is not classified. Every claim above sits in the mainstream literature and can be checked. What has been removed is the frame that lets a reader see the whole system at once. In its place: fragments of a story sold as isolated products, framed as isolated deficiencies.

The terrain paradigm is, in part, an insistence on putting the connective tissue back. Claude Bernard called it the milieu intérieur when he was working out the biology of internal regulation in the nineteenth century. Lovelock extended the same principle to planetary scale with his Gaia framework a hundred years later. And Purdey worked at the smallest scale of all, tracing the sulfur-manganese chemistry that broke down in his neighbors’ cattle when it did not break down in his. The principle operates the same way at every scale. Living systems are integrated systems, and health is what happens when the integration is intact.

Phytoplankton produce this molecule for their own cellular purposes. It escapes as gas, condenses in clouds, falls as rain onto pasture, and reaches the child through raw milk, where the sulfur takes up residence in connective tissue for a lifetime. This is what an intact biosphere does, and what a curious reader in 1985 could still be told.

How To Explain It To A 6 Year Old

Tiny plants in the ocean, so small you can’t see them, make a special kind of smell. That smell is what makes the beach smell like the beach. The smell rises up into the sky, gets turned into invisible bits of dust, and those bits help make the clouds. When the clouds rain, the rain carries something the plants on land need to grow strong. When you eat those plants, or when you drink milk from a cow that ate the grass, you get some of that same something too. It helps hold your body together, from your skin to your joints to everything in between.

Grown-ups have made the rain dirtier, they cook the food too long, they clean the milk in a way that takes the good part out, and they spray the plants with chemicals that stop the plants making the good part in the first place. So people don’t get as much as they used to. Then someone puts it in a little bottle and sells it back to them.

The best answer is to go to the beach, eat food that isn’t cooked to death, drink milk the way it comes out of the cow if you can, and remember that the ocean is helping you every time you take a breath of sea air.

Disclaimer: This essay discusses biochemistry, agricultural practice, and general nutrition. It is not medical advice. Anyone considering changes to diet, use of DMSO or other therapeutic agents, or consumption of raw dairy should educate themselves independently and consider their own circumstances. Nothing here is a treatment recommendation for any specific condition.

References

¹ Curson, A. R. J., et al. (2018). DSYB catalyses the key step of dimethylsulfoniopropionate biosynthesis in many phytoplankton. Nature Microbiology, 3(4), 430–439.

² Charlson, R. J., Lovelock, J. E., Andreae, M. O., & Warren, S. G. (1987). Oceanic phytoplankton, atmospheric sulphur, cloud albedo and climate. Nature, 326(6114), 655–661.

³ Lovelock, J. E., Maggs, R. J., & Rasmussen, R. A. (1972). Atmospheric dimethyl sulphide and the natural sulphur cycle. Nature, 237, 452–453.

⁴ Curson, A. R. J., Todd, J. D., Sullivan, M. J., & Johnston, A. W. B. (2011). Catabolism of dimethylsulphoniopropionate: microorganisms, enzymes and genes. Nature Reviews Microbiology, 9(12), 849–859.

⁵ Sunda, W., Kieber, D. J., Kiene, R. P., & Huntsman, S. (2002). An antioxidant function for DMSP and DMS in marine algae. Nature, 418(6895), 317–320.

⁶ Kettle, A. J., & Andreae, M. O. (2000). Flux of dimethylsulfide from the oceans: A comparison of updated data sets and flux models. Journal of Geophysical Research: Atmospheres, 105(D22), 26793–26808.

⁷ Barnes, I., Hjorth, J., & Mihalopoulos, N. (2006). Dimethyl sulfide and dimethyl sulfoxide and their oxidation in the atmosphere. Chemical Reviews, 106(3), 940–975.

⁸ Quinn, P. K., & Bates, T. S. (2011). The case against climate regulation via oceanic phytoplankton sulphur emissions. Nature, 480(7375), 51–56.

⁹ Herschler, R. J. (1990). Use of methylsulfonylmethane to enhance diet of an animal. United States Patent 5,071,878.

¹⁰ Herschler, R. J. (1986). Methylsulfonylmethane in dietary products. United States Patent 4,616,039.

¹¹ Nimni, M. E., Han, B., & Cordoba, F. (2007). Are we getting enough sulfur in our diet? Nutrition & Metabolism, 4, 24.

¹² Parcell, S. (2002). Sulfur in human nutrition and applications in medicine. Alternative Medicine Review, 7(1), 22–44.

¹³ Samsel, A., & Seneff, S. (2013). Glyphosate, pathways to modern diseases II: Celiac sprue and gluten intolerance. Interdisciplinary Toxicology, 6(4), 159–184.

¹⁴ Purdey, M. (1998). High-dose exposure to systemic phosmet insecticide modifies the phosphatidylinositol anchor on the prion protein: the origins of new variant transmissible spongiform encephalopathies? Medical Hypotheses, 50(2), 91–111.

¹⁵ Purdey, M. (2000). Ecosystems supporting clusters of sporadic TSEs demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant cofactors Cu, Se, Fe, Zn. Medical Hypotheses, 54(2), 278–306.

¹⁶ Herschler, R. J. (1981). Methylsulfonylmethane and methods of use. United States Patent 4,296,130.

¹⁷ Jacob, S. W., Lawrence, R. M., & Zucker, M. (1999). The Miracle of MSM: The Natural Solution for Pain. Berkley Publishing.

¹⁸ Engelke, U. F. H., Tangerman, A., Willemsen, M. A. A. P., et al. (2005). Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by one-dimensional ¹H and two-dimensional ¹H-¹³C NMR. NMR in Biomedicine, 18(5), 331–336.

¹⁹ Jacob, S. W., & de la Torre, J. C. (2015). Dimethyl Sulfoxide (DMSO) in Trauma and Disease. CRC Press.

Additional Sources

Cowan, T. S. Human Heart, Cosmic Heart. Chelsea Green, 2016.

Cowan, T. S. Cancer and the New Biology of Water. Chelsea Green, 2019.

Lester, D., & Parker, D. What Really Makes You Ill? Why Everything You Thought You Knew About Disease Is Wrong. Independently published, 2019.

Purdey, M. Animal Pharm: One Man’s Struggle to Discover the Truth about Mad Cow Disease and Variant CJD. Clairview Books, 2007.

Lovelock, J. E. The Ages of Gaia: A Biography of Our Living Earth. Oxford University Press, 1988.

Lovelock, J. E. The Revenge of Gaia. Penguin, 2006.

Price, W. A. Nutrition and Physical Degeneration. Price-Pottenger Nutrition Foundation, 1939.

Unbekoming. DMSO: The Persecuted Molecule. (Author’s book on DMSO.)

The Microbiologist. “The smell of the sea: how microbes shape Earth’s sulfur story.” Feature article, 2025.

Chemistry World. “The secrets of the sulfur cycle.” Feature article.

Germ theory has a test.

The Controlled Human Infection Model. Take the alleged pathogen from a sick person, transfer it to a healthy person by whatever route the theory says is sufficient, and observe whether the healthy person becomes sick.

Where the test has been run honestly, across every major disease attributed to microbial contagion, it has failed. Smallpox. Measles. Influenza. Yellow fever. HIV. SARS-CoV-2. Healthy volunteers deliberately exposed do not fall ill at the rates the theory predicts. They do not fall ill at all.

No Contagion is the catalogue of that failure. 258 controlled human infection experiments spanning three centuries — the studies germ theory’s defenders do not cite, the ones published and then quietly forgotten. Each entry documents the pathogen, the method, the exposure route, the number of subjects, and the outcome.

I’ve been a supporter of Jamie’s work long before I interviewed him last year — that interview turned out to be the most-read one I published in 2025. His research on contagion already existed as a long Substack piece. When I proposed bringing it to life as a printed book, I was over the moon that he agreed. My part was to publish and shape it into a book you can hand to someone. Then I wrote the foreword.

That was the point: to be the book you can put in front of a family member, a friend, and say “read this.” A physical book on a coffee table is not a tweet. It doesn’t get you the reflexive “conspiracy theorist” dismissal that anything online now attracts. It’s a book. It has an index. It has appendices. It reads like a reference. Because that’s what it is.

There is no shortage of books making the case against vaccination anymore. But too many of the good people leading that fight remain trapped inside the iron grip of virology and its evil twin, contagion. That is why this book matters. That is why I was so motivated to do it with Jamie.

The Index of Diseases at the front lets a reader look up any specific disease — measles, polio, chickenpox, whooping cough, cholera, HIV — and jump straight to the studies that tested it. Grouped under three headings: What medicine calls Viruses, then Bacteria and Parasites.

The two case appendices at the back — developed for this edition — go deep on the two most-cited epidemics in the germ theory record. Appendix I documents the connection between polio and the arsenic-DDT pesticide era, 1869 to 1960 — a pesticide-poisoning history sold as a viral epidemic. Appendix II covers the 1918 flu — First World War chemical warfare and the Rockefeller Institute’s meningitis vaccine trial at Camp Funston. The “what actually happened” answer for the two events germ theory keeps pointing to.

Jamie wrote his own launch post yesterday from his side of the collaboration — read it here.

The book is on sale now, print only, ships worldwide in 3-5 business days:

Buy No Contagion on Lulu

Buy one to keep. Buy one to give away.

In 1908, a Russian physician published a novel in which a Martian astronomer, in the course of arguing for the extermination of Earth’s population, made the following observation about socialism: any regime established in isolated countries surrounded by a hostile capitalist sea would be “perverted deeply and for a long time to come by years of encirclement, unavoidable terror and militarism, and the barbarian patriotism that is their inevitable consequence.” Nine years later, the Bolshevik Revolution took place. Twenty years later, Stalin’s consolidation fulfilled the description almost exactly. The novel was Red Star, and its author was one of the original twenty-two Bolsheviks Lenin had gathered in Switzerland four years earlier to build a disciplined revolutionary group. The Indiana University Press edition of 1984, edited by Loren R. Graham and Richard Stites, collects Red Star, its 1913 prequel Engineer Menni, and a 1924 poem sketching a third novel Bogdanov never completed.

Alexander Bogdanov (1873–1928) took his medical degree in 1899 after studying science and psychology in Moscow and Kharkov. By that point he had already moved from Populism into Marxism and was working in the underground network of the Russian Social Democratic Party. Among the Social Democrat leaders he was one of the best informed about actual factory conditions inside Russia, having spent the years 1904 to 1907 running the underground cells while Lenin remained in emigration. He broke with Lenin over both philosophy (his embrace of Ernst Mach’s epistemology in a system he called empiriomonism) and tactics (his insistence that armed uprising remained possible after 1907). Lenin answered the philosophy in the polemical Materialism and Empiriocriticism (1908). The tactical dispute ended their partnership permanently. Bogdanov went on to teach at the Capri school for workers with Gorky and Lunacharsky, to write the three-volume Tektology now cited as an early sketch of cybernetics and systems theory, and in 1926 to found the Institute for Blood Transfusion. He was written out of the official Bolshevik story after his death and not reprinted in the Soviet Union for nearly fifty years.

The novel appeared in the aftermath of the failed 1905 Revolution, at a moment when the Tsarist regime had answered a nationwide uprising with martial law, drumhead trials, punitive expeditions, and the massacre of the radical wing. Bogdanov saw what superior military technology could do against insufficiently armed forces, and his tactical quarrel with Lenin over whether the revolution was over drew him toward the writing of a utopia. The Russian science fiction of the period was already crowded with visions of Mars, drawing on Giovanni Schiaparelli’s canali observations and Percival Lowell’s Mars and Its Canals (1906). Kurd Lasswitz had brought large-eyed Martians to Earth in 1897; H.G. Wells had published War of the Worlds in 1897–98; Konstantin Tsiolkovsky was publishing on space flight in the same years. What Bogdanov added to this tradition was a fully worked communist utopia on the red planet, complete with a Central Institute of Statistics that computed labor requirements hour by hour and broadcast them on shifting display boards at every factory. Beneath that surface, without announcement, he installed a second story about the problems the utopia had not solved.

Bogdanov’s political defeat did not end his influence, which arguably grew more consequential after 1928 than during his life. Tektology, his proposed universal organisational science, is now cited by systems theorists as the precursor to Ludwig von Bertalanffy’s General Systems Theory and Norbert Wiener’s Cybernetics. He devised Input-Output Analysis, the technique for tracking circulatory flows through a system, decades before Wassily Leontief received a Nobel Prize for its formal development. A version of the Gaia Hypothesis appears in his work long before Lovelock formalised it. I came to Bogdanov through the work of esc, whose Substack has documented the continuous line from Bogdanov’s twin projects (Tektology as the science of organisation, Proletkult as the cultural and educational arm) to the contemporary machinery of Adaptive Management embedded in pandemic planning, environmental policy, supply chain governance, urban planning, and the Digital Twin architecture of the Fourth Industrial Revolution. What esc calls “second-order Marxism,” the embedding of Marxist analytical principles into scientific, systemic, and institutional structures rather than their explicit teaching, is precisely the framework Bogdanov proposed to Lenin as an alternative to violent class struggle. Lenin rejected it. Its principles now run through the pipeline connecting the ICSU (now the ISC) to UNESCO to the school curriculum. The utopian architect who lost the political fight quietly won the organisational one.

Bogdanov’s acknowledged place in the historical record remains his role as the founder of Soviet science fiction. Darko Suvin has called him the progenitor of the entire genre, whose 1920s explosion produced roughly two hundred works largely reworking his themes; Zamyatin’s We (1920) is an emphatic repudiation of the utopia, Alexis Tolstoy’s Aelita an inversion.

The full summary unpacks the material behind the 1908 prophecy of encirclement-perverted socialism; the dystopian second layer of the Martian utopia (radioactive fuel depletion, forests destroyed for minerals, suicide clinics generated by medical life extension, tragedy as the planet’s favorite dramatic form); and the extermination debate in which the astronomer Sterni argues for the annihilation of Earth’s population and Netti replies with what Graham reads as an early ecological defense of irreplaceable biological and cultural diversity. On April 7, 1928, Bogdanov exchanged his own blood with that of a young student suffering from malaria and tuberculosis, continuing to take clinical notes on his own condition until the last minutes of his life. It was one day after Stalin’s Central Committee plenum on the Shakhty trial, which prosecuted engineers along the lines Bogdanov’s Engineer Menni had described as “wrecking” fifteen years earlier.

Read more

Author’s Note

This essay operates in two registers. When examining what the establishment claims, I use its vocabulary (virus, isolation, contamination, promoter) to show where the establishment’s own evidence contradicts its story. When stating my own view, I use terrain language. The body is a self-healing organism poisoned by four things: toxic exposure, nutritional depletion, electromagnetic radiation, and psychological strain. Injection of foreign biological matter is toxic exposure of the most direct kind. Cancer is what happens when the cell’s internal environment is corrupted by that exposure. SV40, in both its imagined and manufactured forms, is a mechanism for delivering that corruption.

Two groups argue online about SV40, and neither has the whole story.

One group says SV40 is imaginary. A monkey virus that was never isolated and never shown to cause disease. The other waves plasmid maps and points to Kevin McKernan’s laboratory findings of “SV40 promoter sequences” inside Pfizer mRNA vials, and calls the first group unhinged.

Sasha Latypova, a former pharmaceutical industry executive who has spent the last four years documenting the manufacturing fraud behind the covid injections, has done something more useful than pick a side. She has explained what both groups are actually looking at.¹

The natural monkey virus called SV40 was never isolated. The bubbles the Merck scientists photographed in 1960 and named “vacuolating virus” were cellular debris in a dying culture of the wrong species of monkey. Nothing was purified from a sick person and shown to cause disease.

The chemical compound sold today under the label “SV40 promoter” is an industrial construct. It has almost nothing in common with the 1960 bubbles except the name. It is a stack of synthetic DNA sequences built on ceramic beads through automated washes of acids, solvents, and corrosive reagents, designed to force a target cell into rapid, chaotic division.

Both truths point in the same direction. The story of SV40 is the story of an industry that learned how to manufacture cancer by injection and built a regulatory framework to protect the practice.

Audio Deep Dive (for Paid Subscribers)

Two Things Are Being Called SV40

The confusion is entirely upstream of the science. It sits in the word itself.

When people say “SV40,” they might mean one of two things.

The first meaning is historical. A monkey particle allegedly discovered in 1960 by Merck scientists Ben Sweet and Maurice Hilleman, which they called “vacuolating virus” because it caused foamy bubbles (vacuoles) in the kidney cells they were poisoning. This is what Herbert Ratner and Michele Carbone would later look for in preserved 1955 Salk polio vaccine vials.¹

The second meaning is chemical. A class of synthetic DNA constructs designed decades later to drive cells into rapid division. This is what Kevin McKernan detected in Pfizer mRNA vials in 2023. McKernan, a geneticist whose laboratory ran the first independent sequencing of the covid injection contents, found the sequences at nanogram-to-microgram quantities per dose. This is a product of chemical manufacture, not a biological entity.

The two things do not share a lineage. The chemical was not extracted from the monkey. The chemical was designed. Once the functional effects of the 1960 “bubbles” were experimentally described (irritation, rapid division, abnormal cellular structures), laboratories began building synthetic constructs that would produce those same effects on command. Today’s SV40 promoter is a chemical tool, sold by biotech supply catalogs, with a family tree that runs through automated DNA synthesis equipment and not through any monkey.¹

Both of the arguing groups are right about their own object. One is right that no natural monkey virus was ever isolated. The other is right that a chemical labeled “SV40” exists and turns up where it should not. Both truths damn the establishment story. Neither truth requires the other.

Peyton Rous and the Prize for a Population Weapon

To understand where SV40 comes from, follow the Nobel money back to 1911.

Peyton Rous, a young pathologist at the Rockefeller Institute in New York, was handed a Plymouth Rock hen with a sarcoma. He minced the tumor, passed the extract through a filter fine enough to remove all visible cells, and injected the cell-free filtrate into healthy chickens. Some of them developed tumors.²

Rous concluded that an invisible causative agent had been transmitted. He himself hedged, conceding in his 1911 paper in the Journal of Experimental Medicine that “an agency of another sort is not out of the question.”² Mark Bailey, reviewing the paper more than a century later, points out that Rous did not isolate anything, and that his own control experiments (which used unfiltered tumor material) produced larger tumors than the filtered version. The experiment demonstrated something simpler than a viral agent. It showed that diseased tissue introduced by an unnatural route into another animal can cause that animal to exhibit a similar disease process.²

The finding was ignored as a curiosity for over half a century. Then, in 1966, the Nobel Committee awarded Rous the Prize in Physiology or Medicine. What had changed was not the evidence. What had changed was the industry.

By the mid-1960s the pharmaceutical sector had discovered the marketing power of the phrase “cancer-causing virus.” If cancer had a viral agent, then a vaccine could be developed. If a vaccine could be developed, patents could be filed. If patents could be filed, indemnified markets could be captured. Rous’s Prize was the seal on an industrial hypothesis, and it launched a search that continues to consume public research budgets to the present day.

The mechanism Rous had described was straightforward once stripped of viral framing. Introduce cell-free filtrate (ground-up organs and tumors passed through a fine filter) into the bloodstream or organs of another animal by injection, and that animal’s cells will do what cells do when foreign biological matter reaches them. They will attempt to expel the material. In the process some of them will divide chaotically, and some of those divisions will produce tumors.

Rous had discovered how to induce cancer by injection. The industry called it a virus and gave him a Prize.

Bernice Eddy and the Mouse Experiments

Bernice Eddy is often remembered as a public health heroine. She was the government scientist at the U.S. National Institutes of Health who, in 1954, warned her superiors that Salk’s polio vaccine was paralyzing test monkeys. She was ignored. The vaccine was released. Within weeks children began developing polio from the injections.³

The rest of Eddy’s work is quieter in the historical record and more important. Through the late 1950s she injected mice with ground-up organs of other mice known to contain leukemia, and she observed the development of aggressive, unrelated tumors. Cancers that appeared faster and struck younger animals than anything seen in nature.

Sasha Latypova reads Eddy’s work through a colder lens. A brick does not know what building it is holding up. That is the point of compartmentalization, and it is how large research apparatuses are organized. In the 1950s the U.S. government’s biologics division sat inside a broader research apparatus that also funded covert chemical and biological weapons programs. Eddy worked inside that apparatus. The stated purpose of her mouse experiments was to find the cause of cancer so that a cure could be developed. The operational reality was that she was building the mechanism for inducing cancer reliably, aggressively, and at younger ages, by injection.

Eddy may have been sincere in the stated purpose. That does not change what her results were used to build. Her mouse experiments were preserved and scaled by an industry that had been given the marketing hypothesis (cancer-causing virus) and the regulatory infrastructure (mass vaccine rollout) to deploy them. The brick did its job. The building went up.¹

Eddy did whistleblow, in her limited way, when she found that the Salk vaccine was causing tumors in test hamsters. She was silenced by her superiors and forced out of polio research. The work she did on inducing tumors by injection did not stop. It became the foundation of an industry.

What Merck Actually Photographed in 1960

This is where the first argument (no natural virus was ever isolated) becomes concrete. The original 1960 paper by Sweet and Hilleman is a peculiar document. It declared the existence of a previously undetectable monkey virus and named it “vacuolating virus SV40.” SV stood for “simian virus.” The 40 was for the fortieth such alleged agent cataloged.¹

Two features of the paper deserve close attention.

First, the alleged virus was not detected in the monkey species it was said to infect. Rhesus monkey kidney cells (the substrate on which Salk’s polio vaccine was grown) did not display the effect. Instead, the effect appeared when material from those cells was inoculated onto kidney cells of a different monkey species. Grivet monkeys. African green monkeys. In these cells the cultures developed vacuoles, foamy bubbles that Merck interpreted as evidence of viral replication.¹

Second, the Merck team ran no control experiments. They did not perform the same procedure on cultures that had never been exposed to Salk material. They did not test whether the vacuolation was produced by the culture conditions themselves, by the starvation and antibiotic poisoning and mechanical trauma that make up the standard virology protocol. Sasha Latypova reads the methods section plainly. What Merck produced was foam in dying cell cultures.¹

Foam is what breaking cells do. When cells are starved, poisoned, and mechanically disturbed, they release internal contents, form vesicles and vacuoles, and eventually disintegrate. This process is called cytopathic effect in the virology literature, and it is attributed to viral invasion. The same process occurs, at identical rates, in cultures that have never been exposed to any patient material. Stefan Lanka has demonstrated this with control experiments that produced the “measles virus” cytopathic effect using nothing but the standard laboratory poisoning protocol.⁴

The 1960 Merck paper established the existence of “SV40” the same way virology has established every alleged virus. By declaring cellular breakdown to be a biological entity. The “vacuolating virus” was cellular debris in a dying culture.

That declared entity, foam in the wrong species of monkey, was then used to justify sixty years of cancer research, and eventually to name the synthetic construct McKernan would detect in the covid injections.

The Ratner Vials and the Carbone Analysis

The Ratner-Carbone finding is where the two arguments start to look like they might collide. Herbert Ratner, director of the Oak Park Health Department in Illinois, kept a small cardboard box of Salk vaccine vials in his refrigerator from 1955 until his death. He was one of the few figures in American public health who did not trust the vaccine, and he preserved the vials because he suspected that whatever was in them would need to be examined by future generations who had not been captured by the story.³

In 1997, Ratner gave some of the vials to Michele Carbone, a molecular pathologist. Carbone tested them using PCR, a technique that did not exist in 1960 and one that has significant limitations. What Carbone found, published in 1999, was that the 1955 vials contained two versions of “SV40.” One with a single 72-base-pair enhancer sequence, one with two.¹

Two problems with Carbone’s finding are worth stating directly.

The first is methodological. Testing biological material that has sat in a refrigerator for forty-four years is not testing what was originally in the vial. Whatever process of degradation, contamination, and interaction occurred over four decades produced the material Carbone tested. What Carbone found in 1999 is not necessarily what Ratner had put in his refrigerator in 1955.

The second problem is deeper. PCR does not detect whole organisms. It works by looking for short fragments of nucleic acid that match a reference sequence programmed into the test. When a laboratory says it “found SV40” in a sample, what it means is that it found sequences that match a database entry labeled “SV40.” The database entry itself was assembled from earlier PCR runs on earlier cultures, tracing back eventually to the 1960 Merck bubbles. The whole chain rests on the assumption that a real organism corresponds to the database sequence. If no such organism ever existed, PCR is chasing an echo of an assumption.¹

What Carbone actually demonstrated is that the 1955 vials contained genetic material matching an established laboratory reference. That is a real finding. It does not establish that a natural monkey virus existed. It establishes that whatever chemical, biological, or degradation products were in the Salk vaccine vials produced sequences resembling the reference. That is enough to indict the vaccine, a vaccine that was administered to tens of millions of Americans between 1955 and 1963 and to millions more worldwide. What was in it is not what the public was told was in it.

The children of Niles, Illinois, eight of whom developed leukemia in the years after their 1955 vaccinations, knew this before anyone had the tools to test for it.³

What Schaeffer Actually Demonstrated

Standard oncology places the cause of cancer in the cell nucleus. Damaged DNA, activated oncogenes, mutations accumulated over years, all located, as the theory has it, in the genetic code. This framing has consumed sixty years of federal cancer research budgets and produced little clinical improvement.

Two experiments in the late 1980s should have ended the genetic theory. Warren Schaeffer at the University of Vermont and Jerry Shay at UT Southwestern independently performed nuclear transfers between cancerous and healthy cells.⁵ The design was straightforward. Take the nucleus of a cancer cell, containing all the mutated DNA supposedly driving the cancer, and transplant it into a healthy cell whose own nucleus had been removed. Do the reverse. Observe.

Cancerous nucleus in healthy cytoplasm produced one tumor out of sixty-eight recipient cells. Healthy nucleus in cancerous cytoplasm produced cancerous cells ninety-seven percent of the time.

The disease was not in the nucleus. It was in the cytoplasm, the watery, mitochondrial, structured interior of the cell where division actually takes place. The mechanism by which that interior loses the electrical charge and gel-phase structure that respiration requires is developed at length in What Is Cancer? in this series, drawing on Cowan, Pollack, Warburg, and Riddick.⁶ For present purposes, only the endpoint of that chain matters. When the cytoplasm loses its structure, mitochondria cannot respire. Cells shift to fermentation. The body walls off the region. The wall is what medicine calls a tumor.

Sasha Latypova has read Schaeffer’s experiment for what it actually shows.¹ Seyfried cites it as evidence for his metabolic theory of cancer. He does not ask what property of the transferred material produced the ninety-seven percent effect. Latypova asks. What Schaeffer did, mechanically, was introduce foreign cytoplasmic material across the membrane of a healthy cell (proteinaceous debris, damaged organelles, fragments of no identified provenance). The recipient cell attempted to expel what it could not identify as its own, divided haphazardly in the process, and passed the compromised state to its descendants. This is a model of transfection. Schaeffer performed it with a pipette and cancerous cytoplasm. An injection performs it with a needle and whatever is in the vial.

The lipid nanoparticle platforms industrialize this. LNPs were built to solve the very problem Schaeffer’s setup addressed manually: the cellular barriers that historically limited how much injected material reached the cytoplasm. The stated design purpose of the platform is transfection.⁷ What Schaeffer’s experiment demonstrated is what a cell does after transfection has occurred. His result was the tumor.

The “SV40 promoter” sequences McKernan detected are not incidental contaminants. They are functional tools. Their purpose in manufacturing is to force cells to import and process the surrounding chemical cargo. Their effect on a living cell, once injected, is to do the same thing at scale. Every recipient cell that took up an LNP performed the Schaeffer transfer on itself. What pathologists began reporting in 2021 is the population-scale endpoint of that operation.¹

The mainstream position calls this an unfortunate contamination. The mechanism suggests something more direct.

What “Synthetic SV40” Actually Is

This is what the second argument (SV40 exists as a chemical in the vials) is pointing to. The modern SV40 construct is not a virus. It is not even biology. It is a specific stack of chemical residue on a ceramic bead.

Sasha Latypova has provided the clearest description of oligonucleotide manufacturing to appear in general circulation. The process bears no resemblance to any biological event. It resembles semiconductor manufacturing, and it uses some of the same equipment.¹

The synthesis begins with a small ceramic bead that carries one of four starting molecules, described as the “letters” of DNA. The bead is subjected to sequential chemical washes in a fully automated reactor. Each wash adds one more molecule to the growing chain.

The reagents used at each step are all industrially hazardous. Trichloroacetic acid in dichloromethane serves as the deprotection wash, a corrosive acid combined with a carcinogenic solvent. Tetrazole and its derivatives activate the coupling step, all explosive or flammable and all classified as respiratory irritants. Acetic anhydride and N-methylimidazole cap the unreacted chains, both causing severe skin burns on contact. Iodine dissolved in water, pyridine, and tetrahydrofuran oxidizes the phosphate backbone, the latter two being flammable carcinogens. Final cleavage is performed with ammonium hydroxide, sometimes combined with methylamine, both severely corrosive.¹

The chain grows through hundreds of these wash cycles. Each one adds one base while contributing measurable error rates. Manufacturers claim per-step efficiency of 99 to 99.5 percent. Compounded across hundreds of steps, that efficiency collapses.

After 10 bases, roughly 90 percent of the resulting molecules are correct. After 50 bases, roughly 60 percent. After 100 bases, roughly 37 percent. At 200 bases, the typical length of a commercial building block, the fraction of perfectly-formed molecules is a minority. The rest are errors. Partial chains, mis-inserted bases, side reactions with the toxic solvents that leave chemical modifications no one intended and no one tests for.¹

The “SV40 promoter” delivered in mRNA injections is a sequence roughly 500 base pairs long, assembled from multiple smaller fragments and stitched together using PCR. Each fragment carries its own error distribution. The final construct is a chemical soup of intended sequence, misassembled variants, and impurities from every solvent used in every wash. This is what is being injected into people, alongside the surrounding lipid nanoparticle payload, at concentrations several orders of magnitude above anything that would ever appear from a biological source.

The oligonucleotide industry sells these constructs for laboratory use with explicit disclaimers that they are not for medical purposes. Even when a manufacturer claims cGMP (current good manufacturing practice) compliance, the guarantee typically covers only 60 to 70 percent of the product shipped. The regulatory pathway that allowed such material to be injected into hundreds of millions of people during the covid rollout is documented in Sasha’s earlier work on the U.S. Department of Defense contracts and the PREP Act indemnification structure.¹ ⁷

The relevance for SV40 is precise. Whatever effects the modern “SV40 promoter” produces in a recipient’s cells (cellular irritation, forced import of foreign chemical material, aberrant division, disruption of cellular architecture) are produced not by a virus but by a stack of industrial chemicals with declared carcinogenic and toxic properties, delivered directly to the cytoplasm and nucleus by design.

The mainstream story asks whether there is SV40 contamination in the mRNA injections. The correct question is what this chemical is, what it does to cells, and why it is being injected into anyone at all.

The Closed Loop

The pattern that emerges once the pieces are placed side by side is not a series of accidents.

Peyton Rous demonstrates in 1911 that injecting cell-free filtrates of ground tumor tissue produces tumors in recipient animals. The industry names his finding a virus. Bernice Eddy in the 1950s establishes that injecting cellular material from leukemic mice produces aggressive tumors in unrelated tissues in healthy mice. The Salk polio vaccine, grown on monkey kidney cells, is administered to over a hundred million people. Sweet and Hilleman at Merck, in 1960, find “SV40” in the vaccine. Foam in the wrong species of monkey, declared to be a virus, quietly acknowledged behind closed doors, publicly denied. The vaccine is left on shelves for another eighteen months while a substitute is prepared. The 1955 vials are almost all destroyed. The children of Niles begin developing leukemia. Herbert Ratner keeps his refrigerator running.

The Rous Nobel Prize is awarded in 1966. The cancer-causing-virus framework becomes the organizing hypothesis of cancer research for the next half-century. Federal research dollars flow into virus hunting. The chemical structure of the “SV40” construct is worked out through the 1970s and 1980s. By the 1990s the sequence is available in laboratory supply catalogs as a promoter tool. Automated DNA synthesis technology, developed alongside the semiconductor industry, allows manufacturers to produce the construct on demand.

The covid mRNA injections, developed under U.S. Department of Defense contracts and delivered to billions of people worldwide, contain synthetic SV40 promoter sequences at concentrations that surprised even the researchers who found them. Regulators acknowledge the presence of the sequences and decline to act on the finding. The PREP Act, passed in 2005, protects the manufacturers from liability. Judges have ruled that the presence of undeclared toxic ingredients in vaccine vials does not constitute willful misconduct, because it is the U.S. government’s policy to permit those ingredients to be there.¹ Sasha Latypova has argued that the amplification of the SV40 story itself serves to focus outrage on Pfizer while shielding the U.S. Department of Defense program that produced the injections.¹

The loop is closed. What Rous demonstrated with a syringe and a chicken has been industrialized. Injection of foreign biological and chemical material into healthy people produces cancer, at scale, in a population that has been told the injections prevent disease. The Nobel Prize identified the mechanism, the industry scaled it, and the regulatory apparatus protected the whole arrangement.

What Is Being Delivered Now

What the pathologists are calling turbo cancer is what this mechanism looks like at population scale. Aggressive tumors in young patients, multi-focal presentations, recurrences within weeks of surgery: the pattern falls out of the same causal chain, compressed onto a shorter timeline. SV40 is not the whole input. The Diblasi analysis published in 2024 cataloged fifty-five other undeclared chemical elements in the injectables, twelve of the fifteen lanthanides among them. The fuller mechanistic and clinical picture is developed in What Is Turbo Cancer? in this series.⁸

The word “SV40,” first attached to bubbles in a dying monkey kidney culture, later attached to a synthetic chemical designed to force cellular division, is what ties the historical origin to the present product.

Both groups arguing online are right about the piece of the story they can see. The natural monkey virus never existed. The synthetic chemical does exist and is now inside a substantial fraction of the world’s population. Neither fact is the whole picture. The whole picture is that “cancer-causing virus” was a marketing invention that grew into a manufacturing capability, and the population is the market.

The document is publicly available. The signatures are on it. The mechanism was published in 1911. The children of Niles were the first cohort. They were not the last.

How To Explain It To A 6 Year Old

Imagine a story with two versions.

In the first version, a scary monster is hiding inside your body. You cannot see it. Scientists say they found it long ago in some monkeys, and it might give you cancer. They want to make a medicine to fight it.

In the second version, there was never a monster. What the scientists found in the monkeys was just broken pieces of the monkeys themselves, because the scientists had poisoned the monkey cells to make them break. They mistook the broken pieces for a monster.

But here is the strange part. The scientists took what they thought was the monster shape, and they built something new. A real chemical, made in a factory, still called by the monster’s name. When they mixed this factory chemical into other medicines, it made cells go wild and grow into lumps.

The monster was never real. The factory chemical is real, and it is being put into things and given to people. Both things are true at the same time. That is what makes the story confusing, and that is what this essay is about.

References

¹ Sasha Latypova, “’SV40’: How to turn bubbles into a vaccine injury cover up and a multi-billion industry, too,” Due Diligence and Art, July 2026. See also Latypova, “The SV40 Promoter in Covid Injections,” September 2023, and “Breaking: Pfizer is going under the bus...,” October 2023, for the argument that the SV40 discourse itself has been amplified as a Pfizer-focused distraction from the broader Department of Defense program. See also Latypova, “Is cancer a metabolic disease? Critical review of Dr. Thomas Seyfried’s presentation,” Due Diligence and Art, April 2026, for the transfection reading of the Schaeffer cytoplasm-transfer experiment.

² Peyton Rous, “A Sarcoma of the Fowl Transmissible by an Agent Separable from the Tumor Cells,” Journal of Experimental Medicine, 1911. Analysis by Mark Bailey in A Farewell to Virology (Expert Edition), September 2022, and in Mark Gober, Sam Bailey, Mark Bailey, and Stefan Lanka, An End to Upside Down Medicine, Waterside Productions, 2023.

³ Helen Ratner Dietz, “Salk vaccine cover-up resonates today,” Oak Leaves, July 20, 2005. See also Torsten Engelbrecht, Claus Köhnlein, Samantha Bailey, and Mark Bailey, Virus Mania, third edition, 2021.

⁴ Stefan Lanka, control experiments on the measles virus cytopathic effect, documented in Mark Gober et al., An End to Upside Down Medicine, Waterside Productions, 2023.

⁵ Israel BA, Schaeffer WI, “Cytoplasmic suppression of malignancy,” In Vitro Cellular & Developmental Biology, 1987;23(9):627–632. Howell AN, Sager R, “Tumorigenicity and its suppression in cybrids of mouse and Chinese hamster cell lines,” Proceedings of the National Academy of Sciences, 1978;75(5):2358–2362. See also Thomas Seyfried, Cancer as a Metabolic Disease, Wiley, 2012, for the broader metabolic framework in which the Schaeffer experiment is typically cited.

⁶ Unbekoming, “What Is Cancer? An Essay on the Warburg Shift, the Cytoplasm, and the Particle in the Vial,” Lies are Unbekoming, July 2026.

⁷ Sasha Latypova, extensive documentation on the covid-19 countermeasure programs, U.S. Department of Defense contracting, PREP Act indemnification, LNP platform design, and manufacturing quality failures, published across Due Diligence and Art, 2022 through 2026.

⁸ Unbekoming, “What Is Turbo Cancer? An Essay on the Cocktail in the Vial, the Cation Charge State, and the Cancer That Is Not New,” Lies are Unbekoming, July 2026.

Additional Sources

Michele Carbone and colleagues, “SV40-Like Sequences in Human Bone Tumors,” Oncogene, 1996. Carbone and Ratner analysis of preserved 1955 Salk vaccine vials, published 1999.

B.H. Sweet and M.R. Hilleman, “The Vacuolating Virus, S.V. 40,” Proceedings of the Society for Experimental Biology and Medicine, 1960.

Kevin McKernan, “Sequencing of bivalent Moderna and Pfizer mRNA vaccines reveals nanogram to microgram quantities of expression vector dsDNA per dose,” Anandamide Substack, 2023.

Otto Warburg, “On the origin of cancer cells,” Science, 1956.

Thomas Cowan, Cancer and the New Biology of Water, Chelsea Green, 2019.

Thomas Cowan and Sally Fallon Morell, The Contagion Myth, Skyhorse, 2020.

Dawn Lester and David Parker, What Really Makes You Ill?, independently published, 2019.

Christopher Exley, “The toxicity of aluminum in humans,” Morphologie, 2016.

Herbert Shelton, Natural Hygiene articles on vaccination and anaphylaxis.

Lida Mattman, Cell Wall Deficient Forms: Stealth Pathogens, CRC Press, 2000.

Diblasi J, et al., “True or False? At Least 55 Undeclared Chemical Elements Have Been Detected by ICP-MS in COVID-19 ‘Vaccines,’” International Journal of Vaccine Theory, Practice, and Research, 2024.